University of Louisville

ThinkIR: The University of Louisville's Institutional Repository
Electronic Theses and Dissertations
12-2015

Functional characterization of Aggregatibacter
actinomycetemcomitans QSEBC : a bacterial adrengeric receptor
and global regulator of virulence.
Whitney Weigel

Follow this and additional works at: https://ir.library.louisville.edu/etd
Part of the Bacteriology Commons

Recommended Citation
Weigel, Whitney, "Functional characterization of Aggregatibacter actinomycetemcomitans QSEBC : a
bacterial adrengeric receptor and global regulator of virulence." (2015). Electronic Theses and
Dissertations. Paper 2296.
https://doi.org/10.18297/etd/2296

This Doctoral Dissertation is brought to you for free and open access by ThinkIR: The University of Louisville's
Institutional Repository. It has been accepted for inclusion in Electronic Theses and Dissertations by an authorized
administrator of ThinkIR: The University of Louisville's Institutional Repository. This title appears here courtesy of the
author, who has retained all other copyrights. For more information, please contact thinkir@louisville.edu.

FUNCTIONAL CHARACTERIZATION OF AGGREGATIBACTER ACTINOMYCETEMCOMITANS QSEBC: A
BACTERIAL ADRENERGIC RECEPTOR AND GLOBAL REGULATOR OF VIRULENCE

Whitney Weigel

A Dissertation Submitted to the Faculty of the School of Medicine of the University of
Louisville in Partial Fulfillment of the Requirement for the Degree of

Doctor of Philosophy
In Microbiology & Immunology

Department of Microbiology and Immunology
University of Louisville
Louisville, Kentucky

December 2015

i

ii

FUNCTIONAL CHARACTERIZATION OF AGGREGATIBACTER ACTINOMYCETEMCOMITANS QSEBC: A
BACTERIAL ADRENERGIC RECEPTOR AND GLOBAL REGULATOR OF VIRULENCE
By
Whitney Weigel
A Dissertation approved on
October 29, 2015
by the following Dissertation Committee:

Donald Demuth (Dissertation Director) ___________________________________________

Pascal Alard (Co-mentor)_______________________________________________________

David Scott__________________________________________________________________

James Graham_______________________________________________________________

Matthew Lawrenz_____________________________________________________________

iii
ii

ACKNOWLEDGEMENTS
There are so many people who made this possible without which I would not be in the
position I am today, and for all these people I am grateful. First and foremost, I want to thank Dr.
Don Demuth for all of his support, kindness and understanding. I can’t imagine having had as
wonderful an experience nor learning as much as I have under a different mentor. I have always
appreciated your patience and openness in helping students and really look up to your abilities
as a scientist and mentor. Whenever I think of how I can try to be a better scientist and writer, I
try to think of what you would do.
I’d also like to thank all my committee: Dr. Pascale Alard, Dr. James Graham, Dr. David
Scott and Dr. Matt Lawrenz. Thank you Dr. Alard for being my co-mentor, giving me an
appreciation for immunology, and for the experience of working briefly in your laboratory. Dr.
Graham, thank you for the advice on working with RNA, especially, but for other technical issues
as well. Thank you Dr. Scott for teaching me to be more detailed in my work, for looking out for
me and also for all the times hanging out at the bar. Dr. Lawrenz, I wish I would have had time to
work with you more particularly on the luciferase experiments I wanted to do. Thank you also for
getting me in touch with Dr. Guo and Dr. Dersch. I have enjoyed my conversations with all of you
on both a professional and personal level.
Besides Dr. Demuth, the two people who had the greatest impact in shaping me as a
scientist are Drs Ascension Torres-Escobar and Maria Delores Juarez-Rodriguez. You were always
so patient and helpful to me, and I hope one day to have even a fraction of your talent, precision
and dedication. I’d also like to thank Liz Novak who was my student mentor when I started the
Ph.D. program in Dr. Demuth’s lab. Thank you for being so patient. Even though you were always
so busy, you took the time to help me. Thank you also to all the members of lab, both former

iv
iii

and current. Particularly, thank you to Blair Schneider who was always willing to help me, answer
my questions or even just talk and hang out. Thank you also to Julie Tan. You always work so
hard on your own project, but at the same time you make sure all of our stuff is ordered and the
lab runs smoothly. Taylor Johnston, thank you for being my first student to train and for having
patience with me while I try to figure out this whole mentor thing. My experience in lab would
have been so different without all of you.
To the Microbiology and Immunology department, I’d like to thank you for taking a risk
on a student with very little science background and admitting into the program and for making
this department an amazing one. To the Oral Immunology and Infectious Diseases department, I
don’t think any other department is as close knit and friendly as this one. Thank you to every
one of the PI’s, the lab members, and the staff for being so friendly and also encouraging each
other to be better scientists. Thank you especially to Barbara Potempa for always looking out for
me. You were like my mom at work and always made my day.
To the former members of the department, Jeremy Camp, Iris Zeller and Justin
Hutcherson, thank you for helping me to be a better scientist, listening to my rants, and being
really good friends. I miss you all.
I probably would not be here today if it wasn’t for you Dr. Quin Chipley. You are true
professional and great at what you do. Thank you for just listening. I will miss you.
On a personal note, I’d like to thank my mother for inspiring and showing me that a
woman can be independent and smart. Thank you also to all my friends and family. I’d also like
to thank my partner, Kwame Hagan, who has stood by me and supported me through very trying
times while I finish this. Your love and patience has given me the strength to do something I
didn’t know I was capable of doing.
Lastly, to all the groups we have collaborated with: the UofL sequencing core, the

viv

microarray core, the metabolomics core, and Dr. Guo, thank you for sharing your expertise and
skills to make these studies possible.
Thank you everyone, listed and unlisted who supported me. I wouldn’t be here today
without you.
-Whitney

vi
v

ABSTRACT
FUNCTIONAL CHARACTERIZATION OF AGGREGATIBACTER ACTINOMYCETEMCOMITANS QSEBC: A
BACTERIAL ADRENERGIC RECEPTOR AND GLOBAL REGULATOR OF VIRULENCE
Whitney Weigel
October 29, 2015
In order for a pathogen to successfully colonize the host, it must be able to acquire
essential nutrients and regulate gene expression to respond to environmental fluctuations. One
mechanism bacteria have evolved in order to detect these fluctuations and respond is the two
component signal transduction systems (TCS). Aggregatibacter actinomycetemcomitans, a
dental commensal associated with localized aggressive periodontitis, contains a TCS designated
QseBC that was previously shown to regulate expression of several iron acquisition genes,
biofilm formation and virulence, but the activating signal was unknown []. QseBC is a conserved
TCS in the Enterobacteriaceae and Pasteurellaceae, but the activating signal for QseC varies for
each species [125]. The QseC in Escherichia coli responds to catecholamines whereas the QseC
homolog (FirS) in Haemophilus influenzae responds to ferrous iron. Here we show that the
activating signal for the A. actinomycetemcomitans QseC is a combination of iron and
catecholamines (CAT-Fe). The sensing of the CAT-Fe complex leads to a significant stimulation of
biofilm and planktonic growth, as well as induction of genes involved in anaerobic metabolism,
electron transport and oxidative stress while down-regulating expression of genes involved in
iron acquisition and fatty acid and LPS biosynthesis. Using a combination of RNA analysis and
metabolomics, we identified an increased flux through the TCA cycle to pyruvate and then to
anaerobic respiration and metabolism with exposure to CAT-Fe. Cells exposed to Cat-Fe also
expressed higher levels of catalase and were more resistant than untreated cells to oxidative
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stress.
Finally, QseB also appears to play a role in regulating the general stress response in A.
actinomycetemcomitans since a ΔqseB mutant exhibits increased transcription of several stress
response genes, including the Lon protease. Ectopic expression of lon resulted in an increase in
transcription of ygiW-qseBC. Lon is involved in activating type II toxin/anti-toxin (TA) systems,
one of which (D11S_2133-2134) was shown to be highly up-regulated during iron starvation.
Further, it was found that ectopic expression of the putative anti-toxin D11S_2134 resulted in a
significant increase in transcription of qseBC. Based on this data, it is likely that D11S_2133-2134
regulates expression of qseBC allowing QseBC and D11S_2133-2134 to tightly control iron
acquisition and regulate adaptation to the host.
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CHAPTER ONE: INTRODUCTION
As awareness of germ theory gained acceptance in the early 1900's, the idea that
systemic and chronic diseases, such as atherosclerosis, mental illness and cancer, were caused by
the systemic spread of microbes and their toxins through the body also gained traction. The idea
behind the theory of focal infection was that the root cause of these systemic diseases could
eventually be traced back to some sort of infectious origin [1]. In the 1890’s W.D. Miller and
later in 1911 William Hunter, were the earliest to make the link between oral infections and
systemic health issues [2, 3]. As a result, one of the methods that was employed to treat and
prevent systemic disease included the therapeutic extraction of teeth, sometimes even healthy
teeth [1]. One piece of evidence given to support this therapy is the claim that Hippocrates
cured arthritis in 400 B.C. by extracting infected teeth [2]. This lead to widespread extraction of
infected and sometimes even healthy teeth as a way to treat and prevent disease although much
of the evidence given in support of the theory was anecdotal [4]. The theory was discredited as
additional studies were conducted that showed the extraction of teeth did not on a whole lead
to or prevent disease and there was no proof of a direct cause and effect between oral infections
and some systemic diseases [2, 4]. The problem of cause and effect was difficult to solve at this
time since the molecular technology was not advanced enough to prove pathogens isolated
from other sites had an oral origin [3]. Recently, some of the ideas of focal infection have started
to regain popularity as people have done epidemiological studies looking at the association
between periodontal disease and systemic inflammatory diseases such as atherosclerosis [5],
diabetes [1], and rheumatoid arthritis [6]. Numerous case studies have shown systemic issues
such as urinary tract infections [7], brain abscesses [8] and pneumonia [8] can occur from oral
infections or after routine dental procedures. One of the strongest links is data suggesting a
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strong correlation to periodontal disease and endocarditis [9]. Evidence exists of the presence of
oral pathogens in numerous extra-oral tissues including the heart [10] and brain [11] suggesting
that oral bacteria can use the oral cavity as a reservoir from which to disperse, most likely after
dental procedures were small cuts in the gum allow the bacteria access to the bloodstream [2].
It has also been suggested that depending on the oral hygiene, activities as innocuous as
chewing could cause cuts from which the bacteria can enter the blood stream and travel
throughout the body [3]. From there, depending on the health of the patient, the bacteria can
travel and potentially colonize other sites in the body.
Periodontal Diseases
There are two types of periodontal diseases: periodontitis, a chronic inflammatory
disease of the periodontium characterized by massive soft tissue destruction, irreparable bone
and tooth loss, and bleeding upon probing. Gingivitis is a milder inflammation of the gingiva
that with proper treatment can be reversed, but if left untreated can result in periodontitis [12].
In clinical terms, gingivitis is characterized as a subgingival pocket depth of 4-5 mm with bleeding
of the gums, while periodontitis is characterized by a subgingival pocket depth greater than 6
mm, and severe periodontitis giving a subgingival pocket depth greater than 7mm [12].
Forty six percent of the adult population of the United States have some form of
periodontitis and 8.9% have severe periodontitis, making it the most common chronic
inflammatory disease [13]. The prevalence of periodontitis varies with race with Hispanics
having the highest percentage (63.5%) and non-Hispanic whites having the lowest percentage
(40.8%) [13]. $14.3 billion was spent on treating periodontal disease in the US alone in 1999
[14]. This amount has undoubtedly increased since then. In addition, research correlating
periodontal disease to the development of other potentially life-threatening and costly diseases
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such as atherosclerosis [5], arthritis, diabetes, pulmonary disease and adverse pregnancy
outcomes means that the cost of periodontal disease in terms of dollar amounts and in terms of
morbidity/mortality is much higher. This suggests that there is a high need for innovative
treatments and preventative therapies.
Numerous risk factors can influence the onset of periodontitis including age, race,
gender, oral hygiene, diet, socio-economic status, education status, smoking, and stress [13, 15].
Hispanics, males, people over the age of 30, and smokers are much more likely to develop
disease, with 63% of current smokers having periodontal disease and 18.9% of current smokers
having severe periodontal disease compared to 5.5% of non-smokers with severe periodontal
disease [13]. The bias towards males developing periodontal disease is interesting since more
often it is females that are more likely to develop inflammatory diseases, which is thought to be
due to the influence of hormones on immune cell development [16]. The reasons for the
increase incidence of periodontal disease in males is still not well known, since female mice in
lab settings are more likely to develop periodontal disease [17]. This could be explained by
differences in oral hygiene between males and females since when age and oral hygiene are
taking into account, incidence of disease between males and females, females are more likely to
have periodontal disease [117]. The impact of socio-economic and education status can be
explained in these populations due to reduced access to oral healthcare. In addition, the
association between race, in particular Hispanics, with the development of periodontal disease
could have a two-fold explanation. One explanation is that Hispanics may be less likely to receive
proper oral healthcare [18]. Several of these risk factors (i.e. smoking and diet) are due to the
direct impact on the microbiome, whereas other risk factors (i.e. smoking, age, sex and stress)
may have indirect influences on the microbiome by modulating the immune response. These
impacts on the microbiome can cause significant population shifts resulting in the presence of
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more pathogenic bacteria. For example, several studies have shown an increase in the
prevalence of pathogenic bacteria such as Tannerella forsythia, Aggregatibacter
actinomycetemcomitans, Porphyromonas gingivalis, and Treponema denticola in the oral cavity
of smokers [19, 20]. In addition, smoking has been shown to cause a dampening of the immune
response and causes also changes in the oral biofilm [21] by increasing the incidence of
pathogenic bacteria such as F. nucleatum, P. intermedia, and Actinomyces spp [22]. It can also
promote colonization by P. gingivalis by causing an increase in fimbriae expression which
augments the immune response [23].
In healthy gums, the teeth are connected to the soft tissue via gingival fibers and the
alveolar bone via the periodontal ligament fibers. Colonization with pathogenic bacteria triggers
inflammation resulting in a massive influx of infiltrating neutrophils, macrophages, and
lymphocytes and eventually leads to deterioration of the supporting soft tissue around the
teeth, destruction of the periodontal ligaments and gingival fibers, and loss of attachment to the
tooth. Ultimately the activation of bone-resorbing osteoclasts, over the bone-forming
osteoblasts, results in alveolar bone loss that causes a reduction in the height of the alveolar
bone crest and an increase in vertical bone loss. The pro-inflammatory cytokines released by
invading immune cells and leading to the activation of osteoclasts include IL-1B, IL-6, TNF-α, IL-8,
and RANKL [24]. Osteoclast activation leads to bone resorption and alveolar bone loss [24]. In
addition, infiltrating neutrophils can release a whole host of chemicals from their granules (e.g.
defensins, proteases, lactoferrin, and catecholamines [25]) when triggered by pro-inflammatory
signals.
A second form of periodontitis differs from the typical chronic periodontitis. Localized
aggressive periodontitis (LAP) is a rapid onset periodontal disease, and when left untreated
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results in rapid alveolar bone loss and destruction of the supporting tissues around the teeth,
particularly in the incisors and first molars. LAP has significant differences in geographic burden
with people from Moroccan descent more likely to have LAP suggesting that geographic location,
socio-economic factors and race play an important role in its development [26]. It is more often
seen in juveniles compared to chronic periodontitis and is strongly associated with colonization
with A. actinomycetemcomitans [26], and in particular, a hyper-leukotoxic strain of the organism
[37].
Biofilms
Periodontitis is an inflammatory response triggered by certain oral bacteria that form
biofilms, structured communities of bacteria in a self-generated matrix of proteins, nucleic acids,
and carbohydrates, in the subgingival pocket. The plaque deposited on the teeth (hard tissue)
and in the subgingival pocket (soft tissue) is comprised of a microbial biofilm. The presence of
plaque is the most important risk factor for the development of periodontitis. The development
of biofilms is advantageous to the bacteria since the structured community allow them to more
tightly adhere to the salivary pellicle or each other, making them more difficult to remove by
chemical or physical means. Biofilms also help bacteria to resist antibiotic mediated killing and
can promote slow-growing persister cell formation [122]. These are cells that are physiologically
dormant and more resistant to anti-bacterial treatment. The oral biofilm is extremely complex,
containing both pathogens and commensals, and usually exists in homeostasis with the host.
However, a variety of environmental stimuli can induce populational changes in the biofilm that
disrupt homeostasis and initiate disease. Development of biofilms on the teeth starts within
hours of tooth eruption from the gingiva [123]. In addition, routine cleanings can clear the
biofilm, but it will start to reform soon after [123]. Formation begins with the deposition of the

5

salivary pellicle and initial colonizers such as Streptococci spp. and Actinomycetes spp. attaching
to these immobilized salivary components [27]. Early (i.e. Neisseria, Prevotella, Eikenella, Rothia,
Porphyromonas, and Veillonella), middle (i.e. Fusobacterium nucleatum) and late colonizers (i.e.
those most associated with disease, such as P. gingivalis, T. denticola, T. forsythia, and A.
actinomycetemcomitans [28]) will then attach to the established biofilm making it more complex
and diverse.
The oral biofilm consists of around 700 species, but only some of these bacteria have
been associated with the progression from health to disease. A shift of mostly Gram-positive
aerobes to Gram-negative anaerobes is associated with the development of disease [27]. Some
of the better characterized bacteria that have been associated with periodontitis include
bacteria of the “red complex” (T. denticola, T. forsythia, and P. gingivalis), Filifactor alocis,
Prevotella intermedia, and A. actinomycetemcomitans [26, 28]. The colonization of the
subgingiva by these pathogens is aided by several virulence factors that help in evading the
immune response. Biofilm development depends on the interaction of not only bacteria to the
surface of the tissues of the host, but also on bacteria-bacteria interactions [27].
Aggregatibacter actinomycetemcomitans
A. actinomycetemcomitans is gram-negative, non-motile, facultative anaerobe of the
Pasteurellaceae family. Other members of the Pasteurellaceae family include Haemophilus
influenzae and Actinobacillus pleuropneumoniae. There are five serotypes (a-e), with variation
in the global population in serotype burden, with a, b, and c being globally dominant, while d
and e are rare [29, 30]. This study utilizes the smooth strain D11S c seroptype of A.
actinomycetemcomitans due to its role in pathogenesis of localized aggressive periodontitis.
Although A. actinomycetemcomitans is now considered to be an oral opportunistic
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pathogen, it wasn't recognized as being a member of the oral microbiota until 1975, 63 years
after it was first isolated [31]. It is associated with a particular type of periodontitis called
localized aggressive periodontitis (LAP) [26]. Geographic and race disparities have been
reported in terms of incidence of LAP, but A. actinomycetemcomitans remains prevalent in the
overall population and is commonly present in the subgingival plaque. A.
actinomycetemcomitans has also been shown to cause extra-oral infections and complications
such as infective endocarditis [10], soft-tissue abscesses [8], reactive arthritis [32], urinary tract
infections [7], pneumonia [8] and has been associated with atherosclerosis [33].
A. actinomycetemcomitans has a variety of virulence factors including a 116 kDa
leukotoxin, a member of the repeats-in-toxin (RTX) family of pore-forming toxins that specifically
kills polymorphonuclear leukocytes, monocytes and T-cells in humans, apes and Old-World
monkeys [34, 35]. Previous studies have shown that people harboring an A.
actinomycetemcomitans strain JP2 that expresses higher levels of leukotoxin due to a deletion in
the toxin promoter have earlier onset of periodontitis than patients colonized with a non-JP2
strains [36, 37]. In addition, A. actinomycetemcomitans produces other virulence factors such as
a cytolethal distending toxin that causes apoptosis of lymphocytes [38], lipopolysaccharide (LPS)
[39], collagenase [39], a capsular polysaccharide that has been shown to inhibit IL-6 and IL-8
production [40], an IgA protease [41], an adhesin associated with infective endocarditis EmaA
[42] , and fimbriae that allows it to form robust biofilms [43]. The fimbriae play an important role
in the ability of A. actinomycetemcomitans to attach to itself or to other surfaces and resist
salivary flow when forming biofilms [44].
A. actinomycetemcomitans is also resistant to complement mediated phagocytosis and
killing by neutrophils [45] although the exact mechanism by which it resists neutrophil killing is
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unknown. The b serotype of A. actinomycetemcomitans is capable of resisting phagocytosis via
serotype b-specific polysaccharide antigen [46]. However, it’s also able to invade epithelial [47]
and endothelial cells [48]. The ability to invade into these cells may be an important mechanism
by which the bacteria shields itself from immune killing or a way for the bacteria to disseminate
through the host [39].
Since a virulence factor can be defined as anything that helps a pathogen to successfully
colonize a host, the definition of virulence factors has started to be expanded to include things
that would have been considered house-keeping genes before, such as essential metabolic
genes. Recent research now suggests that metabolites and changes in metabolism itself can be
considered a virulence factor since many virulence factors and quorum sensing systems are
under metabolite control, for example, the regulation of carbon metabolism via the cAMP
regulatory protein [49-51]. Further, successful colonization of the host requires correct
expression of metabolic pathways. For example, Jorth et al showed that when A.
actinomycetemcomitans grown in in vitro biofilms was compared to A. actinomycetemcomitans
cultured in a mouse abscess model, the largest changes in gene transcription revolved around
genes involved in anaerobic respiration and metabolism [52]. In addition, deletion mutants of
some of the genes that were up-regulated in in vivo conditions (e.g. fumarate reductase and
formate dehydrogenase) were attenuated compared to wild type strains [52].
Two-component Regulatory Systems and QseBC
Successfully colonizing a host requires that a pathogen respond quickly to environmental
fluctuations. One way that bacteria respond to changes in their environments is through the
activity of two component signal transduction systems. These systems have evolved to respond
to a variety of stimuli including pH, temperature, salinity, and concentrations of ions such as zinc
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and iron [59, 62, 60]. They are usually comprised of a membrane bound histidine kinase sensor
and a cytosolic, DNA-binding response regulator that are often co-transcribed in an operon.
When the inner membrane bound sensor senses its cognate stimulus, it becomes activated and
auto-phosphorylates at a highly conserved histidine residue. The histidine kinase sensor will
then transfer the phosphate to the cognate response regulator causing it to change
conformation and become activated. The activated response regulator can then bind to DNA to
either promote or repress expression of certain genes, sometimes including its own operon [60,
101]. There has also been evidence that some sensors can activate response regulators other
than its own cognate response regulator [60]. This suggests that a large and complex signaling
cascade can occur in order to change gene transcription in response to environmental stimuli.
QseBC is a two-component system that is highly conserved in the Enterobacteriaceae
and the Pasteuerellaceae. In A. actinomycetemcomitans, the operon is transcribed with a gene
encoding a small putative periplasmic solute binding protein of the OB-fold family designated
ygiW [53]. The ygiW gene is present in Escherichia coli, but it is divergently transcribed from the
qseBC operon.
Work done in E. coli and Salmonella enterica have shown that this two component
system responds to catecholamines in iron-limiting environments [54-57]. This response is also
dependent on the presence of a functional synthesis and transport system for the enterobactin
siderophore [58]. The E. coli QseBC can also become activated with increased levels of ferric
iron, but it is not directly activated by the iron. Iron activates another TCS, PmrAB [59], and PmrA
binds to the promoter region of qseBC to induce its expression [60]. Further, PmrB will
phosphorylate QseB which in turn auto-regulates expression of the qseBC operon [60]. In
addition, the E. coli QseBC is able to respond to a quorum sensing molecule designated as AI-3
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[55, 61]. It was shown that exposure to catecholamines regulates the production of AI-3 by the
bacteria, and AI-3 goes on to further activate QseBC on its own. Contrary to this, the QseBC
homolog in H. influenzae (FirRS) did not appear to respond to catecholamines, and instead
responded to ferrous, and not ferric, iron [62]. This response to iron was dependent on an ironresponsive motif in FirS, DYRED [62].
Some of the reported changes in response to QseC activation by catecholamines in E.
coli include the activation of genes involved in the formation of the attaching and effacing lesion
[63], the Type Three Secretion System (TTSS) contained on the locus of enterocyte effacement
(LEE) [54], and flagella and motility genes [64, 65]. Other effects of catecholamine exposure
include increase in planktonic growth [66], biofilm formation [65], as well as virulence [65]. This
effect has also been seen in P. gingivalis and A. plueropneumoniae, where catecholamines have
been shown to cause an up-regulation of certain virulence factors [67, 68]. It is not known if
catecholamines cause changes in gene transcription and growth in A. actinomycetemcomitans,
but since the A. actinomycetemcomitans genome lacks many of the QseBC-regulated gene of E.
coli, the potential impact of catecholamines on A. actinomycetemcomitans will likely be novel
and species specific.
Although the activating signal for the A. actinomycetemcomitans QseBC has not been
identified, previous work has shown that QseC plays an essential role in two important and
complex phenotypes. The first phenotype is virulence, since a ΔqseC mutant is attenuated in a
mouse model of periodontitis, and a qseC complemented strain restores the virulence
phenotype, as measured by alveolar bone loss [44]. The other phenotype that QseBC plays a role
in is biofilm formation [44, 53].
The ability of A. actinomycetemcomitans to form biofilms is contingent on its ability to
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sense the quorum sensing molecule AI-2 by the receptors LsrB and RbsB [70]. In an AI-2 synthase
mutant (ΔluxS) biofilm formation is reduced. QseBC is activated downstream of AI-2 detection,
but QseBC is not directly activated by AI-2 [44]. The mechanism linking AI-2 detection to QseBC
activation is unknown, but in E. coli it was shown that qseBC is regulated by the toxin MqsR,
which is activated by AI-2 [71]. Biofilm formation was significantly reduced in a MqsR deletion
mutant in the presence of AI-2 and MqsR was found to positively regulate qseBC expression [71].
Microbial Endocrinology
Microbial endocrinology refers to the rapidly growing field dedicated to understanding
the impact of host hormones on pathogens in terms of virulence and growth. Hormones play an
important and varied role within the host. One process that is controlled by hormones in
humans is the stress response. High catecholamine (i.e. norepinephrine, epineprhine and
dopamine) hormones are associated with stress [15, 72]. When the host encounters some sort
of stressor, the sympathetic nervous system becomes activated causing signaling through the
hypothalamic-pituitary-adrenal axis [73]. This activation triggers the response of the
catecholamine neurotransmitters in order to put the body into a “fight-or-flight” response mode.
Effects of catecholamines include increased heart rate, blood pressure, and glucose levels [73].
Catecholamines are mainly produced in the adrenal glands by chromaffin cells and in the
post-ganglionic fibers of the sympathetic nervous system. Recent research has shown that
norepinephrine can also be produced and released by activated phagocytes (including activated
neutrophils which migrate into the tissue during periodontitis) in response to inflammatory
signals [25, 74]. The concentration of released catecholamines can reach up to millimolar
amounts and work to activate other immune cells, ramping up the immune response [25, 57].
The synthesis of catecholamines begins with L-phenylalanine, which is converted into L-
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tyrosine by aromatic amino acid hydroxylase (AAAH). Using the same enzyme, L-tyrosine is
converted into L-DOPA with tetrahydrobiopterin, O2, and ferrous iron acting as cofactors. L-DOPA
is converted by aromatic L-amino acid decarboxylase (AADC) to dopamine with pyridoxal
phosphate as the cofactor. Dopamine can then act as a precursor for the synthesis of the other
catecholamines: epineprhine and norepinephrine. Dopamine is first converted to
norepinephrine by dopamine β-hydroxylase (DBH) using O2 and L-ascorbic acid as cofactors and
is then converted into epinephrine by phenylethanolamine N-methyltransferase (PMNT) with Sadenosyl-L-methionine acting as the cofactor [75]. There are two enzymes which can degrade
catecholamines: catechol-O-methyltransferase (COMT) and by monoamine oxidases (MAO) [75].
The original studies done on the effect of catecholamines on bacteria began with work
on E. coli and S. enterica. It had been widely reported that animals exposed to stressful
conditions were more susceptible to disease [57, 76]. These reports contradict evidence showing
that catecholamine stress hormones can activate immune cells [25] which would be expected to
decrease susceptibility to disease. It was hypothesized that catecholamines had a direct impact
on pathogens leading to an increase in virulence. This was confirmed with work showing that
catecholamines result in increased growth in minimal, iron-restricted media [57].
Catecholamines can also act as pseudo-siderophores and can scavenge iron from host ironbinding proteins [77]. This ability of catecholamines to scavenge iron was suggested to
contribute to the growth phenotype in response to catecholamines, suggesting that bacteria can
exploit the production of host hormones to acquire the essential nutrient iron. Catecholamines
have been shown to scavenge iron through their catechol moeity by forming a complex with the
iron-loaded lactoferrin [77]. This complex causes reduction of the iron, which destabilizes the
bond between the iron and lactoferrin, allowing iron to be released [77]. Both catecholamines
and lactoferrin can be released by neutrophils in response to pro-inflammatory signals [78, 79],
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so the bacteria may not only exploit the systemic production of hormones, but also the
inflammatory response designed to combat infection.
Normally, free iron is very limited in the host due to host iron-binding proteins that
ensure bacteria cannot easily acquire this essential nutrient [124]. Bacteria have in turn evolved
mechanisms to counter iron sequestration, most notably through the secretion of siderophores
such as enterobactin, which is able to bind iron via a catechol moiety [58]. However, in bacteria
that do not produce siderophores, e.g., A. actinomycetemcomitans, the use of catecholamines to
scavenge iron may represent a novel mechanism for nutrient acquisition [57]. Several different
proteins have been suggested to function as bacterial adrenergic receptors and interact with
catecholamines but the best characterized protein is QseC [55]. The ability of bacteria to sense
catecholamines through bacterial adrenergic receptors like QseC demonstrates the ability of
these organisms to take part in inter-kingdom signaling.
As previously mentioned, stress is a risk factor for the development of periodontitis [15].
In addition, it has been shown that activated polymorphonuclear cells can release up to
millimolar concentrations of catecholamine stress hormones in response to inflammatory signals
[78, 79]. Although macrophages have been shown to release higher amounts of catecholamines,
infiltrating neutrophils are in a higher abundance during periodontitis [95, 96] and are more
likely to have an effect on periodontal microbes like A. actinomycetemcomitans due to their
release of catecholamines. Therefore, a better understanding of how oral bacteria, specifically A.
actinomycetemcomitans, respond to catecholamines and the impact on virulence may provide
insight for understanding the connection between stress and pathogenesis. Understanding the
impact of catecholamines on the pathogenesis of A. actinomycetemcomitans may allow us to
use different therapies to block the recognition of catecholamines by A.
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actinomycetemcomitans. There are already drugs on the market (i.e. alpha blockers and beta
blockers) that block the recognition of catecholamine hormones by adrenergic receptors [80]. If
QseC is functioning as an adrenergic receptor, then these receptor antagonists could potentially
block the recognition of catecholamines by the bacteria and therefore could modulate
pathogenesis and reduce the damage caused by periodontitis. In addition, understanding the
link between catecholamines and periodontitis and the effect on A. actinomycetemcomitans
may allow dentists in the clinical setting to look at which patients will need to be targeted for
more aggressive treatment. Ultimately, this information could also be used to determine
patients that are at higher risk to develop more virulent bacterial infections leading to
periodontitis due to increased catecholamines and target them with more aggressive dental care
and potentially therapeutic agents such as adrenergic receptor antagonists.
Toxin/Anti-toxin (TA) Systems:
Previous work done on E. coli has shown that QseBC activation is directly controlled by
the toxin MqsR, which is directly downstream of AI-2 detection [71]. MqsR is the toxin in the
mqsRA type II toxin/anti-toxin (TA) system. Type II TA systems are comprised of a labile protein
anti-toxin that is co-transcribed in a small operon with its cognate protein toxin [81]. Under
normal conditions, the anti-toxin binds to the toxin to negate its effects. TA systems can be
activated by the Lon [82] or Clp [83] proteases which more readily degrades the labile anti-toxin,
releasing the toxin [85, 83]. Most toxins act as endoribonucleases [84], but some toxins can
target other factors such as DNA gyrase, elongation factors, or uridine diphosphate-Nacetylglucosamine [81]. TA systems are activated by a signaling mechanism involving RelA/SpoT,
the signaling nucleotide (p)ppGpp, and polyphosphate (PolyP) [85]. RelA/SpoT synthesizes
ppGpp which causes an inhibition of exopolyphosphatase (PPX), which is an enzyme that
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degrades PolyP [85]. PolyP is produced by polyphosphate kinase (PPK), and since PPX is
inhibited, the concentration of PolyP within the cell increases, which activates Lon [85]. This
signaling mechanism can be activated stochastically at very low levels [85], or conversely, when
the bacterium is stressed or goes through metabolic transitions [86]. In addition, the Clp
protease can also degrade anti-toxins [83], but it has not been determined if it responds to the
same mechanisms as Lon. A. actinomycetemcomitans contains both the Lon (D11S_1522) and
Clp (D11S_2042-2043) proteases. The activation of TA systems through this signaling mechanism
is hypothesized to be a way for the bacterium to form a persister state in response to stress [81,
84]. TA systems can respond to a variety of stressors, and they can be functionally redundant.
For E.coli, all 10 TA systems had to be knocked out in order to see a phenotype of decreased
persistence [84].
As mentioned previously, qseBC is part of the AI-2 regulon in A. actinomycetemcomitans,
but it is not directly activated by AI-2 detection [44]. The mechanism that links AI-2 and qseBC
remains unknown. There are 10 putative TA systems in A. actinomycetemcomitans, and it is
possible that one of these TA systems plays a role in qseBC expression. The stimuli that activates
these TA systems in A. actinomycetemcomitans, their mechanism of action, and their targets for
regulation are unknown. Previous work done in E. coli has shown that certain TA systems can
have a wide range of targets, for example, the MazF toxin acts as an endoribonuclease that
targets the sequence ACA, which is present in almost all mRNA's [87]. The targets for TA systems
allow the bacteria to down-regulate processes such as transcription and translation, processes
that require a significant amount of energy and are required for a metabolically active cell. By
down-regulating these processes, the cell can go into a persister state and persist under
conditions of environmental stress [125]. Therefore, understanding how TA systems regulate cell
activities could elucidate targets for therapeutics that could be employed as a way to prevent
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persister cell formation and make the bacteria more susceptible to antibiotics.
Significance
QseBC has been previously shown to be essential for the pathogenesis of A.
actinomycetemcomitans and from these studies seem to regulate many key cellular processes
like metabolism, biofilm formation and the stress response. The data presented in this
dissertation demonstrates that the A. actinomycetemcomitans QseBC responds to both iron and
catecholamines (CAT-Fe) and to high concentrations of the adrenergic receptor antagonists
propranolol and phentolamine. CAT-Fe stimulates both planktonic growth and biofilm formation
in a TonB dependent manner. In addition, CAT-Fe significantly alters the metabolic flux of A.
actinomycetemcomitans and results in an up-regulation of genes involved in oxidative stress
which protects the bacteria after exposure to H2O2. The ability of A. actinomycetemcomitans to
respond to CAT-Fe and exploit it as a nutritional niche may provide insight about the connection
between stress and periodontitis. Further, the loss of QseB results in an up-regulation of the
stress response. Ectopic expression of lon, one of the proteases involved in the stress response,
induces increased transcription of ygiW-qseBC. In addition, ectopic expression of the ironresponsive D11S_2133-2134 TA system was shown to modulate expression of ygiW-qseBC. These
results suggest that the D11S_2133-2134 TA system and QseB might be involved in a regulatory
circuit that fine-tunes the response of A. actinomycetemcomitans to changes in iron in the
environment and might represent a target for therapeutics. In addition, our results potentially
provide insights into the structure and nature of QseC that could facilitate the development of
novel therapeutics.
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CHAPTER TWO: MATERIALS AND METHODS
Bacterial strains and culture conditions: All strains used are listed in Table 1. LB (Luria–Bertani)
broth, LB agar (LB broth with 1.5 % agar) and brain–heart infusion (BHI) broth, BHI agar, and a
chemically defined media (CDM) was used to propagate and plate bacteria. A.
actinomycetemcomitans 652 serotype c was grown at 37oC in 5.0% CO2 in either Brain Heart
Infusion (BHI) supplemented with 40 mg of NaHCO3 per liter or CDM supplemented when
required with 100uM of ferrous or ferric iron or 50uM of epinephrine or norepinephrine or 50400uM of phentolamine or propranolol. The components of CDM are essentially described by
Socransky et al [88] listed in Table 2. Cultures grown in CDM for CAT-Fe studies were first
inoculated into BHI and cultured overnight to an O.D.600nm of 0.3-0.4. The overnight culture was
then passaged into fresh BHI at a 1:30 dilution until growth reached an O.D.600nm of 0.5-0.6. The
culture was then passaged into CDM at a 1:30 dilution. The ΔqseC complemented strain and
strains carrying the pDJR29 plasmid were grown as described above but supplemented with
kanamycin (25ug/mL). The A. actinomycetemcomitans strain carrying pWAW28 was grown in
BHI supplemented with kanamycin while the strains carrying pWAW17, pWAW19, pWAW20, and
pWAW31 were grown with kanamycin in BHI with or without 1mM IPTG supplementation. The
A. actinomycetemcomitans strains carrying pWAW14 or pWAW16 were grown in LB with
kanamycin with or without supplementation with 0.2% glucose. XL Blue Escherichia coli cultures
containing the plasmids pWAW17, pWAW19, and pWAW21 were cultured in Luria Broth (LB)
supplemented with tetracyline (50ug/mL), kanamycin (25ug/mL) or with 1mM IPTG. XL Blue
Escherichia coli strains carrying pWAW14 and pWAW16 were grown in LB supplemented with
tetracycline and kanamycin. A.actinomycetemcomitans cultures harboring the suicide plasmid
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pWAW23 were grown in BHI with spectinomycin (25ug/mL) or TYE with 1mM IPTG and 10%
sucrose.
Growth Kinetics: For determining the effect of CAT-Fe on growth, a frozen glycerol stock of A.
actinomycetemcomitans was inoculated into BHI and allowed to grow to an O.D.600nm of 0.3-0.4.
Cells were then transferred to fresh BHI at a dilution of 1:30 until an O.D.600nm of 0.5-0.6 was
achieved. The cells were then inoculated into fresh CDM at 1:30 dilution with or without CAT-Fe
supplementation or adrenergic receptor antagonist supplementation. At various time points,
aliquots were removed from triplicate cultures and the O.D.600nm measured using a BioRad
SmartSpec Plus UV-vis spectrophotometer. Growth kinetics for XL strains or A.
actinomycetemcomitans strains containing plasmids for the ectopic expression of the Lon
protease or the TA systems were done in triplicate using aliquots taken a various times and the
O.D.600nm measured. For all other growth curves, cultures were inoculated from an overnight
stock at a 1:30 dilution into fresh media with the appropriate supplementations. At various time
points, aliquots were removed from triplicate cultures and measured for the O.D.600nm.
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Table 1: Strains and plasmids
Derived, relevant genotype or
characteristics

Strain or plasmid

Source or reference

Escherichia coli

19

XL1-Blue MRF’

∆(mcrA)183
∆(mcrCB-hsdSMR-mrr)173
endA1 supE44 thi-1 recA1 gyrA96 relA1 lac
[F´ proAB. lacIqZ∆M15 Tn10 (Tcr)]
Stratagene

Aggregatibacter actinomycetemcomitans
652 WT
652-JR23
652-JR36

Wild type, serotype c
652 qseCΔp
652 ΔygiW

652-JR37
652-JR38
652-JR39
652-JR39-46

652 ΔqseB
652 ΔqseC
652 ΔqseBC
652 ΔqseBC::46 (YgiW QseBQseC)

Juárez-Rodríguez et al. (2013a)
Juárez-Rodríguez et al. (2013a)
Juárez-Rodríguez et al. (2013a)
Juárez-Rodríguez et al. (2013a)
Juárez-Rodríguez et al. (2014)

652-JR39-61

652 ΔqseBC::61 (YgiW QseBQseCY155A, R156A)

Weigel et al. (2015)

652-WW1

652 ΔD11S_1352

This study

Spr, suicide vector

Juárez-Rodríguez et al. (2013b)

Laboratory stock
Juárez-Rodríguez et al. (2013a)

Plasmids
pJT1
pJT3

r

Km , lacZ promoterless

Juárez-Rodríguez et al. (2013b)

Strain or plasmid
Derived from pJT1

Derived, relevant genotype or characteristics

pWAW4

Spr, D11S_1352

This study

Derived from pJT3
pWAW17

Kmr, pTRC promoter -1 to -87, Lon -87 to -2505

This study

pWAW19

Kmr, pTRC promoter -1 to -87, D11S_2134 -87 to This study

2505

pWAW20

Kmr, pTRC promoter -1 to -87, D11S_2133 -87 to 2505

pDJR29
pWAW31
pWAW16

r

Km , ygiW-qseBC promoter -1 to -372-lacZ
Kmr, pTRC promoter -1 to -87, D11S_1354-1352 87 to-2305
r

Km , lsrA promoter -441 to +182 D11S_2134 +182 to
pWAW14

This study
Juárez-Rodríguez et al. (2013a)
This study
This study

+338

Kmr, lsrA promoter -441 to +182 D11S_2133 +182 to
pATE33

Source or reference

This study

+464

20

Kmr, lsrA promoter -441 to +182 lacZ

Juárez-Rodríguez et al. (2013a)

Construction of TA system and Lon ectopic expression plasmids: pWAW17, pWAW19, and
pWAW20, were constructed from the lacZ-reporter strain pJT3. Using A. actinomycetemcomitans
chromosomal DNA as a template, fragments representing lon, D11S_2133, or D11S_2134 were
PCR amplified using a high fidelity Taq polymerase (Invitrogen) and primer sets: WW64&WW75,
WW76&WW68, and WW70&WW77, respectively. The primers were flanked with restriction
sites as shown in Table 3. The 2.4kb, 156bp, or 282 bp products were digested with BamHI-Xbal
and ligated into the BamHI-Xbal digested pJT3 to make pWAW17A, pWAW19A, and pWAW20A.
Using pJT1 plasmid DNA, primer set WW86&WW87 was used to PCR amplify the pTRC promoter.
The 150 bp product was then digested with BamHI-KpnI and ligated together with BamHI-KpnI
digested pWAW17A, pWAW19A, or pWAW20A to create pWAW17, pWAW19, or pWAW20,
respectively. To make pWAW14 or pWAW16, the reporter plasmid containing the lsrA promoter,
pATE33 [49] was digested with KpnI/BamHI and ligated together with KpnI/BamHI digested
products from the PCR amplification of WW76&WW68 and WW70&WW77, respectively. The
ligation reaction was then transformed into E.coli XL gold electrocompetent cells. Electroporated
cells were incubated for 1 hour in SOC (2% tryptone, 0.5% yeast extract, 10 mM NaCl, 2.5 mM
KCl, 10 mM MgCl2, 10 mM MgSO4, and 20 mM glucose) media with shaking then plated on LB
plates supplemented with 50ug/mL of tetracycline and 25ug/mL kanamycin and incubated
overnight. Colonies were chosen and grown in LB with tetracycline and kanamycin overnight.
Plasmid was extracted from cultures using the Plasmid Miniprep Kit (Qiagen) and confirmed by
sequencing using the University of Louisville Sequencing Core to confirm correct insertion. 25ug
of plasmid was then used to transform A. actinomycetemcomitans by electroporation.
Transformed cells were then cultured on BHI plates supplemented with kanamycin and resulting
colonies were selected for plasmid purification and confirmed again by sequencing.
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Table 2: Composition of CDM

10mL
50mL
50mL
1mL
50mL
10mL
10mL
1mL
10mL
1mL
1mL

1L CDM
CaCl2 (10mg/mL)
Amino Acid Stock
Inorganic Salt Stock
Vitamin Stock
NaHCO3 (20mg/mL)
Cysteine (65mg/mL)
MgSO4 (70mg/mL)
Pimelic acid/Biotin
Riboflavin (0.1mg/mL)
Lipoamide
Folic Acid

Amino Acid Stock
Hydrophilic Amino Acids
10mL
H2O
2.5mL
2M NaOH
499.2mg
L-glutamic Acid
200mg
Glycine
200mg
L-Threonine
200mg
L-Serine
200mg
L-lysine hydrochloride
242mg
L-arginine hydrochloride
270.2mg
L-histidine hydrochloride
200mg
L-glutamine
227.2mg
L-asparagine
200mg
L-proline
200mg
L-aspartic acid
40mg
L-ornithine hydrochloride
40mg
L-hydroxyproline
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Hydrophobic Amino Acids
15mL
H2O
3.125mL
2M NaOH
200mg
L-alanine
200mg
D-alanine
200mg
L-leucine
200mg
L-valine
200mg
L-Tryptophan
200mg
L-methionine
200mg
L-isoleucine
200mg
L-phenylalanine
40mg
L-tyrosine
Purine/Pyrimidine
10mL
H2O
1.25mL
2M NaOH
25mg
Adenine
20mg
Guanine
27mg
Cytosine hydrochloride
20mg
Thymine
20mg
Xanthine
20mg
Hypoxanthine
20mg
Uracil
L-cystine
5mL
H2O
0.625mL
2M NaOH
10mg
L-cystine
Combine hydrophobic, hydrophilic,
purine & pyrimidine and cystine to make
amino acid stock.
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Inorganic Salt Stock
99.5mL
H2O
10mg
MnSO4
200mg
NaCl
400mg
K2HPO4
2000mg
KH2PO4
200mg
KNO3
0.1mg
KI
0.065mg
CuSO4:5H2O
0.5mg
Boric Acid
0.7mg
ZnSO4:7H2O
0.5mg
Sodium molybdate

20mL
1000mg
200mg
20mg
20mg
20mg
20mg
20mg
20mg
20mg
20mg
200mg
20mg
2mg
.00005mg

5mL
5mL
1mg
1mg

Vitamin Stock
H2O
Choline chloride
-alanine
Pyridoxal
Pyridoxine-HCl
Pyridoxamine-di-HCl
Spermidine-tri-HCl
Nicotinic Acid
Calcium pantothenate
Spermine-tetra-HCl
Thiamine-HCl
Myo-Inositol
NAD
p-aminobenzoic acid
Vitamin B12
Pimelic Acid/Biotin
H2O
Ethanol
Pimelic Acid
D-Biotin
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9.975mL
25uL
10mg

Folic Acid
H2O
NH4OH
Folic Acid

25

β-Galactosidase Assay: A. actinomycetemcomitans containing the lacZ reporter plasmid pDJR29
were grown in CDM with or without supplementation of catecholamines, iron, and/or adrenergic
receptor antagonists. Quantitative evaluation of β-galactosidase was carried out using
permeabilized cells incubated with o-nitrophenyl-β-d-galactopyranoside (ONPG) substrate
(Sigma-Aldrich) as previously described by Miller. Briefly, at 24 hours, 1mL of culture was taken
to measure the O.D.600nm and 100uL of culture was taken for a β-Galactosidase assay. 700uL of
Buffer Z (0.06M Na2PO4.7H2O, 0.04M NaH2PO4.H2O, 0.01M KCl, 0.001M MgSO4.7H2O, 0.05M 2mercaptoethanol, pH7.0) was added to the 100uL of culture. Cells were then permeabilized
using 20µL of chloroform and 0.5% SDS. 200uL of o-nitrophenyl-β-galactoside (ONPG) (4ug/mL)
in Buffer Z was added to initiate the reaction. The reaction was stopped by the addition of 500uL
of Na2CO3 after a color change was observed. The absorbance at 420nm and 550nm was read
using a BioRad SmartSpec Plus UV-vis spectrophotometer.
Formate Assay: Formate concentration was calculated by the conversion of formate and NAD+ to
bicarbonate and NADH via formate dehydrogenase using a Formic Acid Kit (r-Biopharm). A.
actinomycetemcomitans was grown in CDM with or without supplementation with
catecholamines and/or iron until 16 hours. Cells were then pelleted and the supernatant was
harvested. The supernatant was then treated with 30mM trichloroacetic acid (TCA) at a 2:1 ratio
of TCA to supernatant. The solution was then neutralized with 2M sodium hydroxide and filtered
to remove all proteins. The filtered product added to the assay was adjusted based on growth
rates of the bacteria and used in the Formic Acid Assay (r-Biopharm) as per manufacturer's
instructions.
Oxidative Stress: A. actinomycetemcomitans was cultured in CDM with or without
supplementation with iron and/or Ne for 16 hours. At this time, the growth was measured at
O.D.600nm and the culture was split into two equal volumes in separate conical tubes. One half of
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the culture was incubated at 37oC for 15 minutes while the other half of the culture was then
stressed for 15 minutes using 0.3% H2O2 at 37oC. The hydrogen peroxide was quenched after 15
minutes with 50mM sodium pyruvate. Growth was measured 5 hours after culture at 37oC and
compared to the pre-stress levels of growth.
RNA Isolation: Total RNA was harvested from mid-log growing cells using the RNA Lipid Tissue
Minikit (Qiagen) as per manufacturer's instructions. To ensure that the RNA was free from any
contaminating genomic DNA, the sample was digested by the Rnase-Free Dnase Set. The
concentration and purity of each RNA sample were measured via spectrophotometry (ND-1000
Spectrophotometer, NanoDrop Technologies, Inc, Wilmington, DE). The RNA was tested for any
genomic DNA contamination using qRT-PCR with primers specific for the 5S rRNA (Table 3) of A.
actinomycetemcomitans and the SYBR Green FastMix (Quanta). RNA samples were considered
free of significant genomic DNA if no amplification product was detected by qRT-PCR after at
least 30 cycles of amplification.
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Table 3
Primer

Primers
Description

Sequence
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5sF
5sR
MDJR263F
ww 26
ww 27
ww 28
ww 29
ww 36
ww 37
ww 38
ww 39
ww 42
ww 64
ww 65

5s
5s

GCGGGATCCTGGCGGTGACCTACT
GCGATCTAGACCACCTGAAACCATACC

pJT1 sequencing
D11S_2135 real-time
D11S_2135 real-time
2134-2135 intergenic real-time
2134-2135 intergenic real-time
D11S_2134 real-time
D11S_2134 real-time
D11S_2133 real-tome
D11s_2133 real-time
D11S_2134 5'RACE
Lon R pjt4
Lon real-time

GTTAGCAGTTCGTAGTTATCTTGGAGAGAATATTGAATGGAC
GGTATGCGCGAAAAAGCCACCAACGCG
CGCCTTTGATTTTATCGACCACATCCATGCC
CCGAATGAGGATGTGGTGATTACTTCGGTTAC
CTTTAGCTTTTACCGCCGCTTGAATCACGC
GATGACACAGGAATATAAGCAGTTTTTGCAACAAAAAG
CATTCCTTCTTTAGCTTTTACCGC
CGAATATGCCGGATTTAGCAGTGC
CAATTCGATAGCCTCTGACATAAATTTCA
CATTCCTTCTTTAGCTTTTACCGCCGCTTGAATCAC
GCTTTTGAAAAACACTGAA TCTAGA TTAATTGACCGCAC
GGATGTTACAAGTGCCTTGGCACAAACGTAGTAAAG

ww 66
ww 68
ww 70
ww 75
ww 76
ww 77
ww 80
ww 81
ww 82
ww 83
ww 84

Lon real-time
2134 pWAW19
2133 pWAW20
lon pWAW17
2134 pWAW19
2133 pWAW20
qseC real-time
qseC real-time
qseB real-time
qseB real-time
ygiw real-time

CGCCACAAACATTACGTCGGATAAATCATAATCC
CTGAATAAATAATT TCTAGA TTATGCAACGTCCTTCATTCC
GGTATCAAAAAAAGGCATGA TCTAGA TTAGAAATTGG
GGAATTTAGATAAGAGAGTACATG GGATCC ATGAGAGC
GGAGGTTATGATG GGATCC ATGACACAGG
GAAGGACGTTG GGATCC CATAAAATTATTTATTCAG
GATAATTTAACCCAAGGTATCGACCGTGCGACG
CATGAAAATACAGGTCGCCGATAAGGGACGGAAC
GAAATTGCCCTGACCACCCGTGAATATAAACTG
CACTTCCAGCGCGTTACTGCTCACTTC
CACAAGGCGGTTTTCAAGACCCGAATGC

ygiW real-time
pTrc
pTrc
Formate Dehydrogenase real-time
Formate Dehydrogenase real-time
Formate Acetyltransferase real-time
Formate Acetyltransferase real-time
focA real-time
focA real-time

CGCGCCAGGCTTTGCGTTCGATTTC
GCGCTTATTGCT GGTACC ATTCTG AAATGAGCTG
CATAGATCT GGATCC CATTTTCCTGTGTGAAATTGTTATCC
GGACACTATTCCTGCCGTTCTATGACAG
CAAACCAAGTCGTTGTTTTTAATACCCAGTGC
GCAATGAATATGATCAATTGTTCTCCGGCG
CGGAAGCTGTTTTTGGTCACGAGAGTAC
CATTATGGTAGTGGTGTGCGGCTCC
CTAAAACAATAAAAATTGCGCCGACGAAATTACCAC

ww123
ww124
ww109
ww110
ww113
ww114
ww 147
ww 148
ww129
ww130
ww131
ww132
ww133

Nitrate Reductase real-time
Nitrate Reductase real-time
Nitrite Reductase nrfD real-time
Nitrite Reductase nrfD real-time
hypF real-time
hypF real-time
Catalase real-time
Catalase real-time
arcA real-time
arcA real-time
arcB real-time
arcB real-time
oxyR real-time

GCGTGCCGAAAGATGTGTTGGAAAATTTGG
GGTCAGCAAATGGATGTTATAAATGAGGTGG
GACAAAAAATGGTCGCCATGCACAACGCCCTAAG
CGGGATGAGGATGCCGATAAGCATGAC
GTGTTACACCACCACGCCCACATCGTCAG
CCTAAATAGTACGCGGCTTTTTCATCTGCCAGC
GGTCATAAATTTTTAACCAACGCAGAAGCGG
GATTTGAATTCGCACGTTCCAACGGGG
GAGTTCCGCGCCATGTTACATTTCTG
CGTGATGATCTTCAAAATGTTTACGAATTCGAC
GCAGACAGCAGAGGAAGAATTTGCGTTG
CACTTCGCTACTGACGGTTAAATCGCC
GGACCTTATCTAATGCCTCATATCGTACCG
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ww 86
ww 87
ww142
ww143
ww138
ww139
ww 149
ww 150

30

ww134
ww127
ww128

oxyR real-time
ahpD real-time
ahpD real-time

CGGTACGGACGCTACAATAGCACAATC
GAGGTCGCCGCCGCACTTGCTATG
GTCTTTTTGTGTATTGTAAGCTTCTAATGCGCGTAATG

ww151

Ferritin real-time

ww 152
ww88
ww89
ww96
ww97
ww111
ww112
ww117

Ferritin real-time
fepA real-time
fepA real-time
FecCD family permease real-time
FecCD family permease real-time
ccmF real-time
ccmF real-time
Fumarate Reductase real-time

GGTTAAACTATTAAACGACCAAATGAATTTAGAG
GCATATGTTGCATTTCTTCACCTGCGTG
GGAAAATTAATGATCATTGGGACATTAATACG
CTGCATTACGATAAATACGTTTATCTAAAATATTATTCACACCC
GGCGTTTAAATTTGCTTTCTTTAGAGGAAGAAG
CAATAAGCCGACCCAACCGATAATGC
GGGTATCGGACCGCTGGTAAAGTGGCG
CGACATCATGGTGCCGAGTACGGCGC
GGTGTTGCTTTACGGTGTGATTTGTTTGGG

ww118
ww119
ww120
ww121
ww122
ww125
ww126
ww136
ww137
ww 154
ww 155
ww 156
ww 157
ww 158
ww159

Fumarate Reductase real-time
Fumarate Hydratase real-time
Fumarate Hydratase real-time
Oxaloacetate Decarboxylase real-time
Oxaloacetate Decarboxylase real-time
Ammonia Aspartate Lyase real-time
Ammonia Aspartate Lyase real-time
2133 reverse sequencing
2134 reverse sequencing
D11S_1352 mutant upstream fragment 5'
D11S_1352 mutant upstream fragment 3'
D11S_1352 mutant downstream fragment 5'
D11S_1352 mutant downstream fragment 3'
D11S_1352 deletion confirmation
D11S_1352 deletion confirmation

CGGTCATGTCAAATAATGTCACGGCGTGC
GGTGAAAATCGGTCGTACGCATTTAATGG
GCCGAGGGCTAATTGACGCAAATG
CCATCGTGGCAACTTTGCAAGGCAC
GCACTTGCGCCACCAAAATTCGGCTG
GGCGCACCCAATTGCAAGATGCGG
CGGTCGCACCTAAGTTCACTTCAAGC
GAAATTGGGATAAAGTCTTTTACAATGAATGATGG
GCAACGTCCTTCATTCCTTCTTTAGC
GATTTATTTG GCGGCCGC CACCTACCCATTTATG
GGCATCATCC CTCGAG AAGAATGGCAAG
GCTAATCTGAAATACAGTTTCTAA CTCGAG TGAATGATATAAGAAAG
GCGCGCTGTTTT CTGCAG TTACCTGCCTAG
CCGTTTACCTTGGGCAGTACCGGCC
CGGCGGCGGAAACGTGATTTCTTCCAC

ww175
ww176

TonB dependent receptor complement 5'
TonB dependent receptor complement 3'

CAAGGACGTACCATGGGATCCAAAAAACTC
GCACTTTCTTATATCATTCATCTAGATTAGAAACTGTATTTCAG
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Microarray: A custom A. actinomycetemcomitans gene expression microarray (GE 8 X 15k per
slide, 60-mer oligonucleotide probes) was printed by Agilent Technologies using oligonucleotide
probes obtained from the OligoArray Database for A. actinomycetemcomitans D11S-1 at the
University of Michigan
(http://berry.engin.umich.edu/oligoarraydb/organismPage.php?ORG=Aggregatibacter%20actino
mycetemcomitans%20D11S-1). This database comprises 5638 oligonucleotides representing
2062 transcripts encoded by the A. actinomycetemcomitans D11S-1 genome. Of the 2062
transcripts, 1552 are represented by three independent oligonucleotide probes, 215 are
represented by two probes and 221 by a single specific oligonucleotide. Each oligonucleotide
was printed twice on the array; thus the majority of genes are represented by six separate spots
on the array and no transcript is represented by fewer than two spots. Seventy two putative
transcripts of A. actinomycetemcomitans D11S-1 are not represented in the oligonucleotide
database; these mostly comprise hypothetical proteins (37) and transposases/integrases of
mobile genetic elements (11).
A. actinomycetemcomitans 652 was cultured in CDM or in CDM supplemented with 50
uM Ne and 100 uM FeCl2 to mid-log phase (roughly 16 hours after inoculation) as described
previously. Labeling of RNA, microarray hybridization, array scanning and data analysis was
carried out by the MicroArray Core Facility at the University of Louisville. Briefly, RNA was
isolated using the Lipid Tissue Minikit (Qiagen) following the protocols supplied by the
manufacturer. The quality of the isolated RNA was assessed using an Agilent 2100 Bioanalyzer
(Agilent Technologies, Inc.). RNA samples were considered to have little or no degradation if
they exhibited an RNA integrity number (RIN) greater than 9 [89]. Total RNA (100ng) was labeled
with Cyanine 3-CTP using the Low Input Quick Amplification WT Labeling Kit for one color
(Agilent Technologies). This kit uses random nucleotide-based T7 promoter primers to first
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synthesize cDNA which is then reacted with T7 RNA polymerase in the presence of NTPs and
Cyanine 3-CTP to generate labeled cRNA. The labeled cRNA was purified using the RNeasy Mini
Elute kit (Qiagen) and total yield and Cy3 incorporation efficiency was determined using a
NanoDrop Technologies spectrophotometer.
Array hybridizations were carried out using the Agilent Gene Expression Hybridization kit
as described by the manufacturer. Briefly, 600ng of each labeled cRNA sample was incubated at
600C for 30 min and then hybridized to the custom A. actinomycetemcomitans gene expression
array at 650C for 17 hours. After hybridization, the microarray slides were washed with Agilent
gene expression wash buffer 1 at 370C for 5 minutes followed by wash buffer 2 at 370C for 1
minute. After hybridization and washing, the slides were scanned using an Agilent microarray
scanner (Model G2505C) set for one-color using the green channel and 5 µm resolution. The
one-color microarray images (.tif) were extracted with the aid of Feature Extraction software (v
9.5.1, Agilent Technologies). The raw data files (.txt) were imported into GeneSpring (GX 11.1)
and the data were transformed to bring any negative or value <0.01 to 0.01. Normalization was
then performed using a per-chip 75 percentile method that normalizes each chip on its 75
percentile to facilitate comparison among chips. A per-gene on median normalization was then
performed to normalize the expression of every gene on its median among samples. An
expression threshold of ≥2-fold was applied and the differentially expressed genes were
evaluated using a pair-wise t-test and genes with p-values <0.05 were considered to be
significantly up- or down-regulated.
cDNA synthesis & qRT-PCR: cDNA synthesis was carried out using the cDNA Synthesis Kit
(Quanta) as per manufacturer's instructions. qRT-PCR was then carried out with the Applied
Bioscience using 50ng of cDNA, 250nM specific primer (Table 3) and PerfeCTa SYBR Green
Fastmix Low Rox (Quanta). The protocol was as follows: 95oC for 3 minutes for 1 cycle, 95oC for
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15 seconds and 60oC for 30 seconds for 45 cycles, with extension and annealing occurring at
60oC. The threshold cycle for each qRT-PCR was determined from a second derivative plot of
total fluorescence as a function of cycle number by using the software package supplied with
the. All gene-specific threshold values were normalized against the values measured from
primers specific to the 5S rRNA. qRT-PCR was carried out in triplicate with two independent
measurements.
cDNA RACE: The Rapid Amplification of cDNA Ends (RACE) allows for the amplification of
messenger RNA and its subsequent sequencing. Primers were designed to specifically amplify
the 5' end of cDNA for identification of the promoter region of the TA system, D11S_2133-2134.
The GeneRacer kit (Invitrogen) was used as per manufacturer's instructions. Briefly, RNA from
the ΔqseB mutant was harvested as previously described and the 5' phosphate of truncated
mRNA's or non-mRNA's was removed using calf intestinal phosphatase (CIP). The mRNA's were
then treated with tobacco acid pyrophosphatase to remove the 5' cap. An RNA oligo of known
sequence was then ligated on to the 5' end of the mRNA's and the mRNA is reverse transcribed.
Primers specific for the ligated cDNA oligo and the gene of interest are then used to amplify a
specific product. The resulting product is then gel purified and cloned into the pCR4-TOPO vector
and transformed into Top10 competent cells. Transformed cells were then plated on LB agar
plates supplemented with ampicillin (50ug/mL). Ten colonies were chosen and plasmid was
purified using the Qiagen Plasmid Miniprep kit. The plasmids were digested with EcoRI to
confirm insertion and also sequenced to determine the promoter region of the genes of interest.
Biofilms: A. actinomycetemcomitans was grown on saliva-coated coverglass in a polycarbonate
flow chamber (model FC81; Biosurface Technologies Corp., Bozeman, MT). Chamber dimensions
are 50.5 mm by 12.7 mm by 2.54 mm) at 25°C. Saliva was harvested, diluted 1:2 with ddH2O, and
filter sterilized. 50uL was then incubated for 30 min at 37oC on a coverglass (60 mm by 24 mm).
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The saliva-coated coverglass was then washed with 1X phosphate-buffered saline (PBS) for 10
min at a flow rate of 5.8mL per hr using a multichannel peristaltic pump (ManoStat Sarah
cassette; Fisher Scientific Co.). The flow cells were inoculated with a 40mL culture of A.
actinomycetemcomitans (O.D.600nm 0.5-0.6) then allowed to incubate for one hour. Biofilms were
fed with fresh media for 62 hours and then stained with 40mL of 0.2 mg/ml fluorescein
isothiocyanate (FITC) in the dark and then washed with 1X PBS for 2 hours. Biofilms were
visualized by using a Leica TCS SP8. Confocal images were captured from 5 randomly chosen
frames from each flow chamber with each biofilm done in triplicate independently. Biofilm
depth was determined by performing z-plane scans from 0 to 100 μm above the glass surface,
and total biomass was determined by integrating fluorescence intensity across the z-stack using
the Volocity software.
Metabolomics: Each cell sample was mixed in a glass vial with 500 µL CH3CN, 375 µL H2O and
250 µL CHCl3. The mixture was grounded with 2 beads at 30 Hz for 2 min, followed by
centrifugation at 4 °C and 13,000 rpm for 20 min. The bottom layer (lipid layer) was dried in
speedvac after removing the liquid layer. Each dried sample was re-dissolved in 100 µL solution
of chloroform:methanol (2:1, v:v) containing 1 mM butylated hydroxytoluene (BHT). The mixture
was then split into two aliquots. One aliquot was diluted 10-fold using a methanol solution
containing 0.1% acetate, 1 mM BHT and 1 µg/mL reserpine. This diluted sample was then
analyzed on FTIRC-MS in positive mode. The other aliquot was also diluted 10 times using a
methanol solution containing 5 mM ammonium acetate, 1 mM BHT and 1 µg/mL reserpine. This
sample was analyzed on FTICR-MS in negative mode.
FTICR-MS experiment was performed on an FT-MS instrument (LTQ-FT; Thermo Electron
Corporation, Bremen, Germany) equipped with a chip-based nanoelectrospray ionization (nESI)
ion source (Triversa NanoMate) (Advion Biosciences, Ithaca, NY, USA). Each sample was
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measured for 15 min and covered the m/z = 150-1,600 range. The mass spectra were recorded
using Fourier Transform Ion Cyclotron Resonance (FTICR) in the profile mode, and the resolving
power (RP) was set at 400,000 at m/z = 400. The maximum ion accumulation time was set at
1,000 ms. The ion optics was tuned for a typical precursor ion mass (taurocholic, m/z 514) in
MS/MS mode with a normalized collision energy of 34 using the linear ion trap (LIT). The two
most important nESI parameters were as follows: the spray voltage = -1.6 kV and the nitrogen
gas pressure = 0.7 psi.
The FTICR-MS data was processed with a software package MetSign. For the metabolite
quantification, the instrument data was first reduced into a peak list using second-order
polynomial fitting (SPF) and Gaussian mixture model (GMM). For metabolite identification, each
peak detected in the FTICR-MS data was first assigned to metabolite(s) recorded in LIPID MAPS,
by matching the experimentally measured metabolite ion m/z value and the profile of the
isotopic peaks with the corresponding theoretical data calculated from the chemical formula of
database metabolites. The threshold for m/z variation was set as ≤ 3 ppm. After cross sample
alignment, contrast normalization was performed to make the abundance of metabolites in all
samples comparable. Pairwise two-tail t-test with up to 1,000 sample permutation was used to
recognize metabolites with significant abundance difference between sample groups by setting
p-value ≤ 0.05.
Catalase Assay: Catalase activity was measured using the Catalase Assay Kit (Cayman Chemical,
707002). Briefly, A. actinomycetemcomitans was cultured in 35mLs of CDM with or without Ne,
ferrous iron, or both for 24 hours. Cells were pelleted at 4,000g for 10 minutes at 4°C. Pelleted
cells were homogenized by sonication in 800 ml of 1X Sample Buffer and then centrifuged at
16,000xg for 5 min at 4°C. A standard curve was constructed using the Catalase Formaldehyde
Standard provided with the kit for different concentrations (0, 5, 15, 30, 45, 60, 75 mM) diluted
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in 1X Sample Buffer. Assays were performed in a 96 well plate and the catalase positive control,
standards, and samples were done in triplicates. Each well contained 1X Assay Buffer, methanol,
and one of the following: catalase positive control, standard or sample of interest. The catalase
reaction was initiated by the addition of 0.035 M hydrogen peroxide, followed by incubation and
shaking at room temperature for 20 minutes. The reaction was terminated by the addition of 10
M Potassium Hydroxide and Catalase Purpald. Covered plates were incubated with shaking at
room temperature for 10 minutes. Finally, Catalase Potassium Periodate was added, and the
covered plates were incubated shaking at room temperature for 5 minutes. Absorbance was
read at 570 nm.
Protein Gels: At 8 hours post-inoculation, 1mL aliquots of A. actinomycetemcomitans cultures
were used to measure the O.D.600nm. 30mL cultures were diluted to similar densities and then
pelleted by centrifugation. The cell pellet was re-suspended in 1mL of phosphate buffer (0.5M
KH2PO4) pH 8 and homogenized by sonication. The cell lysate was centrifuged at 4oC for 5
minutes at 13,000xg to separate the soluble and non-soluble fractions. The soluble fraction was
removed to a clean tube and the non-soluble fraction was re-suspended in 1mL of phosphate
buffer containing 8M urea. Protein concentration of cell extracts was determined using a BCA
assay. 1X of LDS 5X Sample Buffer (141mM Trizma base, 2% lithium dodecyl sulfate, 10%
glycerol, 0.51mM EDTA, 0.22M Serva Blue G, 0.175mM Phenol Red, pH 8.5) (LifeTechnologies)
was added to roughly 1ug of protein and then loaded on a NuPAGE Novex 4-12% Bis-Tris Protein
gel (LifeTechnologies). The gel was run for 50 minutes at 200V. The gel was stained for one hour
with shaking with AquaStain (Bulldog Bio) and then washed with water and visualized.
Construction of TonB Dependent Receptor Mutant: A. actinomycetemcomitans 652 deletion
mutants (Table 1) used in this study were constructed by allelic replacement of the target gene
by double homologous recombination using a suicide vector pJT1 [90]. Briefly, the flanking
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regions of a fragment of the TonB dependent receptor were amplified by PCR using A.
actinomycetemcomitans chromosomal DNA as a template with two primer sets: ww154/155 &
ww156/157. Each primer was flanked with a restriction site as stated above (Table 1). The 1.8kb
and the 393 base pair PCR products were digested with NotI−XhoI and XhoI−PstI respectively,
and both PCR fragments were cloned adjacent to each other (joined by the XhoI restriction site)
into NotI−PstI-digested pJT1 suicide vector to create pWAW23. The recombinant suicide plasmid
was introduced into A. actinomycetemcomitans by electroporation. The cells were incubated for
5 h at 37 °C and plated onto BHI agar containing 50 µg spectinomycin (Sp) ml−1 to select for cells
with single recombinant crossover events. Sp-resistant (Spr) colonies were selected and grown
statically in BHI broth for 24 hr at 37 °C. On the next day, each culture was diluted 1: 200 in
tryptone–yeast-extract (TYE) broth and grown for 24 h at 37 °C. This step was repeated for 3
consecutive days, except that the cultures on day 3 were grown in the presence of 1 mM IPTG.
Afterwards, to select bacteria with a second recombination event resulting in the deletion of the
target gene, cells were diluted 10-fold and spread onto TYE agar supplemented with 1 mM IPTG
and 10 % sucrose and grown for 24 h at 37 °C. Sucrose-resistant (Sucr) colonies were selected
and replica plated onto TYE agar supplemented with sucrose and onto BHI agar supplemented
with spectinomycin. Spectinomycin-sensitive (SpS) colonies were selected to perform PCR to
confirm the deletion of the target gene. SpS colonies that were PCR-positive for the appropriate
gene deletion were chosen for further analysis. Primer sets used to verify by PCR amplification
the expected fragment and nucleotide sequence for each isogenic mutant were: ww158 &
ww159.
Construction of TonB Dependent Receptor Complemented Strains:
For construction of the TonB dependent receptor, complement primers amplifying the entire
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TonB dependent receptor were PCR-amplified from A. actinomycetemcomitans chromosomal
DNA using the primer set: ww175 & ww176. The resulting 2.1kb base pair PCR product was
digested with BamHI-XbaI and cloned with BamHI-Xbal digested pWAW17 resulting in pWAW31.
Statistics:
All experiments were conducted in triplicates for at least three independent experiments. Data
was analyzed by either two-tailed t-test or ANOVA using the InStat program (Graphpad).
Statistical differences were considered significant at the level of p < 0.05.
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CHAPTER THREE: A. ACTINOMYCETEMCOMITANS QSEBC IS ACTIVATED BY CATECHOLAMINES
STRESS HORMONES AND IRON
Introduction:
Bacteria have evolved a specialized signaling transduction mechanism called the twocomponent regulatory system (TCS) as a way to quickly sense changes to the environment and
adapt by changing gene transcription. QseBC is a TCS that is conserved in the Enterobacteriaceae
and the Pasteurellaceae [126]. The A. actinomycetemcomitans QseC sensor kinase contains a
highly conserved acidic motif (EYRDD) [69] and a similar motif (DYRED) in the H. influenzae QseC
homolog (FirS) was shown to be essential for the response to ferrous iron [62]. A.
actinomycetemcomitans QseBC shares 70% sequence similarity to the E.coli QseBC, but differs in
the organization of the operon. In many of the Enterobacteriaceae and Pasteurellaceae, the
qseBC locus is associated with a gene, designated ygiW, that encodes a putative periplasmic
protein in the OB fold family [91], but transcription and genetic organization of ygiW relative to
the qseBC operon varies. In many of the Pasteurellaceae, including A. actinomycetemcomitans,
ygiW is co-transcribed with qseBC but there exists an attenuator region between them [53, 62].
ygiW also resides upstream of qseBC in many of the available Enterobacteriaceae sequences but
in these organisms, it is transcribed from the opposite strand.
The signal that activates the QseC in A. actinomycetemcomitans has not yet been
determined, but it has been shown that QseC regulates virulence and biofilm formation [44, 53].
The expression of qseBC is also regulated by AI-2, but the sensor is not directly activated by AI-2
[44]. qseBC is also part of the AI-2 regulon in E.coli, but quorum sensing-mediated regulation
requires the toxin MqsR of the MqsAR TA system [71].
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In this chapter we show that QseBC is activated by the combination of both
catecholamines and iron (CAT-Fe). In addition, adrenergic receptor antagonists that functioned
to block catecholamine mediated growth responses and QseC activation in E. coli are inactive
against QseC in A. actinomycetemcomitans and at higher concentrations may function as QseC
agonists. These results suggest that there may be significant differences in the structure of the
A. actinomycetemcomitans QseC compared to either eukaryotic adrenergic receptors or the
QseC in E. coli.
Results:
QseC is Not Activated by Catecholamines, Iron, Zinc, or Cold Temperatures
In order to determine the activating signal for QseBC, a lacZ reporter plasmid was
constructed to take advantage of the fact that QseB auto-regulates the operon. The reporter
plasmid, pDJR29, was created by fusing the promoter region for ygiW-qseBC to the lacZ gene.
The strain was then tested in a chemically defined media (CDM) with a variety of conditions that
were reported to activate the QseBC in other bacterial species. Increasing concentrations of
the catecholamine norepinephrine (0-300µM) (Figure 1A), ZnCl2 (Figure 1B), as well as
temperatures down to 4oC (Figure 1C) failed to significantly stimulate QseC compared to the
control condition of A. actinomycetemcomitans grown in CDM at 37oC. Supplementation of
100µM of ferrous or ferric iron failed to significantly stimulate the operon (Figure 2A). In
addition, previous attempts to isolate AI-3 from A. actinomycetemcomitans failed suggesting
that the bacteria does not make that particular quorum sensing molecule [69].
QseC is Activated by a Combination of Iron and Catecholamines
The combination of both ferrous and ferric iron and different catecholamines (i.e.
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norepineprhine or epinephrine) were then tested for the ability to stimulate the QseBC operon
since the individual components failed to do so (Figure 2A). Chemically Defined Media (CDM)
supplemented with either 100 uM ferrous or ferric chloride, 50 uM of norepinephrine (Ne) or
epinephrine (Ep), or a combination of both (CAT-Fe). Supplementation with either single
component, iron or catecholamines, resulted in no significant induction of the operon as shown
previously (Figure 2A).
In contrast, the combination of CAT-Fe resulted in a robust, significant induction of
operon expression suggesting that both signals are required in activating QseBC in A.
actinomycetemcomitans (Figure 2A). The activation of QseC occurred with either
norepinephrine or epinephrine and with either ferrous or ferric iron, in contrast to the qseBC
homolog in H. influenza which responds only to ferrous iron.
To determine if CAT-Fe activation of the QseC sensor was autoinduced and dependent
on a functional QseBC, pJDR29 was transformed into non-polar gene deletion mutants of A.
actinomycetemcomitans that lacked ygiW, qseC or qseB (ΔygiW, ΔqseC and ΔqseB, respectively),
or into a strain in which qseC was replaced by a copy of the qseC gene that did not encode the
periplasmic region of the sensor kinase (qseCΔp). As shown in Figure 2B, lacZ expression in CDM
alone was reduced by approximately 4-fold in the ΔygiW, ΔqseC and ΔqseB strains and no
induction of lacZ expression occurred in the presence of Ep/FeCl2. These results are consistent
with our previous finding that ygiW-qseBC is auto-regulated by QseC-mediated activation of
QseB [53]. Importantly, no Ep/FeCl2-dependent induction of lacZ occurred in A.
actinomycetemcomitans that expressed a QseC protein that lacked the periplasmic domain
(Figure 2B). These results suggest that Ep and Fe+2 function as signals that activate the QseC
sensor and require its periplasmic domain.
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To confirm that Ep/FeCl2-dependent induction of lacZ was mediated by QseB, a family of
reporter plasmids containing a nested series of ygiW-qseBC promoter deletions were tested
(Figure 3A). These constructs were previously described and were used to map the -10, -35 and
QseB binding sites in the ygiW-qseBC promoter [53]. As shown in Figure 3B, ygiW-qseBC
promoter activity was reduced by approximately 35% when nucleotides -94 to -138 were
deleted (compare pDJR63, pDJR57 and pDJR56). However, Ep/FeCl2-dependent induction of
lacZ expression still occurred in each of these constructs. Ep/FeCl2-dependent induction of lacZ
was significantly reduced only after deletion (pDJR58) or site specific mutation (pDJR86) of the
QseB binding site (Figure 3B. This indicates that the interaction of QseB with its binding site is
essential for Ep/FeCl2-dependent induction of the operon and is consistent with a model where
catecholamines and iron represent signals that are recognized by and activate QseC, which in
turn activates the QseB response regulator.
The periplasmic region of A. actinomycetemcomitans QseC contains a sequence (EYRDD,
residues 154-157) that resembles the DYRED motif previously shown to be important for the
sensing of iron by the QseC paralogs of H. influenzae [62]. To determine if this motif in A.
actinomycetemcomitans is important for Ep/FeCl2-dependent activation of QseC, EYRDD was
altered to EAADD by site-directed mutagenesis and the mutant (encoding QseCY155A, R156A) or wild
type qseC alleles together with qseB were integrated by homologous recombination into the
chromosome of A. actinomycetemcomitans ΔqseBC to generate strains ΔqseBC::61 and
ΔqseBC::46, respectively. As shown in Figure 4, lacZ expression from pDJR29 in ΔqseBC::61 was
not significantly induced when cells were cultured in CDM supplemented with Ep and FeCl2. In
contrast, ΔqseBC::46 exhibited a ~5-fold increase in lacZ activity, similar to the wild type (Figure
4). However, lacZ expression in ΔqseBC::61 was approximately 90-fold higher than in the wild
type strain even when cultured in CDM alone (Figure 4). These results suggest that QseCY155A,
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R156A

cannot sense Ep/FeCl2 but may be locked in an activated conformation that results in

constitutive activation of QseB and high expression of the ygiW-qseBC operon.
Adrenergic Receptor Antagonists Fail to Block CAT-Fe Activation of QseC
QseC has been shown to play an essential role in both virulence and biofilm formation.
Therefore, it can be considered a target for any potential therapeutics as a way to modulate the
course of infection. Based on the ability of QseC to sense catecholamines in E. coli, it was
suggested that the sensor acts as a bacterial adrenergic receptor, the eukaryotic receptors that
recognize and respond to catecholamines [55, 102]. Adrenergic receptor antagonists function to
block the recognition of catecholamines by adrenergic receptors in eukaryotes. In E. coli, these
same drugs have been shown to block catecholamine mediated stimulation of growth [80].
Therefore, both the alpha adrenergic receptor antagonist, phentolamine, and the beta
adrenergic receptor antagonist, propranolol, were tested to determine if they could block CATFe activation of QseC.
Both the alpha-blocker phentolamine and the beta blocker propranolol were tested
from 0 µM to 400 µM to determine if they were able to block ygiW- qseBC activation and also
induction of the operon in response to CAT-Fe. At concentrations below 400 µM, both
adrenergic receptor antagonists were unable to block CAT-Fe mediated activation of QseC
(Figure 5A & B). Interestingly, both receptor antagonists alone were able to activate qseBC at
400 µM (Figure 5 C) suggesting that at higher concentrations both drugs might act as QseC
agonists. Activation by propranolol or phentolamine was dependent on the QseC periplasmic
domain since a mutant lacking the periplasmic domain had no significant induction of the
operon in response to either propranolol or phentolamine (Figure 5D).
Discussion:
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The QseBC TCS has been shown previously to play a vital role in pathogenesis of
periodontitis by regulating both biofilm formation and virulence , but little was known about
how it controls these two complex phenotypes or the genes that are regulated by this TCS. In E.
coli and S. enterica, catecholamines and a quorum sensing molecule designated AI-3 have been
shown to activate Qse [61]. Previous work has shown no evidence for the production of AI-3 in
A. actinomycetemcomitans, nor is QseC activated by reduced temperatures or zinc. Instead, our
results show that a combination of iron, either ferrous or ferric, and catecholamines, e.g.
epinephrine or norepinephrine, results in significant induction of the operon and the response
to CAT-Fe is dependent on having a functional periplasmic sensory domain. Thus, the response
of the A. actinomycetemcomitans QseC differs from H. influenzae in that it occurs with either
ferrous or ferric iron and from its E. coli counterpart since activation of A.
actinomycetemcomitans QseBC requires both catecholamines and iron. Ferric iron does cause
an activation of qseBC in E. coli, but not directly [60]. The iron activates the PmrB sensor which
in turn activates the PmrA response regulator which in turn binds to the qseBC promoter and
induces qseBC expression [60]. Interestingly, the QseB binding site of the ygiW-qseBC promoter
region in A. actinomycetemcomitans is identical to the consensus PmrA binding sequence of E.
coli suggesting that in A. actinomycetemcomitans these two TCS might have integrated into one
that responds to both catecholamines and iron.
It remains unclear as to how CAT-Fe is binding QseC: whether both the catecholamine
and iron bind as a complex or if there are separate binding sites for both catecholamine and iron
and activation of QseC only occurs when both sites are occupied. When comparing the amino
acid sequence between eukaryotic adrenergic receptors and QseC there is no striking structural
similarity that would allow for identification of the catecholamine binding pocket. The
differences between eukaryotic adrenergic receptors and QseC is also evident from the data
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that in A. actinomycetemcomitans, drugs that are used as adrenergic receptor antagonists in
eukaryotes do not antagonize Cat-Fe binding and may even function as QseC agonists at higher
concentrations. In addition the inhibition of growth in the presence of high concentrations of
adrenergic receptor antagonists has not been previously observed in E.coli or Salmonella. This
result suggests that these drugs might be toxic to A. actinomycetemcomitans at high
concentration. Although it has been previously reported that some beta adrenergic receptor
antagonists can act simultaneously as agonists and antagonists at high concentration, this has
never been observed for propranolol or any of the alpha blockers [127].
Based on the results from the β-galactosidase assay, YgiW may play a role in QseC
activation by CAT-Fe since the ΔygiW mutant did not show significant induction of the operon in
the presence of Ne/FeCl2. It is possible that YgiW may play a role in delivering catecholamines,
iron, or both to QseC since it is a putative periplasmic solute binding protein. One other possible
explanation for the failure of Ne/FeCl2 to induce qseBC expression is that the overall level of
transcription of the operon may be blocked in the ΔygiW strain. This might occur since a
transcriptional attenuator exists between ygiW and qseB and transcription of qseBC could be
significantly reduced due to the proximity of the transcriptional attenuator to the qseB start
codon in the ΔygiW strain. Therefore, further experiments are needed to determine if YgiW can
interact with CAT-Fe or QseC.
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Figure 1: Expression of the ygiW-qseBC operon in A. actinomycetemcomitans cultures exposed to increasing various
stimuli. β-galactosidase activity was determined after 24 hours of growth. Significant differences (p < 0.05) are indicated
by asterisks and calculated from two independent triplicate experiments by ANOVA. A. A. actinomycetemcomitans 652
harboring the ygiW-qseBC promoter-lacZ reporter plasmid pDJR29 was grown in CDM broth and compared to those
grown in CDM supplemented with increasing concentrations of catecholamine (norepinephrine Ne).

B. A.

actinomycetemcomitans harboring pDJ29 grown in CDM broth and compared to a culture grown in CDM supplemented
with 15µM ZnCl2. C. A. actinomycetemcomitans harboring pDJ29 grown in CDM broth at 37oC then shocked for 15
minutes at 37oC, 25oC, or 4oC.

47

Figure 2: Expression of the ygiW-qseBC operon in A. actinomycetemcomitans cultures exposed to increasing
various stimuli. β-galactosidase activity was determined after 24 hours of growth. Significant differences (p < 0.05)
are indicated by asterisks and calculated from two independent triplicate experiments by ANOVA. A.Expression of
the ygiW-qseBC operon in A. actinomycetemcomitans cultures exposed to catecholamines and iron. A.
actinomycetemcomitans 652 harboring the ygiW-qseBC promoter-lacZ reporter plasmid pDJR29 was grown in CDM
broth and compared to those grown in CDM supplemented with either ferrous or ferric chloride (Fe2+ or Fe3+;
100uM), epinephrine (Ep; 50uM), norepinephrine (Ne; 50uM, or a combination of both catecholamine (50uM) and
iron (100uM). B.1 Expression of ygiW-qseBC in either the Wt strain, ΔqseC, a strain lacking the periplasmic domain of
QseC (qseCΔp), ΔygiW, or ΔqseB grown in CDM broth or CDM supplemented with Ep/FeCl2

Experiments performed in Figure 2B for the ΔqseC, ΔqseB, and qseCΔp mutant were performed by Drs.
Ascension Torres-Escobar and Maria Delores Juarez-Rodriguez.
1
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Figure 32: CAT-Fe-dependent induction of ygiW-qseBC requires a functional QseB binding site. (A) Schematic diagram
of the ygiW-qseBC promoter region and transcriptional fusion constructs pDJR29, pDJR55, pDJR56, pDJR57, pDJR63,
pDJR58, pDJR85 and pDJR86 [53, 101]showing the binding regions for QseB (white boxes), the -10 and -35 promoter
elements (black boxes) and the primary transcriptional start site (bent arrow). Site specific mutations in the QseB
binding site are indicated with the  symbol. The numbering of the nucleotides is relative to the ygiW translational
start codon. (B) β-galactosidase activity in A. actinomycetemcomitans 652 transformed individually with each
reporter plasmid. Cultures were grown in CDM or CDM supplemented with Ep (50µM) and FeCl2 (100µM) and βgalactosidase activity was determined after 24 h of growth. Values are means of results from three independent
experiments ± standard deviations. Statistical analysis was performed by using one-way analysis of variance (ANOVA)
followed by Tukey’s multiple-comparison test. Significant differences (p < 0.05) are indicated by asterisks; n.s., not
significant.

Experiments shown in Figure 3 were performed by Drs. Ascension Torres-Escobar and Maria Delores
Juarez-Rodriguez.
2
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Figure 43: The CAT-Fe induction of ygiW-qseBC is dependent on a putative conserved iron responsive motif, EYRDD.
Point mutations were constructed in the EYRDD motif resulting in QseC Y155A, R156A, which was designated as
ΔqseBC::46. The complemented strain with a fully functional EYRDD motif was designated ΔqseBC::61. Each strain
was tested for QseC activation through the use of the pDJR29 reporter plasmid in a β-galactosidase assay and
compared to that same strain grown in CDM without any supplementation.(n.s. not significant)

Experiments shown in Figure 4 were performed by Drs. Ascension Torres-Escobar and Maria Delores
Juarez-Rodriguez.
3
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Figure 5: QseC is activated by adrenergic receptor antagonists. A & B. lacZ activity of a strain of A.
actinomycetemcomitans harboring the pDJR29 reporter plasmid cultured in CDM supplemented with ferrous iron or
Ne/Fe2+ with 50µM of propranolol (A) or 200µM (B). C. Increasing concentrations of the beta adrenergic receptor
antagonist propranolol (0-400µM) was added to A. actinomycetemcomtians harboring the reporter plasmid pDJR29
and grown in CDM. D. Wt A. actinomycetemcomtians or a strain lacking the periplasmic domain of QseC (qseCΔp)
cultured in CDM with 400µM of phentolamine or propranolol. All experiments were done in triplicate with two
independent trials. P < 0.05.
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CHAPTER FOUR: QSEBC IS A GLOBAL REGULATOR OF A. ACTINOMYCETEMCOMITANS
METABOLISM, OXIDATIVE STRESS RESPONSE, AND IRON ACQUISITION
Introduction:
QseC has been previously shown to be essential for biofilm formation since a mutant
lacking a functional QseC had significant reduction of biofilm formation in A.
actinomycetemcomtians [44, 53]. This same strain was also significantly attenuated in a mouse
model of periodontitis [44]. In addition, QseC has also been suggested to act as a global
regulator of metabolism in E. coli [50]. Together this suggests that QseC plays a vital role in
several essential pathogenesis mechanisms.
In the previous chapter, we showed that the QseC responds to the combination of
catecholamines and iron, suggesting that it acts as a bacterial adrenergic receptor. The field of
microbial endocrinology has evolved in order to characterize the functional outcomes of
catecholamine and other hormone exposure on microbes [57]. The downstream outcomes of
CAT-Fe exposure on A. actinomycetemcomitans was unknown. Although the regulon that is
under the control of QseBC that is differentially regulated in the presence of catecholamines in
E. coli is known, many of these genes do not exist in A. actinomycetemcomitans. For example,
catecholamines have been shown to result in an up-regulation of motility associated genes, but
A. actinomycetemcomitans is non-motile [119]. This suggests that the regulons for E. coli and A.
actinomycetemcomitans evolved in a species specific manner.
Catecholamines are also thought to be used as a vector for the acquisition of an
essential nutrient, iron [57]. Free iron is normally limited in the body, therefore bacteria have
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evolved a wide range of mechanism to acquire it. The use of siderophores, such as enterobactin,
vibriobactin, and yersiniabactin, is often a common tactic employed by bacteria to acquire iron.
Siderophores work by sequestering iron at a higher affinity than host iron-binding proteins. The
siderophores are then recognized by the bacteria and taken up via specific receptors and
transport machinery. The ligands siderophores use to capture iron can vary, such as hydroxamate
in ferrichrome or catecholates in enterobactin, which uses the same mechanism by which
catecholamines can scavenge iron [57]. A variety of iron acquisition and regulatory mechanisms
have been associated with virulence as well as biofilm and growth stimulation [128].
A. actinomycetemcomitans employs a wide-variety of mechanism by which to acquire
iron. It can directly bind heme, and hemoglobin and lactoferrin [97-100], but so far no evidence
has been found to suggest that it can synthesize any kind of siderophore. However,
A.actinomycetemcomitans encodes a putative enterobactin transporter and receptor
(D11S_1352-1357). One possible function of this operon in A. actinomycetemcomitans is that it
imports enterobactin made by other oral pathogens, but it is also possible that it might function
in catecholamine mediated iron acquisition. The catecholamine mediated growth induction seen
in E. coli was dependent on a functional enterobactin biosynthesis and transport system,
suggesting that it plays a vital role in the acquisition of catecholamines [58]. Taken together this
evidence could explain the role of stress in the development of periodontitis since stress is
associated with the development and exacerbation of periodontitis.
In this chapter, we characterize the QseBC regulon and show that exposure to CAT-Fe
results in an up-regulation of genes encoding proteins involved in anaerobic respiration and
metabolism. In addition, exposure to CAT-Fe up-regulates genes involved in the oxidative stress
while down-regulating genes involved in iron acquisition, fatty acid, lipid and LPS biosynthesis.
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Finally, we also show that QseBC stimulates biofilm formation and planktonic growth, which is
contingent on having a functional QseC periplasmic domain and a functional TonB dependent
receptor.
Results:
CAT-Fe exposure Induces Genes Involved in Anaerobic Respiration and Metabolism and
Increases the Flux through the TCA Cycle
To characterize the QseBC regulon, a custom microarray was designed using
oligonucleotide probes from the OligoArray Database for A. actinomycetemcomitans D11S at the
University of Michigan. cDNA from Wt cultures grown in either CDM or CDM supplemented with
Ne/FeCl2 was hybridized to the array. There were 235 genes (roughly 11.5% of the A.
actinomycetemcomitans genome) that were differentially regulated by 2-fold or greater when
exposed to Ne/FeCl2 compared to cells grown in just CDM (Appendix Table 1). Of these 235
genes, 135 genes were down-regulated and 99 genes were up-regulated and for many of these
genes, the array results were confirmed by qRT-PCR (Appendix Table 1). In confirmation with the
previous β-galactosidase assays, one of the most highly up-regulated operons with
norepinephrine and iron treatment was ygiW-qseBC, and this was also confirmed with qRT-PCR.
Interestingly, there was no significant change in expression of many of the well-characterized
virulence factors: tad fimbriae and the collagen adhesin, EmaA. Other virulence determinants
such as the cytolethal distending toxin was down-regulated around 1.5 fold and the biofilm
lipoprotein pgaB and the leukotoxin (ltxA and ltxC) were down-regulated around 2.1 fold.
Leukotoxin expression was also confirmed on a SDS-PAGE gel where the band correlating to the
leukotoxin (116kDa) was reduced in CAT-Fe exposed cells (Figure 6).
Of the 99 genes up-regulated with Ne/FeCl2 treatment, 56 of those genes encoded
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proteins associated with anaerobic respiration and metabolism (Table 4). The differentially
regulated genes included genes encoding proteins for a hydrogenase complex, metabolism of
aspartate, fumarate, malate, oxaloacetate, pyruvate and formate, and reduction of nitrate,
DMSO, trimethylamine-N-oxide, fumarate and formate. Six differentially expressed operons
encoded components associated with anaerobic electron transport, e.g., the nap operon
(D11S_0205–0210), an operon involved in the biogenesis of c-type cytochromes (D11S_2000–
1990), the hydrogenase-4 complex and hydN (D11S_1735–1747 and D11S_1092-1093) involved
in electron transport from formate to hydrogen and the oxidation of hydrogen, D11S_1412-1413
involved in trimethylamine N-oxide anaerobic respiration, and D11S_0493-0494 encoding a
dimethylsulfoxide terminal reductase.
At least four additional induced operons and several other singlet genes encode
proteins that may also be associated with anaerobic metabolism. D11S_0303 and D11S_1771
each encode a C4 dicarboxylate transporter involved in the utilization of aspartate and fumarate.
Consistent with this, D11S_0597 encodes aspartate ammonia lyase which converts aspartate to
fumarate, D11S_0810–0812 encodes a fumarate reductase, and D11S_1061 encodes fumarate
hydratase. Other up-regulated operons code for oxaloacetate decarboxylase (D11S_1379-1381)
which converts oxaloacetate to pyruvate. Other genes associated with anaerobic metabolism
included D11S_1748-1749 and D11S_1986-1989 which encode formate dehydrogenase and
catalyze the formate dependent reduction of nitrite to ammonia, respectively.
Since several of the genes that were differentially regulated were involved in formate
metabolism, an extracellular formate assay was performed using supernatants from cultures
grown in CDM with or without Ne/FeCl2. Formate levels were significantly increased in
supernatants from cultures supplemented with Ne/FeCl2 compared to CDM (Figure 7) confirming
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predictions based on observations from the microarray.
Since the microarray results and the formate assay suggested that significant changes to the
metabolic profile of A. actinomycetemcomitans occur upon activation of QseBC, a metabolomics
approach was used to confirm changes in metabolites suggested by the changes in gene
expression and to further examine the overall global metabolic changes that occur in response
to CAT-Fe. Water soluble and lipid soluble fractions were isolated from A.
actinomycetemcomitans cultured in CDM with or without supplementation Ne/FeCl2 and were
analyzed by mass spectroscopy as described in Materials and Methods (Chapter 2). The first
group of metabolites that were significantly changed were metabolites involved in carbon
metabolism. Data from the water soluble fraction (Table 5) were consistent with changes
suggested by the microarray as there were significant increases in fumarate, malate, aspartate,
and mannose. Combining the data from both the microarray and the metabolomics approaches
suggest that there may be an increase in flux through glycolysis from the import of mannose and
increase in Glucose-6-phosphate, as well as an increase in activity of the TCA cycle since many of
the enzymes and intermediates of the TCA cycle are induced or increased (Figure 8). However,
succinate levels were decreased most likely due to efficient conversion to fumarate. These
pathways converge into the formation of pyruvate which can then be channeled to energy
forming pathways such as fermentation or anaerobic respiration via the electron transport chain
(Figure 8).
Treatment with Ne/FeCl2 also resulted in an increase of gluconic acid, 6phosphocgluconate, and glucose-6-phosphate compared to cells grown in CDM alone (Table 5).
These metabolites are associated with the Entner–Doudoroff pathway that catabolizes glucose
to pyruvate and suggest that Ne/FeCl2 treatment results in stimulation of part of this pathway. A.
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actinomycetemcomitans does not have a complete Entner-Duodoroff pathway but does possess
the genes of the pathway that result in the production of pyruvate and glyceraldehyde 3phosphate, which is eventually converted to pyruvate. This represents one of many pathways,
including oxaloacetate decarboxylase that is up-regulated in A. actinomycetemcomitans and
leads increased pyruvate levels.
The metabolism of several amino acids was also significantly altered. The most striking is
the increase in the levels of aspartate. This amino acid can feed into the TCA cycle through its
conversion to fumarate and the gene encoding the enzyme that carries out this reaction,
aspartate ammonia lyase was also significantly induced. In contrast, treatment with Ne/FeCl2
resulted in a significant decrease of cysteine and tyrosine and consistent with this, the
microarray data showed down-regulation of the tyrosine-specific transport protein (D11S_1053)
and the cysteine synthase subunit alpha (D11S_1533).
CAT-Fe Results in an Up-Regulation of the Oxidative Stress Response
In addition to inducing genes involved in anaerobic metabolism, Ne/FeCl2 treatment also
up-regulates genes involved in the oxidative stress response. The up-regulated genes associated
with oxidative stress included quinol peroxidase (5-fold; D11S_1676), alkylhydroperoxidase ahpD
(4-fold; D11S_0383), catalase (1.4-fold; D11S_2121), and the oxidative stress response regulator
arcA (1.8-fold; D11S_1888). In order to confirm changes in catalase activity, a catalase activity
assay was performed with cell lysates from cultures grown in CDM alone or CDM supplemented
with either Ne, FeCl2, or Ne/FeCl2. As shown in Figure 9B, catalase activity was significantly
increased in cells grown with Ne/FeCl2 supplementation compared to cells grown in CDM alone.
In order to determine if the changes in gene expression and catalase activity correlated
with changes in the ability of the bacteria to respond to oxidative stress, an assay was performed
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to measure growth of A. actinomycetemcomitans after exposure to H2O2 stress. Cells were
cultured in CDM with or without supplementation with Ne, FeCl2, or Ne/FeCl2. . At mid-log, the
cultures were split into two aliquots. One aliquot was then exposed to the H2O2 stress for 15
minutes and the other served as a control. Growth was then assessed 5 hours and 12 hours later
(only 5 hours shown). Cells exposed to Ne/FeCl2 had a significant increase in survival after
exposure to H2O2 compared to cells grown in CDM, norepinephrine or ferrous iron suggesting that
CAT-Fe exposure results in a greater resistance to oxidative stress (Figure 9A).
It has been reported previously that high iron levels can lead to the formation of hydroxyl
radicals [115, 116] which may explain the up-regulation of genes involved in oxidative stress. In
addition, the up-regulation of ferritin also suggests high intracellular iron levels. Therefore, we
determined if the up-regulation in oxidative stress genes and catalase activity in Ne/FeCl2 treated
cells could be explained by a significant increase in intracellular iron. An intracellular iron assay
was performed with cell lysate from cells grown in CDM supplemented with either FeCl2 or
Ne/FeCl2. Surprisingly, there was no significant differences in intracellular iron content for cells
grown in CDM or cells grown in Ne/FeCl2 (Figure 9C), although only cells grown in CDM with
Ne/FeCl2 showed significant up-regulation of oxidative stress genes, catalase activity, and had a
significant reduction of inhibition of growth in the presence of H2O2 stress.
CAT-Fe Results in a Down-Regulation of High Affinity Iron Acquisition Genes and UpRegulation of Ferritin
The genes that were down-regulated with Ne/FeCl2 exposure were more diverse
in their putative functions. However, twenty of the 135 down-regulated genes (~15%) encode
proteins associated with high affinity iron transport (Table 6). Within this group, four operons
encode putative ABC-type iron transporters (e.g., D11S_0621-0622, D11S_815-818, D11S_1128-
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1131 and D11S_1557-1558). Other down-regulated genes encode putative outer membrane
iron receptors (D11S_1630 and D11S_1864) and consistent with this, the expression of tonB
components (D11S_487-489) are also reduced by approximately 5-fold. This suggests that CDM
supplemented with Ne/FeCl2 may represent an iron replete environment and consistent with
this, the iron storage protein ferritin was induced by over 10-fold in the array experiment.
Together these results suggest that Ne/FeCl2 exposure increases intracellular iron storage
capacity and decreases high affinity iron acquisition transporters.
CAT-Fe Exposure Down-Regulates Fatty Acid, Lipid and LPS Biosynthesis and Dramatically
Changes the Lipid Profile in A. actinomycetemcomitans.
The most notable group of metabolites that were decreased in the water soluble group
after treatment with Ne/FeCl2 were fatty acids including myristic acid, palmitelaidic acid,
palmitic acid, nonanoic acid, and hydroxymyrisitc acid. Using a 2-fold cutoff in the microarray
experiment, there was not a notable change in the transcription of genes encoding enzymes
involved in fatty acid biosynthesis. However, using a 1.5-fold cutoff showed a consistent downregulation of genes involved in fatty acid, lipid and LPS biosynthesis (see Table 7). Some notable
examples include acyl coA thioesterase (D11S_0833) which converts palmityl-coA to palimitic
acid, an operon involved in forming long chain fatty acids from acetyl coA (D11S_0525-0526),
rfaL (D11S_0359), and a gene encoding a lipopolysaccharide heptosyltransferase rfaF
(D11S_0203). In addition, several genes encoding various lipoproteins were down-regulated
such as D11S_1952, the lipoprotein vacJ (D11S_0144), D11S_0631, and D11S_0745. There was
also a significant up-regulation of 2.2-fold of D11S_2125, the gene encoding a putative longchain-fatty-acid--CoA ligase-like, which is involved in fatty acid degradation.
Together these data suggest that there may be a substantial alteration of the plasma
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membrane in response to CAT-Fe. Consistent with this, the lipid soluble data from the
metabolomics approach identified numerous lipid species that were increased or decreased in
response to CAT-Fe exposure (see Table 8). While many of these metabolites could not be
specifically identified by mass spectroscopy, the results suggest that for cells exposed to CAT-Fe,
there may be a decrease of long-chained fatty acids (Table 8). Treatment with Ne/FeCl2 also
resulted in a significant up-regulation of an isoprenoid, which is a class of molecules that include
the quinones and hydroquinones. These molecules can function in electron transport which is
consistent with the induction of electron transport systems observed in the microarray results.
Discussion:
Although the QseBC regulon and downstream functional outcomes of catecholamine
exposure have begun to be characterized for E.coli and Salmonella spp., little was known about
the response of A. actinomycetemcomitans. However, give that many of the QseBC-regulated
genes of E. coli are not present in the A. actinomycetemcomitans genome, it is likely that the
QseBC regulon differs significantly. Indeed in E.coli, catecholamines induce a variety of virulence
factors, but using a custom genomic microarray, we showed that under conditions in which
QseBC is activated (i.e., CAT-Fe exposure) the expression of many of the well-characterized A.
actinomycetemcomitans virulence factors, e.g., tad fimbriae, autotransporter epithelial cell
adhesins, and EmaA were unchanged or decreased slightly (e.g., the leukotoxin, pgaB, and the
cytolethal distending toxin). Approximately 11% of the A. actinomycetemcomitans genome was
differentially expressed upon exposure to CAT-Fe and 63% of these genes were organized into
operons where at least one other gene in the operon was also differentially regulated.
The most striking result was the induction of associated with anaerobic respiration and
metabolism, which suggests that a primary function of QseBC is to prime the cell for growth in
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an anaerobic environment. These results were further confirmed using a metabolomics
approach and together, our results suggest that the activation of QseBC increases metabolism
and energy production through glycolysis and the TCA cycle to generate pyruvate, which can
subsequently feed into various fermentation pathways and/or anaerobic electron transport
mechanisms.
Interestingly, many of the QseBC-regulated genes identified in this study were also
shown to be induced using RNA-seq in an in vivo abscess model of A. actinomycetemcomitans
virulence but not when A. actinomycetemcomitans was grown as an in vitro biofilm [52]. In that
study, Jorth et al reported that 14% of the genome was differentially regulated by 2-fold or
greater when A. actinomycetemcomitans grown in vivo, and many of the differentially regulated
genes encoded proteins and enzymes that were involved in anaerobic respiration and
metabolism [52]. Thus, we can speculate that in Jorth et al. [52], QseBC may sense
catecholamines released by neutrophils responding to the infection [25, 74] and may be
essential for priming cellular metabolism for the host environment, e.g., the anaerobic
environment of the subgingival pocket. Furthermore, A. actinomycetemcomitans may be
exploiting this aspect of the host response via QseBC to detect catecholamines and iron in order
to acquire this essential nutrient. Finally, since QseBC does not significantly regulate the
expression of A. actinomycetemcomitans virulence factors, the shift in metabolism that occurs
upon activation of the TCS may represent the primary role of QseC in virulence.
Surprisingly, there was also an up-regulation of genes associated with the oxidative stress
response along with an increase in catalase activity. The induction of oxidative stress genes was
unexpected given the apparent metabolic shift towards anaerobic metabolism and respiration.
One possibility is that A. actinomycetemcomitans is often exposed to H2O2 in the oral cavity,
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produced either from the neutrophil respiratory burst or by other oral organisms such as
Streptococcus gordonii. Therefore, an increase in expression of oxidative stress genes and
resistance to H2O2 may be required to both persist in a complex microbial community and evade
the host response. Alternatively, it has been reported that high iron levels can induce oxidative
stress via hydroxyl radical formation via the Fenton reaction [115, 116]. If hydroxyl radicals from
iron were the cause of the oxidative stress, then a significant increase in intracellular iron in CATFe treated cells would be expected relative to ferrous iron treated cells. However, there was no
significant differences in intracellular iron content for cells grown in CDM or cells grown in CATFe (Figure 4E), although only cells grown in CDM with CAT-Fe showed significant up-regulation of
oxidative stress genes, catalase activity, and had a significant increase in survival in the presence
of H2O2 stress. Therefore, the increase in genes associated with oxidative stress does not appear
to be caused by iron toxicity. Consistent with this, the up-regulation of ferritin suggests that iron
is being safely sequestered by iron storage proteins where it is less likely to cause damage to the
cell via radical formation. Catecholamines have been shown to induce oxidative stress in
eukaryotic cells via their breakdown by monoamine oxidase.

A search of the A.

actinomycetemcomitans genome did not identify a gene with homology to this enzyme but the
metabolomics results did identify putative breakdown products of norepinephrine in A.
actinomycetemcomitans.

The

mechanism

of

catecholamine

degradation

in

A.

actinomycetemcomitans is not currently known, but this may represent another possible
mechanism for inducing oxidative stress and genes involved in the oxidative stress response. It
has also been previously reported that catecholamines can induce oxidative stress genes in P.
gingivalis and Burkoholderia pseudomallei, although the mechanisms behind the induction are
not clear.
An additional group of genes that were differentially expressed upon exposure to CAT-
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Fe encoded iron acquisition transporters. In general, these operons were significantly downregulated, suggesting that CDM supplemented with CAT-Fe represented an iron replete medium
and that under these conditions, A. actinomycetemcomitans does not require high affinity iron
uptake systems. Interestingly, expression of the putative enterobactin transport/receptor
operon was unchanged when cells were exposed to CAT-Fe, suggesting that it may be the main
iron uptake system that is present in cells grown in CAT-Fe supplemented medium. In contrast
to iron transport operons, ferritin was significantly up-regulated by 10-fold, suggesting that the
bacteria required an increase in iron storage. This is consistent with cellular growth in an iron
replete environment and the need to safely sequester high levels of intracellular iron.
Lastly, CAT-Fe exposure dramatically changed the lipid profile of A.
actinomycetemcomitans and resulted in down-regulation of genes involved in fatty acid, and
lipid and LPS biosynthesis. Since LPS is an endotoxin and one of the pathogen associated
molecular patterns (PAMP), the down-regulation of LPS synthesis may aid in the persistence of
the pathogen and evasion of killing by immune cells. In addition, the significant decrease in
several fatty acids, most notably stearic and myristic acid is interesting since these fatty acids
are often used to modify leukotoxin, and important virulence factor. Interestingly, leukotoxin
expression was also significantly down-regulated. The functional outcomes of the changes in
the lipid profile of the cell are still unknown. In cells exposed to CAT-Fe, there appeared to be a
decrease in long-chained fatty acids (Table 8). This may result in greater fluidity in the plasma
membrane. Interestingly, a change in membrane fluidity has been shown to act a mechanism of
regulation of TCS and specifically, temperature dependent membrane fluidity regulates the
activation status of the DesK sensor kinase of Bacillus subtilis. We can speculate that QseBCmediated signaling may be influenced by changes in membrane fluidity.
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Figure 6: Leukotoxin expression in response to Ne/FeCl2. Whole cell extract from cells grown in triplicate
from two independent experiments was run on a PAGE gel and stained to visualize proteins. A representative gel is
shown in Figure 6. The lanes on the representative gel were as follows: 1) the soluble fraction of A.
actinomycetemcomitans grown in CDM, 2) ladder, 3) the soluble fraction of cells grown with ferrous iron
supplementation, 4) the soluble fraction of cells grown with Ne supplementation, 5) the soluble fraction of cells grown
with Ne/FeCl2 supplementation, 6) the insoluble fraction of cells grown in CDM 7) the insoluble fraction of cells grown
with ferrous iron supplementation, 8) the insoluble fraction of cells grown with Ne supplementation, 9) the soluble
fraction of cells grown with Ne/FeCl2 supplementation. The band for the leukotoxin appears at 116 kilodaltons.
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Figure 7: Extracellular concentration of formate. Supernatant from A. actinomycetemcomitans was collected
from cultures grown in CDM or with Ne/Fe2+ supplementation and analyzed for extracellular formate. Formate
concentrations were determined from two independent experiments performed in triplicate. Statistical significance is
determined from a p < 0.05.
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Figure 8: Changes in metabolic flux in A. actinomycetemcomitans in response to CAT-Fe exposure as suggested by
metabolomics and microarray data. Metabolites and enzymes in red are increased or up-regulated, ones in green are
decreased or down-regulated, and ones in black experienced no change.
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Figure 9: Oxidative stress response resulting from exposure to Ne/FeCl2. A) A. actinomycetemcomitans was grown for
16 hours in CDM with or without Fe2+, Ne, or both and then stressed for 15 minutes with H2O2 or rested. Growth was
measured by O.D.600NM 5 hours afterwards and inhibition of growth in response to H2O2 was calculated and subtracted
from 100 to get percent survival. B) A. actinomcyetemcomitans grown in CDM with or without Fe2+, Ne, or both was
lysed after 24 hours and analyzed for catalase activity. C) The intracellular iron content for cells cultured in CDM with
Fe2+ or Ne/Fe2+ as measured by O.D.540nm by the reaction of free iron from cell lysate with Ferene S. All experiments
were done in triplicate with two independent trials. P < 0.05.
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Table 4

Genes Associated with Anaerobic Metabolism

ID Tag

Product

Fold
Change

P-Value

D11S_0205
D11S_0206
D11S_0207
D11S_0208
D11S_0209
D11S_0210
D11S_0303
D11S_0493
D11S_0494
D11S_0495
D11S_0809
D11S_0810

cytochrome c-type protein TorC
periplasmic nitrate reductase, diheme cytochrome
ferredoxin-type protein NapH
quinol dehydrogenase periplasmic component
periplasmic nitrate reductase, large subunit
NapD protein
anaerobic C4-dicarboxylate membrane transporter
anaerobic dimethyl sulfoxide reductase chain A
anaerobic dimethyl sulfoxide reductase chain B
anaerobic dimethyl sulfoxide reductase chain C
fumarate reductase subunit D
fumarate reductase subunit C (Fumarate reductase

3.05
2.94
3.36
2.74
4.92
6.69
2.41
2.26
2.23
1.85
1.95
2.39

3.52E-06
2.25E-06
1.20E-05
1.28E-05
7.68E-06
7.91E-07
5.75E-05
1.52E-04
9.61E-06
2.10E-03
6.12E-04
1.51E-05

D11S_0811
D11S_0982
D11S_1092
D11S_1093
D11S_1094
D11S_1256
D11S_1257
D11S_1264
D11S_1376
D11S_1379
D11S_1380
D11S_1381
D11S_1412

fumarate reductase iron-sulfur subunit
glycerate dehydrogenase
hydrogenase accessory protein HypB
hydrogenase expression/formation protein HypD
hydrogenase expression/formation protein HypE
cytochrome c-type biogenesis protein CcdA
peptide methionine sulfoxide reductase
glycerol-3-phosphate dehydrogenase, (gpd-m)
hydrogenase assembly chaperone HypC/HupF
oxaloacetate decarboxylase gamma chain 3
oxaloacetate decarboxylase alpha subunit
oxaloacetate decarboxylase beta chain
cytochrome c-type protein TorY

2.39
1.66
1.80
1.57
1.40
1.56
1.72
1.95
1.88
4.74
4.44
4.31
7.68

2.15E-05
1.76E-03
3.50E-05
1.16E-03
2.01E-03
2.29E-03
6.12E-04
1.75E-02
6.28E-05
3.30E-07
3.21E-07
2.69E-06
3.50E-05
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D11S_1413
D11S_1735
D11S_1736
D11S_1737
D11S_1738
D11S_1739
D11S_1740
D11S_1741
D11S_1742
D11S_1743

trimethylamine-n-oxide reductase 2
[NiFe] hydrogenase maturation protein HypF
electron transport protein HydN
hydrogenase-4 component B
hydrogenase-4 component B
hydrogenase-4 component C
hydrogenase-4 component D
hydrogenase-4 component E
hydrogenase-4 component F
hydrogenase-4 component G

4.67
2.58
18.44
14.93
15.02
10.68
10.59
7.95
7.76
5.89

1.16E-03
8.83E-04
5.00E-09
1.54E-08
1.42E-09
1.60E-07
3.57E-08
5.22E-07
4.85E-08
1.38E-07

D11S_1744
D11S_1745
D11S_1746
D11S_1747
D11S_1748
D11S_1749
D11S_1771
D11S_1811
D11S_1888
D11S_1982
D11S_1984
D11S_1986
D11S_1987
D11S_1988
D11S_1989

hydrogenase-4 component H
hydrogenase-4 component I
hydrogenase-4 component J
hydrogenase maturation peptidase HycI
formate dehydrogenase H
formate dehydrogenase, alpha subunit
C4-dicarboxylate membrane transporter
bifunctional acetaldehyde-CoA/alcohol dehydrogenase
TorCAD operon transcriptional regulatory protein
cytochrome C-type biogenesis protein
cytochrome c-type biogenesis protein CcmF
NrfD protein
cytochrome c nitrite reductase, Fe-S protein
cytochrome c nitrite reductase, pentaheme
nitrite reductase (cytochrome; ammonia-forming)

5.87
5.40
4.62
4.79
10.42
10.01
1.73
2.72
1.86
1.95
3.87
11.60
13.63
17.09
18.44

3.07E-07
5.18E-07
8.70E-08
1.03E-06
5.29E-09
5.95E-08
1.02E-05
1.04E-06
1.62E-04
5.63E-04
1.84E-05
1.14E-07
4.20E-07
2.38E-09
5.00E-09

D11S_1993

cytochrome c-type biogenesis protein CcmH

1.57

1.41E-03

D11S_1995
D11S_1996
D11S_1997
D11S_1998
D11S_1999
D11S_2000
D11S_2131

cytochrome c-type biogenesis protein CcmF
cytochrome c-type biogenesis protein CcmE
Heme exporter protein D (CcmD)
CcmC
heme exporter protein CcmB
heme ABC exporter, ATP-binding protein CcmA
anaerobic ribonucleotide reductase-activating

2.39
2.45
2.66
3.16
2.69
3.30
1.84

5.05E-05
3.65E-06
5.69E-07
7.34E-06
1.88E-06
1.80E-05
8.83E-04
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Table 5: Water Soluble Metabolites

Malic acid(S);(C ) (Y )

3.22

Fumaric Acid(Y )

3.15

D-glucose 6-phosphate (Y)

2.30

Succinic acid (C ) (Y )

0.42

Oxalic acid (Y)

1.89

Gluconic acid, γ-lactone (Y)

1.52

d-Mannose; d(+)-Mannose (Y)

1.56

Lactic acid (C ) (Y)

0.80

L-Aspartic acid (C ) (Y)

3.18

4-Ketoglucose (Y)

1.17

D-Galactofuranose 6-phosphate (Y)

2.50

Hypoxanthine (Y)

1.78

Uracil (Y)

1.99

Cytosine (Y)

1.97
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Metabolite

Fold
Change

P-value
7.25E06
4.35E05
2.03E04
8.13E04
8.22E04
6.42E03
1.68E02

3.28E02
3.35E03
3.21E02
9.73E04
3.28E02
3.26E05
1.34E04

Confirmed with Standard
Yes
Yes
No
Yes
Yes
No
Yes

Yes
Yes
No
No
No
No
No
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2-amino-6-hydroxypurine (Y)

1.75

Thymine (Y)

1.50

Adenine (Y)

1.49

2,6-Dihydroxypurine (Y)

1.65

4-Hydroxypyridine; 4-Pyridinol (Y)

1.22

5-oxo-L-Proline; L-Pyroglutamic acid; Pidolic acid (C ) (Y)

1.29

Tyrosine (Y )

0.78

L-Cysteine

0.36

L-Isoleucine(Y)

1.56

Hydroxyproline (Y)

1.37

Glycine (Y )

0.90

Palmitelaidic acid (C ) (Y)

0.34

Myristic acid; Tetradecanoic acid (Y)

0.47

Palmitic acid (Y)

0.67

Myristoleic acid (Y)

0.51

3-Hydroxymyristic acid,3-hydroxytetradecanoic acid (Y)

0.52

1.25E03
3.08E03
3.14E03
1.76E02
3.06E02
3.06E02
4.01E03

3.12E03
2.04E02
2.84E02
2.84E02
1.23E03
1.25E03
3.12E03
5.79E03
7.21E03

No
No
No
No
No
Yes
Yes

Yes
No
No
No
Yes
Yes
Yes
Yes
No

Nonanoic acid; Pelargonic acid (Y)

0.73

Pyroglutamic acid; PCA (Y)

1.83

Putrescine; 1,4-Diaminobutane (Y)

0.44

Ethanimidic acid (Y)

2.23

Lanthionine (Y)

2.75

3.27E02
1.89E04
1.81E03
7.21E03
7.67E03

No
No
No
No
No
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Table 6: Genes Involved in Iron Acquisition

ID Tag
D11S_0236
D11S_0237
D11S_0620
D11S_0621
D11S_0622
D11S_0815
D11S_0816
D11S_0817
D11S_0818
D11S_0842
D11S_1128
D11S_1129
D11S_1130
D11S_1131
D11S_1557
D11S_1558
D11S_1559
D11S_1560
D11S_1809

Product
heme utilization protein
heme-utilization protein Hup
ferric cations import ATP-binding protein FbpC
iron(III)-transport system permease protein FbpB
ferric iron binding protein
iron(III) dicitrate transport ATP-binding
ABC transporter, iron chelate uptake transporter
iron(III) dicitrate transport system permease
iron(III) dicitrate-binding periplasmic protein
hemoglobin binding protein A
iron(III) dicitrate transport ATP-binding
iron(III) transport system permease protein
putative iron/heme permease
putative periplasmic siderophore binding protein
high-affinity Fe2+/Pb2+ permease
high affinity Fe2+ transporter
putative Fe2+ permease
FtsX-like permease
heme acquisition system receptor

74

Fold
Change
0.55
0.62
0.57
0.18
0.19
0.12
0.11
0.17
0.16
0.58
0.22
0.33
0.23
0.14
0.25
0.12
0.14
0.16
0.46

P-value
3.28E-02
4.07E-03
3.49E-02
1.94E-05
1.30E-07
2.42E-05
1.72E-04
6.78E-06
1.05E-06
2.67E-02
3.94E-05
1.98E-03
4.24E-04
5.47E-05
3.03E-04
1.28E-05
4.81E-05
3.33E-04
1.04E-04

Genes Involved in Fatty Acid, Lipid and LPS
Synthesis

ID Tag

Product

Fold
Change

P-value

D11S_0011
D11S_0033
D11S_0077
D11S_0079
D11S_0144
D11S_0166
D11S_0167
D11S_0168
D11S_0203
D11S_0250
D11S_0253

phosphatidylserine decarboxylase
phospholipase/carboxylesterase
acetyl-CoA:acetoacetyl-CoA transferase subunit
short chain fatty acids transporter
lipoprotein VacJ
PgaA
biofilm PGA synthesis lipoprotein PgaB
biofilm PGA synthesis N-glycosyltransferase
lipopolysaccharide heptosyltransferase II
UDP-3-O-[3-hydroxymyristoyl] glucosamine
lipid-A-disaccharide synthase

0.71
0.63
0.51
0.51
0.50
0.53
0.47
0.56
0.70
0.67
0.77

2.80E-03
3.49E-03
1.76E-02
1.53E-02
5.55E-03
6.91E-03
3.95E-06
7.22E-03
1.03E-02
1.71E-03
1.95E-02

D11S_0257
D11S_0259
D11S_0284
D11S_0352
D11S_0359
D11S_0381
D11S_0394
D11S_0525
D11S_0526
D11S_0533
D11s_0534
D11S_0631
D11S_0745

CDP-alcohol phosphatidyltransferase
phosphatidate cytidylyltransferase
N-acetylmuramic acid 6-phosphate etherase
CDP-diacylglycerol--serine
RfaL protein
3-deoxy-D-manno-octulosonic acid kinase (KDO
glycerophosphoryl diester phosphodiesterase
beta-ketoacyl-ACP synthase IV
3-oxoacyl-(acyl-carrier-protein) reductase,
glycosyl transferase, family 2
glycosyl transferase, group 2 family protein
lipoprotein
lipoprotein, putative

0.72
0.67
0.41
0.52
0.42
0.78
0.59
0.61
0.79
0.54
0.57
0.65
0.65

5.28E-03
1.59E-03
4.20E-05
1.74E-03
1.20E-03
1.95E-02
1.12E-02
6.46E-04
1.11E-02
3.33E-03
2.86E-02
1.83E-03
6.93E-03
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Table 7
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D11S_0829
D11S_0833
D11S_0916
D11S_0994
D11S_1076
D11S_1181
D11S_1219
D11S_1221
D11S_1260
D11S_1320

monofunctional biosynthetic peptidoglycan
hypothetical protein; acyl-CoA thioesterase YciA
CDP-diacylglycerol--glycerol-3-phosphate
phosphatidylglycerophosphatase A
enoyl-[acyl-carrier-protein] reductase
acetyl-CoA carboxylase, carboxyl transferase,
3-deoxy-D-manno-octulosonate
tetraacyldisaccharide 4'-kinase
phosphoheptose isomerase (Sedoheptulose
2-acyl-glycerophospho-ethanolamine

0.51
0.58
0.50
0.45
0.75
0.80
0.49
0.54
0.79
0.82

2.75E-04
8.78E-04
5.96E-04
6.65E-03
4.95E-03
9.47E-03
2.82E-03
6.65E-03
1.94E-02
3.25E-02

D11S_1369
D11S_1578
D11S_1610
D11S_1612
D11S_1667
D11S_1668
D11S_1704
D11S_1944
D11S_1945
D11S_1952
D11S_2089
D11S_2104
D11S_2137
D11S_2154

3-deoxy-D-manno-octulosonate 8-phosphate
N-acetylglucosamine-6-phosphate deacetylase
lipid A biosynthesis (KDO)2-(lauroyl)-lipid IVA
peptidoglycan amidase MepA
HldE
lipid A biosynthesis lauroyl acyltransferase
lipopolysaccharide biosynthesis protein
UDP-2,3-diacylglucosamine hydrolase
1-acyl-sn-glycerol-3-phosphate acyltransferase
lipoprotein, putative
acetyl-CoA carboxylase, biotin carboxylase
prolipoprotein diacylglyceryl transferase
lipoic acid synthetase
fatty acid/phospholipid synthesis protein PlsX

0.78
0.66
0.62
0.78
0.59
0.36
0.63
0.72
0.73
0.63
0.80
0.57
0.52
0.43

7.95E-03
3.58E-03
4.48E-03
3.13E-02
4.36E-03
3.73E-03
1.59E-03
8.05E-03
4.92E-03
6.99E-03
4.04E-02
3.04E-03
3.00E-03
2.01E-04

Table 8: Lipid Soluble Metabolites in Ne/FeCl2
MetSign_ID
m/z
C37H72O5
579.53
C52H100N1O8P1
897.72
C22H30O6
432.24
C20H26O6
404.21
C37H70N1O8P1
686.48
C68H112O6
1024.85
C42H78N1O10P1
786.53
C39H76O5
642.60
C37H72N1O8P1
688.49
C18H34N1O10P1
438.19
C39H76O5
647.56
C64H112O6
977.85
C18H28O11
438.20

Fold_change (C/NF)
41.31
2.18
0.61
0.60
0.61
16.65
0.45
11.71
0.59
1.77
2.81
3.73
1.24

Class of molecule
Diacylglyerol
Diacylglycerolphosphocholine
Isoprenoid
Flavanoid
Glycerophospholipid
Triacylglycerol
Diacylglycerolphosphoserine
Diacylglycerol
Diacylglycerolphosphocholine
Diacylglyerolphosphoserine
Diacylglycerol
Triacylglycerol
Isoprenoid
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C19H22O6
C30H42O6
C30H56N1O8P1
C16H30O2
C42H70O5
C35H68O5
C21H36O5
C37H72O5
C21H42N1O7P1
C39H47N1O14

410.16
516.33
588.37
253.22
689.49
591.50
391.24
631.51
450.26
795.34

1.50
3.46
0.25
0.50
0.69
2.26
0.41
11.51
0.44
0.65

Isoprenoid
Sterol
Glucuronide
Branched Fatty Acid
Diacylglyerol
Diaclyglycerol
Prostaglandin
Diacylglyerol
Glycerophosphocholine
Polyketide

C57H108O6

906.85

14.04

Triaclyglycerol

C40H76N1O10P1
C24H24O6; C24H26O7
C35H67N1O8S1
C39H74N1O8P1
C59H112O6
C37H74N1O8P1
C37H71O8P1; C39H74N1O8P1
C53H98N2O16

760.51
409.16
660.45
714.51
934.88
714.50
738.50
1017.68

0.25
2.01
0.59
0.57
5.28
0.29
0.12
5.17

Glycerophosphoserine
Polyketide
Sphingolipid
Glycerophosphoethanolamine
Triacylglycerol
Diacylglycerophosphocholine
Glycerophosphoethanolamine
Sphingolipid
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CHAPTER FIVE: CAT-FE EXPOSURE STIMULATES BIOFILM FORMATION AND PLANKTONIC
GROWTH OF A. ACTINOMYCETEMCOMITANS
Introduction:
Work done on E. coli and other bacteria has shown that catecholamines can stimulate
planktonic growth and biofilm formation [119, 103, 58, 94]. This stimulation of planktonic
growth is independent of a functional QseC [92], but biofilm formation is attenuated for a QseC
mutant in the presence of catecholamines [119]. In addition, the stimulation of planktonic
growth in E. coli can be blocked by the addition of adrenergic receptor antagonists [80, 55].
For A. actinomycetemcomitans, QseC is essential for biofilm formation [44,53]. A strain
lacking qseC has a significant decrease in biofilm depth and mass compared to Wt, but no defect
in planktonic growth is observed [44, 53]. It is unknown as to whether activation of QseC by CATFe would result in any changes in planktonic growth or biofilm formation.
The microarray data in Chapter 4 showed a significant up-regulation 2.7 fold of
the anaerobic ribonucleoside triphosphate reductase (D11S_2128) of fold. In addition, the
metabolomics showed significant increases in every ribonucleoside (Table 5). The increase of flux
to pyruvate and energy producing pathways (Figure 9) as well as the significant up-regulation of
the ribonucleoside triphosphate and increase in the pool of available ribonucleosides suggested
that CAT-Fe was priming the cell for rapid growth. Therefore, the effect of CAT-Fe exposure on
planktonic growth and biofilm formation was explored.
Results:
A. actinomycetemcomitans QseC has been shown to be essential for biofilm formation
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since a strain lacking qseC exhibited a significant reduction in biofilm depth and biomass [44,
53]. To determine if CAT-Fe influenced biofilm growth in a QseBC-mediated manner, the ability
of the bacteria to form biofilms in the presence of CAT-Fe, ferrous iron or Ne was examined. A.
actinomycetemcomitans was grown for 62 hours in CDM (Figure 10) and analyzed by confocal
microscopy. As shown in Figure 9, the Wt strain grown in CDM supplemented with Ne/FeCl2
resulted in a significant increase in biomass compared to CDM alone. In contrast, the qseCΔp
mutant did not exhibit a significant increase in biofilm formation in the presence of CAT-Fe
(Figure 11A) relative to ferrous iron (Figure 11B) supplementation, suggesting that stimulation of
biofilm growth required a functional QseC sensor.
In E.coli, catecholamine mediated stimulation of growth was dependent on having a
functional enterobactin biosynthesis and uptake system. As previously discussed, A.
actinomycetemcomitans does not have the capability to synthesize enterobactin or other
siderophores, but does code for a putative enterobactin receptor and transport system
(D11S_1357-1352; Figure 12). The potential role of this putative enterobactin transport system
was explored by making an in-frame deletion of the beta-barrel region of the TonB dependent
receptor (D11S_1352) and comparing biofilm formation of this mutant strain and wt cells. As
shown in Figure 13A & B, biofilm growth of the mutant strain was similar when cultured in CDM
supplemented either with FeCl2 or CAT-Fe, respectively, and was significantly less than the Wt
strain cultured in CDM supplemented with CAT-Fe (see Figure 10D). The wt biofilm phenotype
was restored in the TonB dependent receptor mutant by complementing the strain with a full
length copy of the gene (Figure 13D).
Freestone et al previously showed that catecholamines act as pseudosiderophores by
scavenging iron from holo-transferrin and the concentration of catecholamine (50uM) used in
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these experiments also resulted in increased planktonic growth of E.coli [57, 80]. This suggests
that catecholamines may function as siderophores. To determine if exposure to CAT-Fe also
induces A. actinomycetemcomitans growth, cells were cultured in CDM supplemented with
either 100µM of ferrous iron, 50µM of Ep or Ne, or a combination of the both (CAT-Fe). There
were no significant changes in growth when A. actinomycetemcomitans was cultured in CDM or
in CDM/Ne, but growth was significantly increased with the supplementation of ferrous iron
(Figure 14A). Growth of the bacteria was further increased significantly upon supplementation
with Ne/FeCl2 (Figure 14A). Ep/FeCl2 also resulted in significant induction of growth over
bacteria grown in just CDM (Figure 14B). However, in contrast to biofilm growth (see above), the
increase in planktonic growth was not contingent on a functional QseC since the mutant strain
lacking the periplasmic domain of QseC (qseCΔp) still showed a significant increase of growth
with Ne/FeCl2 supplementation over ferrous iron supplementation (Figure 14C).
CAT-Fe stimulation of planktonic growth was also tested for the TonB dependent
mutant and the complemented strain. This mutant strain still exhibited significant activation of
QseC in the presence of Ne/FeCl2 compared to the control CDM (Figure 15A), indicating the
QseC function in unaffected by inactivating the siderophore receptor. The TonB dependent
receptor mutant strain exhibited no significant changes in planktonic growth under these
conditions, suggesting that a functional TonB receptor is required for growth stimulation by
CAT-Fe (Figure 15B). When the mutant strain was complemented with an intact copy of the
TonB receptor gene, the Wt growth phenotype was restored (Figure 15C).
Adrenergic Receptor Antagonists Fail to Block CAT-Fe Growth Stimulation and Inhibit Overall
Growth of A. actinomycetemcomitans
In Chapter 3, it was shown that the alpha and beta adrenergic receptor antagonists failed
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to block QseC activation by CAT-Fe and at a concentration of 400µM appeared to stimulate
QseBC. Therefore, the effect of these drugs on CAT-Fe stimulation of planktonic growth of A.
actinomycetemcomitans was tested to confirm that the growth phenotype is independent of
QseC. At a concentration of 200µM, both adrenergic receptor antagonists failed to block CAT-Fe
stimulation of growth (Figure 16A), consistent with the previous β-galactosidase results obtained
with these drugs. At 400µM of propranolol or phentolamine, there was an overall inhibition of
growth compared to Wt when grown in CDM (Figure 16B) or BHI. The growth inhibition was
independent from QseC signaling since the mutant lacking the periplasmic domain of QseC still
showed significant growth inhibition in response to 400µM of propranolol or phentolamine
(Figure 16C).
Discussion:
Catecholamines have been shown to lead to a stimulation of planktonic growth and
biofilm formation in a wide variety of species such as E.coli, Salmonella, P. burkholderia, A.
pleuropenumoniae, and a variety of dental pathogens [58, 57, 66, 103, 93]. In addition,
catecholamines also lead to an increase in biofilm formation in E. coli [119]. For A.
actinomycetemcomitans, exposure to CAT-Fe and the resulting QseBC activation resulted in an
increase in the nucleoside pool and up-regulation of the anaerobic ribonucleoside triphosphate
reducatase (D11S_2128) which converts nucleosides to deoxyribonucleosides (Chapter 4).
Together with the metabolomics and microarray data suggested that energy production was
increased (Chapter 4), this data suggested that CAT-Fe primed the cell for increase growth,
which was confirmed when analyzing planktonic growth and biofilm formation.
Exposure to ferrous iron resulted in a significant increase of planktonic growth, but
growth was further significantly stimulated with the addition of CAT-Fe. For the biofilms,
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although one of the lipoproteins associated with biofilm formation, pgaB, was down-regulated
in response to CAT-Fe exposure, biofilm formation was significantly increased during exposure
to CAT-Fe.
For E.coli, Salmonella, and A. pleuropneumoniae, it was found that the stimulation of
planktonic growth was independent of QseC since a mutant strain still underwent
catecholamine mediated planktonic growth stimulation [57, 80, 92]. This is consistent with the
results of the CAT-Fe mediated planktonic growth stimulation in A. actinomycetemcomitans,
which was also independent of a functional QseC. However, for both E.coli and A.
actinomycetemcomitans, a functional QseC was required for the biofilm phenotype in response
to catecholamines [119] or CAT-Fe, respectively.
One possible explanation for the planktonic growth stimulation in the presence of CATFe but in the absence of qseC is that there exists the possibility of another sensor that is
responsive to CAT-Fe. Several other putative receptors (QseE, BasS and CpxA) have been
reported to function as catecholamine sensors [102]. The other explanation is that QseC has not
been shown to be essential for planktonic growth, but has been for biofilm formation. It has
already been shown that the loss of qseC resulted in significant biofilm reduction [44, 53]. The
significant increase in biofilm formation during QseC activation by CAT-Fe is consistent with
these previous results. In addition, the role of QseC as a regulator of anaerobic metabolism fits
within this narrative (Chapter 4). Since QseC activation results in an up-regulation of anaerobic
respiration and metabolism, this response might assist A. actinomycetemcomitans during
growth in the biofilm where oxygen levels may be decreased.
The planktonic growth stimulation and biofilm stimulation in response to CAT-Fe was
found to be dependent on the TonB dependent receptor. This is consistent with the reports that
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E.coli requires a functional enterobactin transport and synthesis operon [58]. A.
actinomycetemcomitans does not encode for enterobactin, nor any other siderophore.
Therefore, one potential reason for A. actinomycetemcomitans encoding the enterobactin
transporter and receptor could be for acquiring iron via catecholamine mediated scavenging. It
is also possible that this operon functions to scavenge enterobactin made by other oral species,
or that the operon can be used for both functions.
Interestingly, the TonB dependent receptor mutant still underwent CAT-Fe mediated
activation of QseC. This suggests that the enterobactin transport and receptor operon may lay
downstream of QseC activation. The enterobactin transport and receptor operon was not one of
the high affinity iron acquisition genes that was down-regulated in the microarray. One possible
reason for this could be that the operon is required for A. actinomycetemcomitans to respond to
CAT-Fe.
As reported in Chapter 3, the growth stimulation in response to catecholamines could
be blocked in the presence of adrenergic receptor antagonists in E.coli [80], but in A.
actinomycetemcomitans, the activation of QseC was not blocked by these drugs. Instead, at high
concentrations, they appeared to act as QseC agonists. Therefore, the effect of the adrenergic
receptor antagonists was analyzed in A. actinomycetemcomitans to see if the activation of QseC
at high levels of antagonist resulted in a growth phenotype. The reason for this is that QseC has
been proposed as a potential target for therapeutics since it plays such a vital role in regulating
virulence, metabolism, and biofilm formation [107].
At concentrations that were sufficient to block catecholamine stimulation of growth (i.e.
50µM), there was no significant effect on CAT-Fe stimulation of planktonic growth in A.
actinomycetemcomitans. However, the addition of 400µM of adrenergic receptor antagonist,
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the same concentration that resulted in QseC activation in Chapter 3, resulting in a significant
inhibition of growth in either CDM or BHI. This inhibition of growth was independent of QseC,
therefore it appears these drugs have an overall toxic effect on the cell at high concentrations.
Interestingly, this inhibition of growth was not reported in E.coli or Salmonella. It is unlikely that
these drugs can be used as a therapeutic against A. actinomycetemcomitans, since it was only at
high concentrations this effect was observed, and this same concentration is well outside the
recommended dose for humans.
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Figure 10: Biofilm formation in A. actinomycetemcomitans grown in CDM with iron and/or catecholamines.
Representative photos of A. actinomycetemcomitans grown in a biofilm in CDM (A), or with supplementation of FeCl2
(B) Ne (C), or Ne/FeCl2 (D). All biofilm experiments were performed independently in triplicate with 5 to 10 pictures
taken per biofilm.
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Figure 11: Biofilm formation in qseCΔp strain. Representative photos of the qseCΔp strain of A.
actinomycetemcomitans grown in CDM with ferrous iron (A) or Ne/FeCl2 (B). All biofilm experiments were performed
independently in triplicate with 5 to 10 pictures taken per biofilm.
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Figure 12: The enterobactin transport and receptor operon of A. actinomycetemcomitans serotype c D11S.
The TonB receptor was originally annotated as D11S_1354 with D11S_1353 being an outer membrane receptor and
D11S_1352 annotated as either fepA or a pseudogene. However, based on sequence similarity from E.coli and the D7S
strain of A. actinomycetemcomitans and the data from this study, it is most likely that D11S_1354-1352 together
encode the TonB dependent receptor.
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Figure 13: Biofilm formation in ΔTonB dependent receptor strain. Representative photos of the ΔTonB
dependent receptor mutant strain of A. actinomycetemcomitans grown in CDM with ferrous iron (A) or Ne/FeCl 2 (B) or
of the TonB dependent receptor complement strain grown in CDM with ferrous iron (C) or Ne/FeCl2 (D). All biofilm
experiments were performed independently in triplicate with 5 to 10 pictures taken per biofilm.
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Figure 14: Planktonic growth response in the presence of CAT-Fe. A) Aliquots were taken at various time points of A.
actinomycetemcomitans grown in triplicate for two independent experiments in CDM with or without
supplementation with Ne, ferrous iron, or both and measured for the O.D. 600nm. B) Growth was followed using the
same methods but for A. actinomycetemcomitans grown in CDM with or without supplementation with ferrous iron,
Ep, or both. C) Growth of wild type bacteria or a strain lacking the periplasmic domain of Qsec (qseCΔp) was measured
using OD600 for cultures grown in CDM with either ferrous iron or Ne/FeCl2+ supplementation. All experiments were
done in triplicate with two independent trials. P < 0.05.
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Figure 15: The response of the ΔTonB dependent receptor strain to CAT-Fe. A) Expression of ygiW-qseBC was
measured in a β-galactosidase assay after 24 hours for the ΔTonB dependent receptor strain of A.
actinomycetemcomtians grown in CDM or with Ne/Fe2+. Each condition was tested in triplicate in two independent
assays. B) Growth was measured using the O.D.600NM of the Wt strain or the ΔTonB dependent receptor strain grown in
CDM with either ferrous iron supplementation or Ne/FeCl2. C) Growth of the ΔTonB dependent receptor complement
strain in CDM with Fe2+ or Ne/Fe2+ supplementation. All growth curves were performed in triplicate with two
independent experiments. P<0.05
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Figure 16: The growth response of A. actinomycetemcomitans to the alpha adrenergic receptor antagonist
phentolamine or the beta adrenergic receptor antagonist propranolol. A) Growth was measured by O.D.600NM for A.
actinomycetemcomitans was grown in CDM with supplementation of either Fe2+, Ne/Fe2+, and 200µM propranolol. B)
Growth was measured for A. actinomycetemcomitans grown in CDM with of supplementation either Fe2+, Ne/Fe2+,
400µM of propranolol or 400µM of phentolamine. C) Growth was measured for the qseCΔp strain of A.
actinomycetemcomtians grown in BHI with or without 400µM of propranolol. All experiments were done in triplicate
with two independent trials. P < 0.05.
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CHAPTER SIX: THE IRON-RESPONSIVE TOXIN/ANTI-TOXIN (TA) SYSTEM D11S_2133-2134 AND ITS
ROLE IN YGIW-QSEBC REGULATION
Introduction:
The oral cavity is a harsh environment due to fluctuations in pH, nutrients, temperature,
exposure to antibiotics, competition from other resident microbes and the shear force arising
from the flow of saliva [129]. In order to compete and thrive, bacteria need to tightly regulate
gene expression and adapt quickly to changes that occur in the local environment. Inter- and
intra- species communication allows bacteria to sense changes in population sizes and adapt
accordingly through quorum sensing. A. actinomycetemcomitans is able to quorum sense via the
production of AI-2 by LuxS and its subsequent detection by the receptors LsrB and RbsB [44].
The qseBC TCS is downstream of AI-2 detection, but its activation is not directly controlled by AI2 detection [44]. In E. coli, AI-2 detection leads to the activation of MqsR, which positively
regulates expression of qseBC [71] and it is possible that a similar mechanism occurs in A.
actinomycetemcomitans. In E. coli, MqsR is the toxin in the MqsRA TA system that acts as a CGUspecific mRNA interferase [108].
TA systems are mechanisms that allow bacteria to respond to stress [84]. They comprise
an anti-toxin that is co-transcribed with its cognate toxin [81]. In type II TA systems, both the
toxin and the anti-toxin are proteins with the anti-toxin being more labile and therefore more
easily degraded by proteases such as Clp [83] and Lon [82]. Normally, the anti-toxin protein
binds to the toxin protein to neutralize its effects. Many anti-toxins also bind to their own
promoter to auto-regulate expression of the operon. Toxin activity can vary but most toxins
function as either ribosome dependent or independent mRNA endoribonucleases that cleave
mRNA at certain specific sequences [81, 109, 110]. Some cleave mRNA promiscuously such as
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the RelE of E.coli which cleaves between the second and third position of an upstream purine
[111]. TA systems are also thought to play a vital role in the development of the persister
phenotype that allows the cell to survive environmental stress [81].
In bacterial populations there exists phenotypic heterogeneity meaning that there can
be distinct populations within a community of the same species. This often happens during
persister cell formation where a small percentage of the population represents the slow-growing
persister phenotype [86]. This phenotype is thought to be the result of activation of TA systems.
In these cells, there may be a stochastic switch to the persister phenotype that activates the Lon
protease, which then degrades the anti-toxin to activate the toxin [85]. This mechanism of TA
activation is dependent on the accumulation of (p)ppGpp [85] which is produced by RelA/SpoT
and accumulates in cells and inhibits exopolyphosphatase (PPX) [85]. PPX degrades polyphosphate (polyP), which is synthesized by polyphosphate kinase (PPK) [85]. At high levels, polyP
activates the Lon protease, which will in turn degrade the anti-toxins and release the toxin [85].
A. actinomycetemcomitans contains 10 putative type II TA systems and previous work identified
various environmental stressors that induced expression of these TA systems and showed that
one TA system (D11S_2133-2134) was highly up-regulated under iron limited growth conditions
(i.e., the presence of the iron chelator 2,2′-bipyridyl [DIP]).
In this Chapter, we show that QseB plays a role in the stress response of A.
actinomycetemcomitans and influences expression of the Lon protease and the iron-responsive
TA system D11S_2133-2134. We also show that over-expression of D11S_2133 inhibits growth in
E. coli while D11S_2134 over-expression had no significant effect on growth, suggesting that
D11S_2133 is the toxin and D11S_2134 is the anti-toxin. In addition, over-expression of
D11S_2134 results in a significant up-regulation of expression of the ygiW-qseBC operon in A.
actinomycetemcomitans.
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Results:
Deletion of qseB Results in an Up-regulation of Stress Response Genes
QseB is the DNA binding response regulator of the QseBC TCS that is activated by QseC
in response to CAT-Fe. In Chapter 3, we identified changes in the transcriptome of Wt A.
actinomycetemcomitans when QseC was activated by CAT-Fe. To further define the QseBC
regulon, a genomic microarray was used to identify differentially expressed genes in a ΔqseB
strain of A. actinomycetemcomitans. A total of 250 genes were differentially regulated 2 fold or
greater in ΔqseB compared to Wt (Appendix Table 2). Of the 250 genes, 89 were up-regulated
and 161 were down-regulated.
Of the 89 genes that were up-regulated, 16 were genes involved in the stress response
(Table 9). These genes were highly up-regulated with 6 of the top 10 results being genes
associated with the stress response, e.g., the ATP-dependent ClpB protease (D11S_0551), the
chaperonin groS-groEL (D11S_599-600), the universal stress protein A (D11S_0656), molecular
chaperone dnaK (D11S_D11S_0922), and lon (D11S_1522). In order to confirm the role of QseBC
in the stress response, qRT-PCR was performed to measure the expression of lon in ΔygiW,
ΔqseB, ΔqseC, and a ΔqseC complemented strain (Figure 17). While the ΔygiW did not show a
significant change in lon expression, ΔqseC and ΔqseB exhibited up-regulation of lon and the
QseC complemented strain was able to restore lon expression back to Wt levels (Figure 17).
Interestingly, the activation of QseC by CAT-Fe also resulted in an up-regulation of several genes
involved in the stress response: the universal stress protein A (D11S_0656), clpB (D11S_0551),
groS-groEL (D11S_0599-0600), two putative relEB TA systems (D11S_1194-1195 & D11S_17981799), and the molecular chaperone dnaK (D11S_0922).
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Ectopic Expression of lon Induces ygiW-qseBC and Results in Significant Decrease in
Growth
The Lon protease (D11S_1522) degrades the labile anti-toxins of TA systems
thereby releasing the toxin during the stress response [82]. Since deletion of qseB and
qseC resulted in an up-regulation of lon, we next determined the effect of ectopic
expression of lon on expression of qseBC. The lon gene was ectopically expressed using
the Trc inducible promoter of plasmid pWAW17. A. actinomycetemcomitans harboring
pWAW17 was confirmed to exhibit up-regulation of lon (Figure 18A). The
A.actinomycetemcomitans strain carrying pWAW17 also showed significant upregulation of ygiW suggesting that Lon may play a role in regulating ygiW-qseBC (Figure
18B).
Activation of Lon results in the activation of TA systems by degrading the antitoxin and release of the toxin. The toxins are hypothesized to inhibit cellular processes
like translation and inhibit growth. In part, this mechanism may allow the cell to
transition to a slow-growing persister cell. In E.coli transformed with pWAW17, no
significant growth difference was observed with or without 1mM IPTG until late log
phase (Figure 19A). At late exponential and stationary phase, induction of the Lon
protease resulted in significant reduction of cell density in E. coli (Figure 19A). A similar
result occurred with A. actinomycetemcomitans transformed with pWAW17 (Figure
19B).
D11S_2133-2134 is Up-regulated during Iron Starvation and in ΔqseC and ΔqseBC
Different stress conditions, including iron stress, were used to determine under
which condition each of the 10 putative TA systems were activated. D11S_2133-2134, a
putative RelE- like type II TA system, was highly up-regulated during iron starvation
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(Figure 21A). Consistent with this, the D11S_2133-2134 TA system was significantly upregulated when cells were cultured in CDM without any iron supplementation relative
to iron replete cultures grown in BHI. In addition, there was no significant change in
expression of the TA system in the Wt strain when cultured in CDM supplemented with
CAT-Fe (Figure 20B). Finally, D11S_2133-2134 was up-regulated in the ΔTonB receptor
strain, a strain that did not have a growth response to CAT-Fe and therefore may have a
defect in acquiring iron (Figure 20C).
Real-time PCR was also used to determine expression of D11S_2133-2134 in
both ΔqseC and ΔqseBC strains relative to Wt. Consistent with the previous microarray
results using the ΔqseB mutant, the TA system was significantly upregulated in both
ΔqseBC and ΔqseC (Figure 20D). Together with the data showing that this TA system is
activated during iron starvation, it is possible that this system may be involved in
regulating qseBC and fine-tuning the response of A. actinomycetemcomitans to changes
in environmental iron content.
D11S_2133 and D11S_2134 are Co-transcribed and Ectopic Expression of D11S_2133
but Not D11S_2134 Results in Inhibition of Growth in E. coli
We next confirmed the identities of the putative toxin and anti-toxin. In Type II
TA systems, the toxin and the anti-toxin are co-transcribed [81, 118]. To confirm that
D11S_2133 and D11S_2134 were co-transcribed, primers were designed to amplify the
intergenic region between D11S_2133 and D11S_2134. The positive control genomic
DNA and the cDNA resulted in a fragment for the intergenic region (Figure 21A). In
contrast, primers amplifying an intergenic region between D11S_2134 and the unrelated
D11S_2135 gene gave a product only for the genomic DNA, but not the cDNA confirming
that D11S_2133 and D11S_2134 are co-transcribed. In addition, the promoter which
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transcribes D11S_2133-2134 was identified by 5' cDNA RACE as being within the
intergenic region between D11S_2134 and D11S_2135. The transcriptional start site was
mapped to nucleotide -36 as shown in Figure 21B.
Conventionally, the anti-toxin is transcribed first followed by the toxin [118], but
there have also been reports of this operon structure order being reversed. In order to
confirm their functional identities, both D11S_2133 and D11S_2134 were ectopically
expressed using the Trc inducible promoter to generate pWAW20 (Trc-D11S_2133) and
pWAW19 (Trc-D11S_2134). Confirmation of ectopic expression in both strains was
performed by qRT-PCR. The growth of E.coli and A. actinomycetemcomitans strains
transformed with these plasmids was then determined. When the E.coli strain carrying
pWAW19 (D11S_2134) was grown in LB or LB with 1mM IPTG, there was no significant
difference in cell density (Figure 22A). In contrast, the E.coli strain carrying pWAW20
(D11S_2133) showed significant reduction of cell density when IPTG was added to
induce expression of D11S_2133 (Figure 22C). The reduction in cell density of the strain
carrying D11S_2133, but not D11S_2134 suggests that the organization of the operon is
similar to the normal convention for type II TA systems in that the anti-toxin
(D11S_2134) is transcribed first followed by the toxin (D11S_2133).
In A. actinomycetemcomitans, the strains carrying pWAW20 or pWAW19
showed no difference in cell density in the presence or absence of IPTG. In addition,
there were no changes in cell density of the Wt strain in the presence of absence of IPTG
(Figure 23A). However, there was a significant reduction of cell density for both the
pWAW19 and pWAW20 strains versus the Wt strain (Figure 23A &B). The reduction of
growth due to the ectopic expression of D11S_2134 could also be seen in E.coli when
high levels (2mM) of IPTG was added to the media to induce higher levels of expression
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from the pTRC promoter (Figure 22B).
Ectopic Expression of D11S_2134 Induces the Expression of the ygiW-qseBC Operon
In order to test the hypothesis that D11S_2133-2134 regulates expression of the
ygiW-qseBC operon, qRT-PCR was performed with Wt A. actinomycetemcomitans and
each of the ectopic expression strains. Since ectopic expression of lon resulted in an upregulation of ygiW-qseBC mRNA, we hypothesized that ectopic expression of the
putative toxin, D11S_2133, would result in the up-regulation of ygiW-qseBC mRNA.
Both strains for the ectopic expression of either D11S_2133 (pWAW20) or
D11S_2134 (pWAW19) were confirmed by qRT-PCR to exhibit increased mRNA
expression (Figure 24A & B). Using qRT-PCR, induction of pWAW19 resulted in a 5000
fold increased expression of the ygiW-qseBC operon, whereas induction of pWAW20
resulted in only a 4 fold increase (Figure 24C). These results were also confirmed using
the inducible lsrA promoter to generate plasmids pWAW14 (D11S_2133) and pWAW16
(D11S_2134). The lsrA promoter contains a crp binding site and in the absence of
glucose, expression is induced. Again, ectopic expression was confirmed by qRT-PCR
(Figure 25A & B). In agreement with the results seen with pWAW19 and pWAW20,
ectopic expression of D11S_2134 (pWAW16) still resulted in a significant increase in
mRNA expression of ygiW-qseBC while expression of D11S_2133 (pWAW14) did not
(Figure 26B). There was no significant difference in ygiW-qseBC expression in Wt cells
grown in LB or LB with glucose (Figure 26A).
Discussion:
QseBC appears to be involved in sensing iron via CAT-Fe which activates the TCS
and results in regulation of iron acquisition genes. However, as shown in Chapter 3, this
TCS is not highly activated during times of iron-limitation (i.e. CDM), and there is a basal

99

level of activity under iron limiting conditions. In addition, our previous results and
studies of QseBC in other species suggest that QseB may be activated by non-cognate
sensor kinases [60, 101]. This suggests that a minimal level of QseB activity is essential
for A. actinomycetemcomitans and the absence of functional QseB triggers a stress
response. As seen in the microarray data and confirmed with qRT-PCR data performed
with ΔqseC, the absence of this TCS elicits the up-regulation of several stress response
genes, including lon.
Lon is involved in activating TA systems by degrading the labile anti-toxin and
releasing the toxin. Most of these toxins act as endoribonucleases allowing them to
post-transcriptionally regulate a variety of mRNA’s in the cell. The ectopic expression of
lon in A. actinomycetemcomitans was shown to result in an up-regulation of ygiW-qseBC
mRNA, suggesting that it may regulate the expression of this TCS and our hypothesis is
that the activation of an iron responsive TA system by Lon regulates the expression of
qseBC under iron limitation. Only one TA system in A. actinomycetemcomitans,
D11S_2133-2134, was found to be highly up-regulated during iron starvation, suggesting
that it may be the TA system involved in qseBC regulation. The proposed regulatory
circuit involving QseBC, Lon and the TA system is illustrated in Figure 27. We propose
that these component function in concert to fine tune the response of A.
actinomycetemcomitans to changes in environmental iron content.
D11S_2133-2134 was significantly up-regulated in the ΔqseC and ΔqseBC strains,
yet the consensus binding sequence for QseB, CTTAA-N6-CTTAA, does not exist the
putative promoter of D11S_2133-2134 [49]. This suggests that QseBC might regulate
expression of the TA system through indirect means, possibly through the stimulation of
lon expression.
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Based on the growth kinetics in E. coli from the ectopic expression strains,
D11S_2133 encodes for the toxin and D11S_2134 for the anti-toxin. Based on the qRTPCR results to confirm expression of D11S_2133/2134, the Trc promoter appears to be
“leaky” in A. actinomycetemcomitans and this could explain the less robust growth
phenotypes seen in A. actinomycetemcomitans. In addition, high level induction of
D11S_2134 led to significant growth inhibition even in E. coli suggesting that at high
levels, the product encoded by this gene may be toxic to the cell.
Since ectopic expression of lon resulted in a significant increase in expression of
ygiW-qseBC mRNA, we hypothesized that ectopic expression of the putative toxin
(D11S_2133), would result in a significant increase in expression of ygiW-qseBC.
Therefore, it was unexpected that ectopic expression of the putative anti-toxin
(D11S_2134) resulted in significant up-regulation of ygiW-qseBC. There are several
explanations for this result. First, the functional assignment of the toxin and anti-toxin
based on the growth phenotypes may be misleading and clearly there are examples
where the toxin gene precedes the anti-toxin [120, 121] Second, since D11S_21332134 is a RelE-like TA system and presumably functions as an endoribonuclease, the use
qRT-PCR to measure changes in qseBC expression using only one housekeeping gene as
reference may be misleading. These results could be confirmed by using additional
internal controls or alternatively by determining the levels of QseBC proteins.
The data from this chapter suggests then that Lon and the D11S_2133-2134 TA
system are involved in regulating expression of the ygiW-qseBC operon (Figure 27) and
co-ordinating the response of the bacteria to iron-limiting conditions. In addition,
appropriate expression and activation of QseB appears to be essential for the cell since
the absence of qseB results in a significant up-regulation of the stress response.
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Therefore, QseBC may play a vital role in adapting to the host environment by regulating
metabolism, iron uptake, virulence and biofilm formation in response to activation by
CAT-Fe (Figure 27) and loss of that function results in an attenuation of virulence [44].
Since QseBC appears to play such a vital role, it may represent a target for potential
therapeutics. In order to develop these potential treatments, more information is
needed about the regulation of QseBC by D11S_2133-2134 and other mechanisms as
well as about the structure of QseC and the potential role of YgiW.
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Figure 17: Expression of lon. Real-time expression of the Lon protease compared to the Wt strain of A.
actinomycetemcomitans grown in BHI compared to ΔygiW, ΔqseB, ΔqseC, and ΔqseC complement. RT-PCR
was done in triplicate with two independent trials. P < 0.05.
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Figure 18: Regulation of ygiW expression by Lon. A) Real-time expression of lon in Wt A.
actinomycetemcomitans compared to strains harboring pWAW17 grown in BHI or BHI with IPTG. B)Real-time
expression of ygiW in Wt A. actinomycetemcomitans grown in BHI compared to a strain carrying a plasmid
for the ectopic expression of Lon (pWAW17) grown in BHI with or without 1mM IPTG. All experiments were
done in triplicate with two independent trials. P < 0.05.
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Figure 19: Growth response of E.coli and A. actinomycetemcomitans to ectopic expression of Lon. A) Growth
of E.coli carrying the plasmid for ectopic expression of Lon (pWAW17) grown in LB or with 1mM IPTG. B)
Growth of Wt A. actinomycetemcomitans with the empty vector pJT3 or strain carrying pWAW17 in BHI. All
experiments were done in triplicate with two independent trials. P < 0.05.
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Figure 20: Response of TA systems to iron starvation. A) Real-time expression of putative TA systems in A.
actinomycetemcomitans grown in CDM with 2,2'-dipyridyl (DIP) 4. B) Real-time expression of D11S_21332134 grown in BHI, CDM and CDM with Ne/Fe2+. C) Real-time expression of D11S_2133-2134 in Wt A.
actinomycetemcomitans or ΔTonB dependent receptor mutant grown in BHI. D) Real-time expression of
D11S_2133-2134 in Wt A. actinomycetemcomitans, ΔqseC, or ΔqseBC grown in BHI. . All experiments were
done in triplicate with two independent trials. P < 0.05.

4

Experiments shown in Figure A were completed by Blair Schneider
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Figure 21: The D11S_2133-2134 Operon. A) DNA gel showing 1) 5000kb ladder, 2) PCR product from
chromosomal DNA amplified with primers specific for the intergenic region between D11S_2134-2135, 3)
PCR product from cDNA amplified with primers specific for the intergenic region between D11S_2134-2135,
4) PCR product from chromosomal DNA amplified with primers specific for the intergenic region between
D11S_2134-2133, 5) PCR product from cDNA amplified with primers specific for the intergenic region
between D11S_2134-2133, 6) 1kb ladder. B) The sequence for the upstream and coding region for
D11S_2133-2134, including the transcriptional start site (purple and italic), ribosome binding site (green)
and start codon (red). The transcriptional start site was determined by cDNA RACE using 10 transformed
colonies that were sequenced for the inserted 5’ untranslated region.
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Figure 22: Growth response of E.coli to ectopic expression of D11S_2133 and D11S_2134. A) Growth of
E.coli strain carrying plasmid for ectopic expression of D11S_2134 (pWAW19) grown in LB or with 1mM IPTG
supplementation. B) Growth of E.coli strain carrying pWAW19 grown in LB or with 2mM IPTG
supplementation. C) Growth of E.coli strain carrying plasmid for ectopic expression of D11S_2133
(pWAW20) grown in LB or with 1mM IPTG supplementation. All experiments were done in triplicate with
two independent trials. P < 0.05.
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Figure 23: Growth of A. actinomycetemcomitans in response to ectopic expression of D11S_2133 or
D11S_2134. A) Growth of Wt strain of A. actinomycetemcomitans with the empty vector pJT3 or a strain
carrying pWAW20 grown in BHI or BHI with 1mM IPTG. B) Growth of Wt of a strain carrying pWAW19 grown
in BHI. All experiments were done in triplicate with two independent trials. P < 0.05.
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Figure 24: Real-time expression of D11S_2133, D11S_2134, and ygiW. A) Real-time expression of
D11S_2133 in Wt A. actinomycetemcomitans compared to a strain carrying a plasmid for ectopic expression
of D11S_2133 (pWAW20) grown in BHI with or without 1mM IPTG. B) Real-time expression of D11S_2133 in
Wt A. actinomycetemcomitans compared to a strain carrying a plasmid for ectopic expression of D11S_2134
(pWAW19) grown in BHI with or without 1mM IPTG. C) Real-time expression of ygiW in Wt A.
actinomycetemcomitans compared to a strain carrying the plasmid for ectopic expression of D11S_2134
(pWAW19) or D11S_2133 (pWAW20) grown in BHI with or without 1mM IPTG . All experiments were done
in triplicate with two independent trials. P < 0.05.
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Figure 25: Real-time Expression of D11S_2133 or D11S_2134. A) Real-time expression of D11S_2133 in Wt
A. actinomycetemcomitans grown in LB compared to Wt grown in LB with 0.2% glucose or a strain carrying
plasmid for ectopic expression of D11S_2133 (pWAW14) grown in LB or LB with 0.2% glucose. B) Real-time
expression of D11S_2134 in Wt A. actinomycetemcomitans grown in LB compared to Wt grown in LB with
0.2% glucose or a strain carrying plasmid for ectopic expression of D11S_2134 (pWAW16) grown in LB or LB
with 0.2% glucose. All experiments were done in triplicate with two independent trials. P < 0.05.
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Figure 26: Regulation of ygiW expression by D11S_2133-2134. A) Real-time expression of ygiW in Wt A.
actinomycetemcomitans grown in LB compared to grown in LB with 0.2% glucose. B) Real-time expression of
ygiW in Wt A. actinomycetemcomitans grown in LB compared to A. actinomycetemcomitans carrying
pWAW16 (D11S_2134) or pWAW14 (D11S_2133) grown in LB or LB with 0.2% glucose. All experiments were
done in triplicate with two independent trials. P < 0.05.
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Figure 27: Schematic of QseBC activation by CAT-Fe and regulation by D11S_2133-2134. Activated
polymorphonuclear cells release catecholamines and lactoferrin. The holo-lactoferrin is bound by
catecholamines that scavenge the iron from them. The CAT-Fe complex is recognized by QseC (with or
without the help of YgiW) and activates QseC, in turn activating QseB. QseB regulates genes involved in iron
uptake, virulence and biofilm formation. Increased levels of the anti-toxin encoded for by D11S_2134 results
in increased expression of qseBC.
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Table 9: Expression of Genes Involved in Stress Response

ID Tag
D11S_0146
D11S_0147
D11S_0551
D11S_0599
D11S_0656
D11S_0739
D11S_0795
D11S_0838
D11S_0841
D11S_0922
D11S_1074
D11S_1431
D11S_1480
D11S_1522
D11S_1798
D11S_1799

Product
heat shock protein HslVU, ATPase
subunit HslU
ATP-dependent protease peptidase
subunit
ATP-dependent chaperone ClpB
chaperonin GroS
universal stress protein A
RNA polymerase sigma factor RpoE
heat shock protein 90
RecN protein
heat shock protein GrpE
molecular chaperone DnaK
DNA protection during starvation
protein
cold shock domain protein CspD
DNA mismatch repair protein
ATP-dependent protease La
Stability protein StbD
putative relE protein

114

Fold
Change

P-value

8.24

8.79E-03

8.15
14.5
5.36
2.17
4.3
11.32
1.77
6.96
8.91

7.00E-03
9.08E-03
7.96E-03
3.35E-04
4.10E-02
1.97E-02
1.09E-02
3.77E-02
7.63E-03

1.74
1.8
2.16
4.51
2.41
2.13

1.72E-02
2.05E-02
1.28E-02
6.74E-03
3.07E-02
2.94E-02

CHAPTER SEVEN: SUMMARY
QseBC is a conserved TCS in the Enterobacteriaceae and Pasteurellaceae that
has been shown previously to play a role in regulating several complex phenotypes
including virulence [44, 112], biofilm formation [44, 53, 71, 113], and metabolism [50,
69]. Interestingly, the activating signal varies from species to species. In E. coli and
Salmonella, QseC was shown to be activated by AI-3 and by catecholamines [54-56]. In
H. influenzae, QseBC (FirRS) did not respond to catecholamines but was activated by
ferrous iron, cold temperatures and zinc [62]. The activating signal for the QseC in A.
actinomycetemcomitans was found to be the combination of both catecholamines and
iron (either ferrous or ferric), and the activation was dependent on having a functional
YgiW, QseB and QseC. The exact role of YgiW is still unclear as to whether it binds to
catecholamine and/or iron in the periplasm and perhaps shuttles the complex to the
QseC sensor or if perhaps YgiW interacts with QseC. In addition, questions still remain as
to the nature of the binding pocket(s) of CAT-Fe: whether there are two different pockets
for each component, or if CAT-Fe binds one pocket as a complex.
Although it was previously shown that QseC is vital for virulence and biofilm
formation, the complete regulon and downstream functional outcomes of QseC
activation via CAT-Fe was unknown. Interestingly, the largest group of genes that were
differentially transcribed in A. actinomycetemcomitans were genes involved in anaerobic
respiration and metabolism. There was a significant up-regulation of genes involved in
formate, fumarate, mannose, succinate, and aspartate metabolism as well as an upregulation of components of the electron transport chain. Metabolomics performed
with samples treated with Ne/FeCl2 confirmed the outcomes suggested by changes in
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gene transcription. The up-regulation of genes and increase in metabolites associated
with anaerobic respiration and metabolism is consistent with the findings of Jorth et al
that showed that the same genes and pathways were highly up-regulated in vivo and
therefore might be essential for the ability of A. actinomycetemcomitans to colonize the
host [52].
In contrast, genes involved in the metabolism of fatty acids, lipid and LPS
biosynthesis were consistently down-regulated. The down-regulation of these genes
translated into significant decreases in the amount of several fatty acids such as palmitic
acid, myristic acid, and palmitelaidic acid and significant changes in the lipid profile of
the plasma membrane. Most notable was that several long-chained fatty acids were
decreased in cells treated with Ne/FeCl2 compared to CDM. The decrease in length of
fatty acid chains suggests that there is a change in membrane fluidity, specifically an
increase in fluidity with Ne/FeCl2 treatment.
Ne/FeCl2 represents an iron-rich environment, which is confirmed by the fact
that ferritin was highly up-regulated while iron acquisition genes were down-regulated.
The genes involved in iron acquisition were most likely down-regulated as a mechanism
to maintain iron homeostasis. In addition, there was an up-regulation of genes involved
in oxidative stress with exposure to Ne/FeCl2, but this up-regulation was most likely not
due to iron toxicity. The up-regulation of oxidative stress genes was confirmed by a
significant increase in catalase activity and a protective effect against H2O2 stress. This
suggests that the ability to detect Ne/FeCl2 might prepare A. actinomycetemcomitans for
growth in the oral cavity, an environment where H2O2 exposure is common either from
host cells like the respiratory burst from neutrophils or other oral bacteria.
Other functional outcomes due to Ne/FeCl2 exposure included increase in
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planktonic growth and biofilm formation. The increase in planktonic growth was not
dependent on a functional QseC as a strain lacking the periplasmic domain of QseC still
saw a significant increase in growth with Ne/FeCl2 supplementation. However, the
increase in biofilm formation in response to Ne/FeCl2 was dependent on QseC. The
presence of a planktonic growth phenotype despite the absence of a functional QseC
suggests that there might be other receptors that might respond to catecholamines or
CAT-Fe, as has been suggested for other bacteria [102], or that QseC isn’t as vital to
planktonic growth as biofilm formation. The dependence on QseC for biofilm formation
has been previously shown [44], so the lack of a biofilm phenotype in response to CAT-Fe
may be due to the overall important of QseC on the ability of A. actinomycetemcomitans
to form biofilms.
In contrast, the TonB dependent receptor was found to be essential for both the
planktonic growth and biofilm phenotype, but not for the ability of QseC to respond to
catecholamines. The TonB dependent receptor is part of the putative enterobactin
receptor of A. actinomycetemcomitans. Enterobactin biosynthesis and uptake was
shown to be essential for catecholamine mediated growth enhancements in E. coli [58].
Since it was shown to also be essential for catecholamine mediated growth phenotypes,
but not for QseC activation, the TonB dependent receptor likely lies downstream of QseC
activation and plays a role in allowing A. actinomycetemcomitans to take advantage of
catecholamine mediated iron acquisition. This also suggests there is some other uptake
system that is responsible for bringing catecholamines or CAT-Fe into the periplasm to be
sensed by QseC.
The impact of both alpha and beta adrenergic receptor antagonists to block CATFe activation of QseC and the downstream effect on planktonic growth was also
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explored. Surprisingly, both adrenergic receptor antagonists resulted in a significant
activation of QseC at 400µM. At this same concentration the activation of QseC in the
presence of just the receptor antagonists was not significantly different than the
activation of QseC in the presence of the antagonists and Ne/FeCl2. The adrenergic
receptor antagonists could still be potential therapeutics since the addition of them to
the media resulted in significant inhibition of growth suggesting that it has some overall
toxic effect to the cell that is not dependent on QseC.
The role that QseBC plays on a variety of complex and essential processes in A.
actinomycetemcomitans means that its presence is essential for the cell to sense the
environment and adapt to any changes. Therefore, the lack of QseB results in an upregulation of the stress response, either due to a direct role of QseB on regulating the
stress response or an indirect role of the lack of regulating genes via QseB causing stress
to the bacteria. Several of the genes that were up-regulated in the ΔqseB strain include
the TA response system: the Lon protease and two putative RelE TA systems
(D11S_1194-1195 & D11S_1798-1799). Lon was also up-regulated in the ΔqseC strain
showing that both components of this two-component system play a role in the stress
response.
One of the putative RelE TA systems was shown to be highly up-regulated during
iron starvation suggesting that it might play a role in regulating the response of A.
actinomycetemcomitans to variations in environmental iron, particularly in regulating
expression of ygiW-qseBC. Ectopic expression of the anti-toxin encoded for by
D11S_2134 resulted in a significant up-regulation of expression of the ygiW-qseBC
operon as did the Lon protease suggesting that these systems function together to
regulate ygiW-qseBC expression to fine tune it depending on the concentration of iron in
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the local environment.
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CHAPTER EIGHT: FUTURE DIRECTIONS
Determining the Structure and the Binding Pocket(s) for CAT-Fe:
The QseC of E. coli and Salmonella can be activated by catecholamines in ironlimiting conditions, but the QseC of A. actinomycetemcomitans is only activated in the
presence of both catecholamines and iron. In addition, unlike the QseC of E. coli, the
QseC of A. actinomycetemcomitans was activated by adrenergic receptor antagonists.
There is a 70% sequence similarity between the QseC of E. coli and A.
actinomycetemcomitans and no strong similarity has been shown between QseC and the
eukaryotic adrenergic receptors.
Since the QseC of A. actinomycetemcomitans functions uniquely, it suggests that the
structure and binding pocket of QseC might also be unique. In order to understand more
about how QseC recognizes the activating signal or why adrenergic receptor antagonists
activate QseC, the structure of the binding pocket still needs to be elucidated.
Particularly, it is unknown as to whether CAT-Fe binds in the same pocket or if there are
separate binding pockets for catecholamine and iron. Since QseC plays an essential role
in virulence, it offers a good target for therapeutics. Understanding more about the
binding pocket may be essential for the development of therapeutics for targeting A.
actinomycetemcomitans mediated periodontitis.
In order to answer this question, equilibrium dialysis using purified QseC and
either catecholamine, iron or both will be used to determine if QseC binds to the CAT-Fe
complex or to each individual component. Furthermore, if catecholamine and iron bind
separately, the question remains as to whether there are two binding independent
binding pockets or one. Each component could bind separately, but based on the βgalactosidase assay, both are needed for QseC to become activated. In order to answer
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this, further structural and functional analysis of QseC would need to be done,
particularly of the periplasmic domain. One possible approach is to crystallize this
domain for 3-dimensional structural determination.
Determining the Potential Role of YgiW in Binding CAT-Fe
YgiW is a putative solute binding protein of the OB-fold family. It is also cotranscribed with qseBC in A. actinomycetemcomitans and closely associated with the TCS
in E. coli on the chromosome. Since the ΔygiW strain showed no activation of QseC in
the presence of CAT-Fe, this suggests that it is essential for QseC mediated CAT-Fe
binding. However, whether it directly binds either component is unknown. This question
could also be addressed by equilibrium dialysis. Further structural analysis of YgiW can
be done by introducing mutations in the putative solute binding loops.
CAT-Fe Mediated Changes to Virulence:
Stress is one of the risk factors for the development and worsening of
periodontitis [130]. One possible explanation for this link is that stress causes an
increase in catecholamine stress hormones which can be exploited by the bacteria in
order to acquire iron. The link between stress and worsening of infection has been
demonstrated previously and the exposure of E. coli, P. gingivalis, and Salmonella to
catecholamines has been shown to increase virulence and expression of various
virulence factors. It remains unknown if exposure to CAT-Fe results in increased
virulence. CAT-Fe did result in the down-regulation of several well-characterized
virulence factors in the microarray, e.g. leukotoxin, cytolethal distending toxin, and pgaB.
Interestingly, pgaB was down-regulated, but CAT-Fe exposure resulted in a significant
increase in biofilm formation. The ability of bacteria to form biofilms has been linked to
disease and persistence of infection, so it is possible that although many well-
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characterized virulence factors were down-regulated, there could be an increase in
virulence in a mouse model of periodontitis. Further, there was a large overlap between
the genes that were up-regulated in the microarray to those that were up-regulated
when A. actinomycetemcomitans was grown in vivo in an abscess model. This suggests
that the ability of the bacteria to detect catecholamines is essential for its ability to
respond and adapt to the host environment.
In addition, the inflamed gingiva is most likely an environment high in
catecholamines and lactoferrin due to their release by activated neutrophils. The
exposure to CAT-Fe would lead to an activation of QseC, which has been shown to be an
important regulator of virulence in A.actinomycetemcomitans. The previous work
showing that QseC is vital for virulence in A. actinomycetemcomitans was performed
using a mouse model of periodontitis [44]. Any changes to bone loss levels is correlated
to changes in virulence. Mice could be given exogenous catecholamines in their water
prior to infection with A. actinomycetemcomitans or alternatively, the C.129Chgatm1Gnh/J strain of mice (https://www.jax.org/strain/023514) with high systemic
levels of catecholamines can be used for these studies.
Determine if QseC can be Activated by Catecholamines and Holo-Transferrin
Catecholamines have been shown to act as pseudosiderophores by being able to
scavenge iron from holo-transferrin or holo-lactoferrin [57]. QseC is activated by the
combination of catecholamines and ferrous iron, but there is little free iron in the host.
Most iron is bound by a host iron binding protein like lactoferrin or transferrin. In order
to confirm that A. actinomycetemcomitans is responding to CAT-Fe in the host by
recognizing catecholamines that have scavenged iron from lactoferrin, catecholamines
and holo-lactoferrin, instead of ferrous iron, can be added to the media to determine if it
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results in the same phenotype of QseC activation in response to CAT-Fe. Similarly, the
addition of apo-lactoferrin and catecholamines should not result in any QseC activation
since there would be no iron for the catecholamine to scavenge.
Determining the effect of A. actinomycetemcomitans on Neutrophils in Terms of
Catecholamine Release
Activated neutrophils have been reported to release catecholamines up to
millimolar amounts in response to inflammatory signals [25]. Based on this information,
we hypothesized that the CAT-Fe activating signal for QseC is from activated neutrophils
that are releasing catecholamines in response to being activated by A.
actinomycetemcomitans. However, the degree to which A. actinomycetemcomitans can
stimulate neutrophils to release catecholamines has not been extensively examined.
Therefore, it is important to demonstrate that A. actinomycetemcomitans induces
catecholamine release and at what multiplicity of infection (MOI) the release occurs at.
For this experiment, different MOI’s for A. actinomycetemcomitans will be tested against
isolated neutrophil. The mechanisms of catecholamine release by neutrophils can also
be studied.
Determining the Mechanism of Action for the D11S_2133-2134 TA system
The toxins from most type II TA systems work as endoribonucleases, either
ribosome dependent or ribosome independent [84]. D11S_2133-2134 is a putative RelElike type II TA system. Based on the growth results in E. coli with the ectopic expression
of D11S_2133 and D11S_2134, D11S_2133 is correctly annotated as a putative toxin and
D11S_2134 is the anti-toxin, but in order to confirm these labels, functional assays will
need to be performed. RelE toxins have been shown to act as endoribonucleases that
cleave between the second and third position of an upstream purine [111]. In order to
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confirm that D11S_2133 acts as endoribonuclease, then different mRNA’s with known
sequences will be incubated together with the purified toxin and then ran on a gel to
look for RNA degradation. Since some of the toxins act as ribosome dependent
nucleases then the experiment would also need to be repeated using isolated ribosomes
from A. actinomycetemcomitans.
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Table 1

Genes Differentially Regulated by Ne/FeCl2
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ID Tag
D11S_0087
D11S_0159
D11S_0160
D11S_0161
D11S_0205
D11S_0206
D11S_0207
D11S_0208
D11S_0209
D11S_0210

Product
asparagine synthetase AsnA
pts system mannose-specific eiiab component
fructose permease iic component
mannose permease iid component
cytochrome c-type protein TorC
periplasmic nitrate reductase, diheme cytochrome
ferredoxin-type protein NapH
quinol dehydrogenase periplasmic component
periplasmic nitrate reductase, large subunit
NapD protein

Fold
Change
2.9
2.99
2.39
2.1
3.05
2.94
3.36
2.74
4.92
6.69

D11S_0270
D11S_0271
D11S_0281
D11S_0303
D11S_0310
D11S_0383
D11S_0493
D11S_0494
D11S_0551
D11S_0597
D11S_0670
D11S_0810

regulatory protein RecX
protein RecA
transporter
anaerobic C4-dicarboxylate membrane transporter
fructose-1,6-bisphosphatase, class II
alkylhydroperoxidase AhpD core
anaerobic dimethyl sulfoxide reductase chain A
anaerobic dimethyl sulfoxide reductase chain B
ATP-dependent chaperone ClpB
aspartate ammonia-lyase
conserved ATP-binding protein
fumarate reductase subunit C (Fumarate reductase

2.32
2.35
2.41
2.41
2.65
4.03
2.26
2.23
2.03
6.86
2.89
2.39

Direction
up
up
up
up
up
up
up
up
up
up

P-value
5.61E-07
7.69E-06
4.84E-06
5.71E-06
3.52E-06
2.25E-06
1.20E-05
1.28E-05
7.68E-06
7.91E-07

up
up
up
up
up
up
up
up
up
up
up
up

9.40E-06
5.87E-05
1.11E-06
5.75E-05
2.19E-06
4.31E-06
1.52E-04
9.61E-06
1.37E-04
7.29E-06
0.021983
1.51E-05

rtPCR

1.9 ± 0.06

5.9 ± 0.13

12.4 ± 0.16
3.35 ± 0.07

132

D11S_0811
D11S_0812
D11S_0838
D11S_0887
D11S_0922
D11S_0939
D11S_1049
D11S_1061
D11S_1092

fumarate reductase iron-sulfur subunit
fumarate reductase flavoprotein subunit
RecN protein
cystathionine beta-lyase
chaperone protein DnaK
ImpA
probable L-ascorbate-6-phosphate lactonase UlaG
fumarate hydratase, class II
hydrogenase accessory protein HypB

2.39
3.86
2.38
2.28
2.1
2.41
2.1
2.43
1.81

up
up
up
up
up
up
up
up
up

2.15E-05
4.10E-05
1.28E-06
1.56E-04
0.001914
4.03E-04
8.44E-04
4.66E-06
3.50E-05

D11S_1093
D11S_1135
D11S_1136
D11S_1137
D11S_1269
D11S_1299
D11S_1305
D11S_1317
D11S_1330
D11S_1331
D11S_1343
D11S_1344
D11S_1345
D11S_1346
D11S_1347
D11S_1376
D11S_1379

hydrogenase expression/formation protein HypD
protein YgiW
protein QseB
protein QseC
fructosamine kinase
hypothetical protein
MacA macrolide exporter
lipoprotein HlpB
nonheme iron-containing ferritin
ferritin
AcrA protein
CcmA protein
ABC-type multidrug transport
ABC-2 type transporter
TolC protein
hydrogenase assembly chaperone HypC/HupF
oxaloacetate decarboxylase gamma chain 3

1.57
17.3
4.63
3.63
3.46
2.6
2.15
2.48
9.87
10.59
5.52
3.73
3.21
4.77
2.5
1.88
4.74

up
up
up
up
up
up
up
up
up
up
up
up
up
up
up
up
up

0.001163
4.67E-07
4.22E-04
7.24E-04
7.19E-07
5.83E-05
0.006983
3.43E-04
5.47E-05
2.38E-04
5.47E-05
3.83E-04
0.019619
0.005669
8.83E-04
6.28E-05
3.30E-07

3.1 ± 0.1

4.18 ± 0.12

13.4 ± 0.29
4.0 ± 0.21
3.4 ± 0.18

5.5 ± 0.07

19.8 ± 0.72
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D11S_1380
D11S_1381
D11S_1387
D11S_1399
D11S_1412
D11S_1413
D11S_1431
D11S_1631
D11S_1676
D11S_1735

oxaloacetate decarboxylase alpha subunit
oxaloacetate decarboxylase beta chain
hypothetical protein
dethiobiotin synthase
cytochrome c-type protein TorY
trimethylamine-n-oxide reductase 2
cold shock domain protein CspD
PqqL peptidase
cytochrome c peroxidase
[NiFe] hydrogenase maturation protein HypF

4.44
4.31
2.17
4.08
7.68
4.67
2.1
2
5.05
2.58

up
up
up
up
up
up
up
up
up
up

3.21E-07
2.69E-06
7.16E-04
2.98E-07
6.78E-09
1.97E-07
0.005718
0.028597
5.12E-07
8.83E-04

D11S_1736
D11S_1737
D11S_1738
D11S_1739
D11S_1740
D11S_1741
D11S_1742
D11S_1743
D11S_1744
D11S_1745
D11S_1746
D11S_1747
D11S_1748
D11S_1749
D11S_1763

electron transport protein HydN
hydrogenase-4 component B
hydrogenase-4 component B
hydrogenase-4 component C
hydrogenase-4 component D
hydrogenase-4 component E
hydrogenase-4 component F
hydrogenase-4 component G
hydrogenase-4 component H
hydrogenase-4 component I
hydrogenase-4 component J
hydrogenase maturation peptidase HycI
formate dehydrogenase H
formate dehydrogenase, alpha subunit
peptidase T

18.44
14.93
15.02
10.68
10.59
7.95
7.76
5.88
5.87
5.41
4.62
4.79
10.42
10.01
6.62

up
up
up
up
up
up
up
up
up
up
up
up
up
up
up

5.00E-09
1.54E-08
1.42E-09
1.60E-07
3.57E-08
5.22E-07
4.85E-08
1.38E-07
3.07E-07
5.18E-07
8.70E-08
1.03E-06
5.29E-09
5.95E-08
9.97E-08

3.6 ± 0.07

3.83 ± 0.36

134

D11S_1771
D11S_1801

C4-dicarboxylate membrane transporter
ribosomal protein L11 methyltransferase

1.73
2.24

up
up

1.02E-05
2.89E-04

D11S_1811
D11S_1888
D11S_1981
D11S_1983
D11S_1984
D11S_1986
D11S_1987

bifunctional acetaldehyde-CoA/alcohol dehydrogenase
TorCAD operon transcriptional regulatory protein
hypothetical protein
thiol-disulfide interchange protein
cytochrome c-type biogenesis protein CcmF
NrfD protein
cytochrome c nitrite reductase, Fe-S protein

2.72
1.86
2.08
3.19
3.87
11.59
13.63

up
up
up
up
up
up
up

1.04E-06
1.62E-04
3.86E-04
1.08E-04
1.84E-05
1.14E-07
4.20E-07

D11S_1988
D11S_1989
D11S_1992
D11S_1993
D11S_1994
D11S_1995
D11S_1996
D11S_1997
D11S_1998
D11S_1999
D11S_2000
D11S_2007
D11S_2125
D11S_2128
D11S_2148

cytochrome c nitrite reductase, pentaheme
nitrite reductase (cytochrome; ammonia-forming)
TPR-repeat-containing protein
cytochrome c-type biogenesis protein CcmH
thiol-disulfide interchange protein
cytochrome c-type biogenesis protein CcmF
cytochrome c-type biogenesis protein CcmE
Heme exporter protein D (CcmD)
CcmC
heme exporter protein CcmB
heme ABC exporter, ATP-binding protein CcmA
lipoprotein GNA1870
putative long-chain-fatty-acid--CoA ligase-like
anaerobic ribonucleoside-triphosphate reductase
transporter protein

17.09
18.44
1.51
1.57
2.04
2.39
2.45
2.66
3.16
2.69
3.31
6.73
2.15
2.7
1.69

up
up
up
up
up
up
up
up
up
up
up
up
up
up
up

2.38E-09
5.00E-09
0.003085
0.001409
1.71E-05
5.05E-05
3.65E-06
5.69E-07
7.34E-06
1.88E-06
1.80E-05
3.00E-07
0.0183
5.42E-04
3.68E-04

8.59 ± 0.5
2.1 ± 0.02
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D11S_2165
D11S_2171

hypothetical protein
hypothetical protein

1.87
1.63

up
up

0.007808
0.01497

D11S_0016
D11S_0017
D11S_0018
D11S_0046
D11S_0052
D11S_0083

YjjP
YjjB
hypothetical protein
multiphosphoryl transfer protein
LysR family transcriptional regulator
carbamate kinase

0.277
0.195
0.332
0.498
0.49
0.493

down
down
down
down
down
down

1.58E-06
1.42E-07
8.55E-04
5.13E-05
0.003419
5.91E-04

D11S_0084
D11S_0085
D11S_0117
D11S_0144
D11S_0152
D11S_0167
D11S_0216
D11S_0231
D11S_0260
D11S_0283
D11S_0284
D11S_0292
D11S_0301
D11S_0302
D11S_0341
D11S_0342

ornithine carbamoyltransferase
EriC protein
LapB
lipoprotein VacJ
Low affinity tryptophan permease
biofilm PGA synthesis lipoprotein PgaB
DNA transformation protein TfoX (Competence
hypothetical protein
molybdopterin biosynthesis mog protein
anhydro-N-acetylmuramic acid kinase
N-acetylmuramic acid 6-phosphate etherase
sulfur relay protein TusB/DsrH
shikimate 5-dehydrogenase
CydD
Na+/H+ antiporter NhaC
aminotransferase

0.469
0.469
0.356
0.495
0.394
0.469
0.493
0.459
0.418
0.413
0.411
0.407
0.208
0.375
0.463
0.469

down
down
down
down
down
down
down
down
down
down
down
down
down
down
down
down

5.07E-04
8.86E-05
7.35E-04
0.005554
0.021582
3.95E-06
1.99E-05
1.19E-04
0.004003
0.005207
4.20E-05
0.002779
4.22E-06
1.56E-06
0.014605
0.001164
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D11S_0343
D11S_0344
D11S_0359
D11S_0360
D11S_0397
D11S_0415
D11S_0487
D11S_0488
D11S_0489

monosaccharide-transporting ATPase
possible xylose ABC superfamily ATP binding
RfaL protein
CrcB protein
RNA methyltransferase, TrmH family, group 3
excinuclease ABC subunit B
TonB-system energizer ExbB
TonB system transport protein ExbD
protein TonB

0.472
0.485
0.422
0.373
0.465
0.357
0.208
0.223
0.229

down
down
down
down
down
down
down
down
down

0.003003
3.87E-05
1.15E-04
3.08E-04
2.63E-06
0.00117
1.30E-05
4.29E-06
6.56E-06

D11S_0621
D11S_0622
D11S_0664
D11S_0671
D11S_0694
D11S_0785
D11S_0815
D11S_0816
D11S_0817
D11S_0818
D11S_0858
D11S_0859
D11S_0860
D11S_0861
D11S_0867
D11S_0868
D11S_0869

iron(III)-transport system permease protein FbpB
ferric iron binding protein
CpxA two component sensor
O-methyltransferase N-terminus family protein
adenylate cyclase, class I
cell division protein FtsW
iron(III) dicitrate transport ATP-binding
ABC transporter, iron chelate uptake transporter
iron(III) dicitrate transport system permease
iron(III) dicitrate-binding periplasmic protein
citrate lyase, alpha subunit
citrate lyase beta chain
citrate lyase acyl carrier protein
[citrate (pro-3S)-lyase] ligase
peptidase B (Aminopeptidase B)
nucleoside diphosphate kinase
Chb protein

0.182
0.195
0.442
0.341
0.426
0.422
0.123
0.108
0.166
0.157
0.498
0.375
0.448
0.474
0.167
0.325
0.202

down
down
down
down
down
down
down
down
down
down
down
down
down
down
down
down
down

1.94E-05
1.30E-07
0.003331
0.001208
1.43E-04
0.007201
2.42E-05
1.72E-04
6.78E-06
1.05E-06
2.92E-04
0.009593
0.001633
3.56E-05
2.69E-05
1.15E-05
7.10E-04

FeS assembly protein IscX
ferredoxin, 2Fe-2S type, ISC system
Fe-S protein assembly chaperone HscA
Fe-S protein assembly co-chaperone HscB
iron-sulfur cluster assembly protein IscA
FeS cluster assembly scaffold IscU
cysteine desulfurase IscS
sugar efflux transporter
relaxase
CDP-diacylglycerol--glycerol-3-phosphate
NlpC cell wall peptidase

0.284
0.282
0.325
0.326
0.345
0.417
0.444
0.481
0.448
0.5
0.378

down
down
down
down
down
down
down
down
down
down
down

6.02E-07
2.33E-05
2.88E-06
3.42E-05
1.45E-05
7.31E-05
1.03E-04
0.003058
8.83E-04
5.96E-04
4.21E-04

D11S_0977
D11S_0993
D11S_0994
D11S_0995
D11S_0999
D11S_1067
D11S_1097
D11S_1125
D11S_1128
D11S_1129
D11S_1130
D11S_1131
D11S_1147
D11S_1179
D11S_1219

hypothetical protein
thiamine-monophosphate kinase
phosphatidylglycerophosphatase A
threonine efflux protein
hypothetical protein
hypothetical protein
5,10-methylenetetrahydrofolate reductase
high-affinity zinc uptake system membrane
iron(III) dicitrate transport ATP-binding
iron(III) transport system permease protein
putative iron/heme permease
putative periplasmic siderophore binding protein
CRISPR-associated helicase Cas3
tRNA(Ile)-lysidine synthase
3-deoxy-D-manno-octulosonate

0.216
0.5
0.448
0.449
0.425
0.268
0.5
0.37
0.215
0.331
0.23
0.143
0.418
0.398
0.5

down
down
down
down
down
down
down
down
down
down
down
down
down
down
down

9.38E-04
0.001987
0.006652
1.64E-04
0.01952
9.22E-04
4.21E-04
0.001867
3.94E-05
0.001976
4.24E-04
5.47E-05
0.027601
0.002894
0.002824
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D11S_0873
D11S_0874
D11S_0875
D11S_0876
D11S_0877
D11S_0878
D11S_0879
D11S_0890
D11S_0902
D11S_0916
D11S_0930

0.59 ± 0.02
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D11S_1226
D11S_1227
D11S_1235
D11S_1238
D11S_1265
D11S_1322
D11S_1324
D11S_1325
D11S_1332

hypothetical protein
phosphate acetyltransferase
tellurite resistance protein TehB
dihydrolipoyl dehydrogenase
Ndh NADH dehydrogenase
chromosome partition protein MukE (Protein
cell division protein MukB
exodeoxyribonuclease I
hypothetical protein

0.332
0.417
0.439
0.465
0.379
0.402
0.412
0.446
0.486

down
down
down
down
down
down
down
down
down

3.75E-04
0.003227
0.010619
2.09E-04
2.17E-04
0.002735
0.005851
2.55E-04
0.00174

D11S_1334
D11S_1360
D11S_1370
D11S_1457
D11S_1519
D11S_1557
D11S_1558
D11S_1559
D11S_1560
D11S_1561
D11S_1562
D11S_1563
D11S_1564
D11S_1601
D11S_1602
D11S_1604
D11S_1630
D11S_1635

UspA universal stress protein
DoxX family protein
anthranilate synthase component I
ATP-dependent DNA helicase RecG
RhaT permease
high-affinity Fe2+/Pb2+ permease
high affinity Fe2+ transporter
putative Fe2+ permease
FtsX-like permease
membrane permease component
macrolide export ATP-binding/permease protein
ResA
cytochrome c-553
hypothetical protein
putative translation initiation inhibitor, YjgF
hypothetical protein
putative TonB-dependent iron receptor
MetR

0.476
0.405
0.436
0.417
0.385
0.245
0.122
0.138
0.156
0.165
0.069
0.183
0.157
0.443
0.357
0.515
0.48
0.365

down
down
down
down
down
down
down
down
down
down
down
down
down
down
down
down
down
down

7.38E-04
4.67E-04
0.017378
4.29E-04
0.026275
3.03E-04
1.28E-05
4.81E-05
3.33E-04
2.62E-05
0.001665
4.38E-04
3.79E-05
5.93E-04
1.23E-04
1.73E-05
0.008308
0.002098
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D11S_1636
D11S_1643
D11S_1644
D11S_1652
D11S_1668
D11S_1685
D11S_1686
D11S_1694

5-methyltetrahydropteroyltriglutamate-AfeC periplasmic iron binding protein
acyl phosphatase
protein-(glutamine-N5) methyltransferase,
lipid A biosynthesis lauroyl acyltransferase
cysteine/glutathione ABC transporter
ABC transporter, CydDC cysteine exporter
hypothetical protein

0.5
0.403
0.404
0.481
0.362
0.435
0.41
0.213

down
down
down
down
down
down
down
down

0.001143
8.22E-04
8.62E-05
0.003915
0.003732
8.63E-04
0.002955
3.94E-05

D11S_1729
D11S_1730
D11S_1731
D11S_1769
D11S_1792
D11S_1793
D11S_1800
D11S_1809
D11S_1819
D11s_1820
D11S_1827
D11S_1843
D11S_1844
D11S_1864
D11S_1954
D11S_1973
D11S_1974

formate dehydrogenase, alpha subunit
formate dehydrogenase, alpha subunit
formate dehydrogenase, alpha subunit
Hypothetical protein
histidinol-phosphate aminotransferase
3-phosphoshikimate 1-carboxyvinyltransferase
cupin 2, conserved barrel
heme acquisition system receptor
LtxA
LtxC
ribosomal-protein-alanine acetyltransferase
cytochrome D ubiquinol oxidase, subunit II
cytochrome D ubiquinol oxidase subunit 1
outer membrane protein 64
23S rRNA (uracil-5-)-methyltransferase RumB
DNA polymerase III, beta subunit
DNA replication and repair protein RecF

0.287
0.467
0.524
0.413
0.319
0.355
0.459
0.463
0.482
0.48
0.472
0.341
0.4
0.106
0.5
0.48
0.455

down
down
down
down
down
down
down
down
down
down
down
down
down
down
down
down
down

0.001835
0.001382
0.007025
0.01957
0.004321
8.83E-04
0.002002
1.04E-04
0.020787
3.43E-04
1.05E-04
8.53E-05
6.65E-04
2.40E-05
0.001068
1.38E-04
0.004321

D11S_1975
D11S_2018
D11S_2029
D11S_2050
D11S_2052
D11S_2056
D11S_2060
D11S_2061
D11S_2118
D11S_2154

methyltransferase domain family
menaquinone-specific isochorismate synthase
hypothetical protein
type I modification enzyme
YaeB
conserved transporter, NadC family
glycerate kinase
transporter, gluconate:H+ symporter
glycosyltransferase sugar-binding region
fatty acid/phospholipid synthesis protein PlsX

0.305
0.457
0.471
0.442
0.5
0.271
0.461
0.426
0.424
0.429

down
down
down
down
down
down
down
down
down
down

2.48E-04
0.01013
0.004366
5.17E-06
4.17E-04
5.47E-05
7.80E-04
6.44E-04
0.005345
2.01E-04
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ID Tag
D11S_0016

Appendix Table 2: Genes Differentially Regulated in ΔqseB
Product
YjjP

D11S_0136

Putative transposase

2.95 up

D11S_0146

heat shock protein HslVU, ATPase subunit HslU

8.24 up

D11S_0147

ATP-dependent protease peptidase subunit

8.15 up

D11S_0171

regulatory protein UhpC

2.29 up

D11S_0204

bifunctional glutathionylspermidine

2.71 up

D11S_0278

transposase

2.88 up

D11S_0279

deoxyribose-phosphate aldolase

2.53 up

D11S_0281
D11S_0297

transporter
hypothetical

2.22 up
2.04 up

D11S_0298
D11S_0310
D11S_0361
D11S_0420
D11S_0460
D11S_0461
D11S_0480
D11S_0551
D11S_0578
D11S_0599
D11S_0600
D11S_0651

hybrid peroxiredoxin hyPrx5 (Thioredoxin
fructose-1,6-bisphosphatase, class II
protein cof
methyltransferase domain family
hypothetical
preprotein translocase subunit SecA
MerR family transcriptional regulator
ATP-dependent chaperone ClpB
hypothetical
chaperonin GroS
chaperonin GroEL
transcriptional repressor protein MetJ

2.58
2.43
2.16
2.06
2.23
2.15
2.28
14.5
2.33
5.36
7.15
2.03

Fold Change
Direction
3.07 up

up
up
up
up
up
up
up
up
up
up
up
up

universal stress protein A
putative outer membrane protein
phosphoenolpyruvate carboxykinase
MclA
RNA polymerase sigma factor RpoE
heat shock protein 90
fumarate reductase
preprotein translocase subunit SecG
hypothetical
heat shock protein GrpE
5-methylaminomethyl-2-thiouridine methyltransferase

D11S_0893
D11S_0894
D11S_0922
D11S_1049
D11S_1050
D11S_1051
D11S_1061
D11S_1070
D11S_1087
D11S_1104
D11S_1114
D11S_1132
D11S_1162

curved DNA-binding protein
MerR family regulatory protein
molecular chaperone DnaK
putative L-ascorbate 6-phosphate lactonase
transcriptional repressor UlaR
putative L-xylulose 5-phosphate 3-epimerase
fumarate hydratase
HTH-type transcriptional regulator HipB
putative periplasmic binding protein CbiK
ModE
malate dehydrogenase
bifunctional 2',3'-cyclic nucleotide 2'-phosphodiesterase/3'-nucleotidase periplasmic protein
protein YegP

2.17
2.04
2.49
4.8
4.3
11.32
2.14
2.15
3.47
6.96
2.28

up
up
up
up
up
up
up
up
up
up
up

3.48
2.9
8.91
4.03
2.45
2.01
2.12
2.27
2.2
2.14
2.21
2.12
4.36

up
up
up
up
up
up
up
up
up
up
up
up
up
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D11S_0656
D11S_0687
D11S_0689
D11S_0738
D11S_0739
D11S_0795
D11S_0812
D11S_0824
D11S_0840
D11S_0841
D11S_0843
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D11S_1163
D11S_1192
D11S_1269
D11S_1331
D11S_1387
D11S_1412
D11S_1414
D11S_1415
D11S_1443
D11S_1444
D11S_1445
D11S_1447
D11S_1480

PTS system maltose and glucose-specific transporter subunit IIBC
putative integrase
fructosamine kinase
ferritin
tryptophan synthase subunit alpha
cytochrome c-type protein TorY
MmcQ protein
CitT protein
MsmK
ATP-dependent metallopeptidase HflB
ribosomal RNA large subunit methyltransferase J
H-NS histone family
DNA mismatch repair protein

2.53
2.4
2.18
2.52
2.61
2.14
2.03
2.5
2.15
3.1
3.37
2.82
2.16

up
up
up
up
up
up
up
up
up
up
up
up
up

D11S_1522
D11S_1662
D11S_1674
D11S_1676
D11S_1735
D11S_1763
D11S_1770
D11S_1771
D11S_1789
D11S_1798
D11S_1799
D11S_1800
D11S_1801

ATP-dependent protease La
hypothetical
hypothetical
cytochrome c peroxidase
hydrogenase maturation protein HypF
peptidase T
seryl-tRNA synthetase
C4-dicarboxylate membrane transporter
hypothetical
Stability protein StbD
putative relE protein
cupin 2
hypothetical (? ribosomal protein L11 methyltransferase?)

4.51
2.23
3.12
4.57
2.11
3.94
2.16
2.15
2.04
2.41
2.13
3.08
2.27

up
up
up
up
up
up
up
up
up
up
up
up
up
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D11S_1822
D11S_1870
D11S_1888
D11S_1911
D11S_1949
D11S_1989
D11S_2007
D11S_2022
D11S_2024
D11S_2047
D11S_2067
D11S_2078
D11S_2165

lipoprotein
hypothetical
TorCAD operon transcriptional regulatory protein
fructose-1,6-bisphosphatase
formate acetyltransferase
nitrite reductase (cytochrome; ammonia-forming)
lipoprotein
S-adenosylmethionine synthetase
serine transporter
copper-translocating P-type ATPase
EbgC protein
sigma 54 modulation protein/ribosomal protein S30EA
hypothetical

D11S_2175
D11S_2183
D11S_2184
D11S_2185
D11S_0039
D11S_0040
D11S_0046
D11S_0047
D11S_0060
D11S_0064
D11S_0101
D11S_0156

hypothetical
I protein
Mu-like phage G protein 1
f protein
DNA Polymerase I
tRNA (uracil-5-)-methyltransferase
multiphosphoryl transfer protein
1-phosphofructokinase
hypothetical
DNA-directed RNA polymerase, beta subunit
Trk system potassium uptake protein TrkA
tryptophanyl-tRNA synthetase

2.32
2.19
3.43
2.81
2.47
2.18
3.28
2.67
2.12
2.36
2.35
3.49
3.39

2.58
2.71
2.74
3.47
0.327
0.435
0.278
0.354
0.381
0.477
0.428
0.436

up
up
up
up
up
up
up
up
up
up
up
up
up

up
up
up
up
down
down
down
down
down
down
down
down

biofilm PGA synthesis lipoprotein PgaB
PnuC transporter
ATP-dependent DNA helicase Rep
UDP-3-O-[3-hydroxymyristoyl] glucosamine
anhydro-N-acetylmuramic acid kinase
N-acetylmuramic acid 6-phosphate etherase
sulfur relay protein TusB/DsrH
sulfur relay protein TusC/DsrF
glycerol-3-phosphate dehydrogenase (NAD(P)+)
F0F1 ATP synthase subunit gamma
F0F1 ATP synthase subunit beta
ATP synthase F1, epsilon subunit

0.404
0.478
0.344
0.495
0.406
0.396
0.332
0.452
0.402
0.466
0.463
0.48

down
down
down
down
down
down
down
down
down
down
down
down

D11S_0370
D11S_0372
D11S_0415
D11S_0422
D11S_0423
D11S_0424
D11S_0434
D11S_0444
D11S_0455
D11S_0520
D11S_0530
D11S_0531
D11S_0532

2-C-methyl-D-erythritol 4-phosphate
tRNA pseudouridine synthase D
excinuclease ABC subunit B
acriflavine resistance protein
AcrA protein
AcrR protein
formamidopyrimidine-DNA glycosylase
cAMP-regulatory protein
DNA adenine methylase
aspartate racemase
hypothetical
outer membrane lipoprotein carrier protein LolA
thioesterase

0.355
0.366
0.247
0.338
0.296
0.254
0.294
0.494
0.45
0.452
0.362
0.485
0.381

down
down
down
down
down
down
down
down
down
down
down
down
down
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D11S_0167
D11S_0180
D11S_0192
D11S_0250
D11s_0283
D11S_0284
D11S_0292
D11S_0293
D11S_0306
D11S_0323
D11S_0324
D11S_0325
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D11S_0533
D11S_0534
D11S_0535
D11S_0536
D11S_0588
D11S_0589
D11S_0594
D11S_0607
D11S_0608
D11S_0609
D11S_0619
D11S_0623
D11S_0652
D11S_0751

glycosyl transferase, family 2
glycosyl transferase, group 2 family protein
AMP-binding enzyme family protein
integral membrane protein
drug/metabolite exporter family transporter
drug/metabolite exporter family transporter
hypothetical
diacylglycerol kinase
GTP pyrophosphokinase
23S rRNA 5-methyluridine methyltransferase
tRNA-dihydrouridine synthase C
hypothetical
UTP-glucose-1-phosphate uridylyltransferase
hypothetical

0.25
0.242
0.286
0.402
0.376
0.358
0.487
0.433
0.492
0.121
0.358
0.5
0.329
0.314

down
down
down
down
down
down
down
down
down
down
down
down
down
down

D11S_0815
D11S_0816
D11S_0817
D11S_0822
D11S_0823
D11S_0831
D11S_0856
D11S_0857
D11S_0858
D11S_0859
D11S_0891
D11S_0909

iron-dicitrate transporter ATP-binding subunit
subunit FecD
iron-dicitrate transporter permease subunit
DNA topoisomerase III
hypothetical
intracellular septation protein A
inner membrane protein YbhI
citrate lyase subunit alpha
citrate lyase subunit beta
gamma
sugar efflux transporter
cytolethal distending toxin protein B

0.177
0.229
0.267
0.487
0.418
0.41
0.248
0.257
0.259
0.176
0.478
0.458

down
down
down
down
down
down
down
down
down
down
down
down

cytolethal distending toxin protein C
CDP-diacylglycerol--glycerol-3-phosphate 3-phosphatidyltransferase
protein-(glutamine-N5) methyltransferase
dipeptide transport system permease DppC
tRNA delta(2)-isopentenylpyrophosphate transferase
hypothetical
hypothetical
glycosyl transferase, family 2
putative inner membrane protein
integral membrane protein
outer membrane-specific lipoprotein transporter subunit LolE
thiamine-monophosphate kinase

D11S_0994
D11S_0995
D11S_1039
D11S_1066
D11S_1067
D11s_1075
D11S_1096
D11S_1123
D11S_1128
D11S_1136
D11S_1179
D11S_1191
D11S_1210
D11S_1218

phosphatidylglycerophosphatase A
threonine efflux protein
sulfate/thiosulfate import ATP-binding protein CysA
valyl-tRNA synthetase
hypothetical
exoribonuclease II
shikimate 5-dehydrogenase
endonuclease III
iron(III) dicitrate transport ATP-binding protein FecE
QseB
tRNA(Ile)-lysidine synthase
putative tail fiber assembly protein
putative DNA repair ATPase
excinuclease ABC subunit C

0.462
0.35
0.386
0.442
0.478
0.433
0.202
0.215
0.197
0.13
0.447
0.408

down
down
down
down
down
down
down
down
down
down
down
down

0.341
0.335
0.397
0.465
0.227
0.418
0.412
0.486
0.315
0.059
0.473
0.465
0.462
0.411

down
down
down
down
down
down
down
down
down
down
down
down
down
down
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D11S_0910
D11S_0916
D11S_0928
D11S_0951
D11S_0960
D11S_0964
D11S_0965
D11S_0966
D11S_0967
D11S_0968
D11S_0985
D11S_0993
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D11S_1219
D11S_1220
D11S_1221
D11S_1225
D11S_1227
D11S_1232
D11S_1261
D11S_1304
D11S_1307
D11S_1324
D11s_1338
D11S_1353
D11S_1389

3-deoxy-manno-octulosonate cytidylyltransferase
hypothetical
tetraacyldisaccharide 4'-kinase
poly A polymerase
phosphate acetyltransferase
4-alpha-glucanotransferase
hypothetical
ABC transporter-like protein
hypothetical
cell division protein MukB
dihydroorotate dehydrogenase 2
TonB dependent outer membrane siderophore receptor protein
ribonucleoside-diphosphate reductase subunit beta

0.38
0.447
0.378
0.362
0.219
0.054
0.493
0.393
0.376
0.332
0.337
0.471
0.421

down
down
down
down
down
down
down
down
down
down
down
down
down

D11S_1419
D11S_1423
D11S_1424
D11S_1437
D11S_1455
D11S_1456
D11S_1457
D11S_1479
D11S_1500
D11S_1501
D11S_1524
D11S_1530
D11S_1568

tRNA pseudouridine synthase A
tellurite resistance protein TehB
exodeoxyribonuclease V subunit alpha
two component Fis family transcriptional regulator
glutamate racemase
chorismate--pyruvate lyase
ATP-dependent DNA helicase RecG
UDP-N-acetylglucosamine 1-carboxyvinyltransferase
threonine synthase
putative 4'-phosphopantetheinyl transferase
DNA primase
NAD-dependent DNA ligase LigA
putative inner membrane protein

0.303
0.372
0.31
0.376
0.442
0.376
0.492
0.46
0.387
0.277
0.496
0.398
0.366

down
down
down
down
down
down
down
down
down
down
down
down
down
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D11S_1574
D11S_1575
D11S_1598
D11S_1606
D11S_1607
D11S_1608
D11S_1611
D11S_1640
D11S_1653
D11S_1654
D11S_1664
D11S_1686
D11S_1700

FAD linked oxidase
esterase YdiI
DNA topoisomerase IV subunit A
hypothetical
DNA polymerase III subunit tau
hypothetical
inner membrane protein YfcA
sulfurtransferase TusE
transketolase, central region
transketolase, N- subunit
protein ParB
cysteine/glutathione ABC transporter membrane/ATP-binding protein
hypothetical

0.398
0.288
0.335
0.389
0.342
0.454
0.497
0.398
0.363
0.36
0.624
0.395
0.451

down
down
down
down
down
down
down
down
down
down
down
down
down

D11S_1701
D11S_1702
D11S_1704
D11S_1709
D11S_1749
D11S_1758
D11S_1780

glycosyltransferase
exopolysaccharide production protein EXOZ
lipopolysaccharide biosynthesis protein
hypothetical
formate dehydrogenase subunit alpha
periplasmic protein
SH3 domain-containing protein
multifunctional tRNA nucleotidyl transferase/2'3'-cyclic
phosphodiesterase/2'nucleotidase/phosphatase
outer membrane lipoprotein LolB
4-diphosphocytidyl-2-C-methyl-D-erythritol kinase
heme acquisition system receptor
putative transposase

0.273
0.479
0.417
0.427
0.44
0.455
0.339

down
down
down
down
down
down
down

0.257
0.26
0.231
0.387
0.491

down
down
down
down
down

D11S_1781
D11S_1782
D11S_1783
D11S_1809
D11S_1860

hypothetical
ThiF family protein
23S rRNA (uracil-5-)-methyltransferase RumB
23S rRNA methyluridine methyltransferase
ribonuclease P protein component
hypothetical
thiol-disulfide interchange protein
cytochrome c-type biogenesis protein CcmF
TPR-repeat-containing protein
acyl-CoA thioester hydrolase YfbB
4-hydroxy-3-methylbut-2-en-1-yl diphosphate synthase

0.448
0.465
0.492
0.272
0.5
0.431
0.498
0.443
0.497
0.339
0.372

down
down
down
down
down
down
down
down
down
down
down

D11S_2031
D11S_2072
D11S_2082
D11S_2083
D11S_2084
D11S_2085
D11S_2086
D11S_2093
D11S_2094
D11S_2102
D11S_2112
D11S_2131
D11S_2147
D11S_2154

histidyl-tRNA synthetase
PilC
ribosomal protein L11 methyltransferase
sodium/panthothenate symporter
sodium/panthothenate symporter
acetyl-CoA carboxylase biotin carboxylase subunit
chromosomal replication initiation protein
O-succinylbenzoate synthase
DNA polymerase, beta domain-containing protein
tRNA-specific adenosine deaminase
cold-shock DNA-binding domain-containing protein
anaerobic ribonucleotide reductase-activating protein
transcription termination factor Rho
putative glycerol-3-phosphate acyltransferase PlsX

0.331
0.44
0.459
0.366
0.402
0.448
0.409
0.411
0.468
0.402
0.475
0.463
0.368
0.469

down
down
down
down
down
down
down
down
down
down
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